https://currentrheuma.com/studies/16s-rna-based-metagenomics-reveal-previously-unreported-gut-microbiota-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/2019-eular-acr-classification-criteria-for-sle-score-predicts-future-lupus-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/2023-acr-eular-classification-criteria-in-existing-research-cohorts-an-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/2023-american-college-rheumatology-acr-american-college-chest-physicians-chest-2024-2/2026-11-04T03:05:02Z https://currentrheuma.com/studies/2023-american-college-rheumatology-acr-american-college-chest-physicians-chest-2024-3/2026-11-04T02:57:06Z https://currentrheuma.com/studies/2023-american-college-rheumatology-acr-american-college-chest-physicians-chest-2024-4/2026-11-04T02:57:06Z https://currentrheuma.com/studies/2023-american-college-rheumatology-acr-american-college-chest-physicians-chest-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/2023-eular-classification-criteria-for-hand-osteoarthritis-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/2023-eular-recommendations-for-the-management-of-fatigue-in-people-with-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/2023-eular-recommendations-on-imaging-in-diagnosis-and-management-of-crystal-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/2024-update-of-the-recommendations-of-the-french-society-of-rheumatology-for-the-2024/2026-11-04T00:06:14Z https://currentrheuma.com/studies/5-hydroxymethylcytosine-in-circulating-cell-free-dna-as-a-potential-diagnostic-2024/2026-11-04T00:09:46Z https://currentrheuma.com/studies/68ga-fapi-and-18f-naf-pet-ct-in-psoriatic-arthritis-a-comparative-study-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/a-12-month-follow-up-study-of-patients-with-systemic-lupus-erythematosus-after-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/a-charter-to-improve-care-for-systemic-lupus-erythematosus-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/a-co-produced-patient-reported-outcomes-driven-dashboard-to-support-shared-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/a-comparison-of-foot-fractures-relative-to-other-fragility-fractures-a-review-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/a-comprehensive-meta-analysis-of-risk-factors-associated-with-osteosarcopenic-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/a-deep-dive-into-monogenic-lupus-insights-on-dnase1l3-mutation-2024/2026-11-03T13:56:47Z https://currentrheuma.com/studies/a-direct-comparison-in-diagnostic-performance-of-cdus-fdg-pet-ct-and-mri-in-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/a-double-blind-placebo-controlled-randomized-multiple-dose-phase-1b-trial-of-a-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/a-genome-wide-association-study-suggests-new-susceptibility-loci-for-primary-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/a-high-polygenic-risk-score-is-associated-with-ssa-ssb-antibody-positivity-and-2024/2026-11-03T13:56:47Z https://currentrheuma.com/studies/a-large-scale-multi-omics-polygenic-risk-score-analysis-identified-candidate-2024/2026-11-04T00:06:14Z https://currentrheuma.com/studies/a-machine-learning-based-prediction-model-for-gout-in-hyperuricemics-a-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/a-meta-analysis-of-previous-falls-and-subsequent-fracture-risk-in-cohort-studies-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/a-mobile-app-to-support-self-management-and-remotely-monitor-disease-impact-in-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/a-multilayered-post-genome-wide-association-study-analysis-pipeline-defines-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/a-multinational-survey-investigating-the-unmet-needs-and-patient-perspectives-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/a-multiomic-analysis-to-identify-drivers-of-subclinical-vascular-disease-in-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/a-multiparametric-risk-table-for-loss-of-clinical-remission-status-in-patients-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/a-multivariable-prediction-model-to-identify-anti-ccp-positive-people-in-those-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/a-new-hip-fracture-risk-index-derived-from-fea-computed-proximal-femur-fracture-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/a-new-instrument-for-the-screening-of-psoriatic-arthritis-among-psoriatic-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/a-non-invasive-model-for-diagnosis-of-primary-sjogrens-disease-based-on-salivary-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/a-novel-long-noncoding-rna-enst00000597482-serves-as-a-potential-biomarker-for-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/a-novel-method-to-monitor-rheumatoid-arthritis-prevalence-using-hospital-and-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/a-novel-nomogram-based-on-the-identification-of-strem2-as-a-biomarker-to-predict-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/a-novel-scoring-system-based-on-sil-2r-for-predicting-ivig-resistance-in-chinese-2024/2026-11-04T03:21:42Z https://currentrheuma.com/studies/a-novel-ultrasound-based-score-for-assessing-carotid-artery-activity-in-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/a-path-to-glucocorticoid-stewardship-a-critical-review-of-clinical-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/a-patient-centred-assessment-of-the-2016-acr-eular-myositis-response-criteria-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/a-phase-2-trial-investigating-the-efficacy-and-safety-of-the-mpges-1-inhibitor-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/a-phase-2b-double-blind-placebo-controlled-randomized-clinical-trial-of-sb-061-2024/2026-11-04T03:22:35Z https://currentrheuma.com/studies/a-pilot-trial-of-integrating-the-patient-reported-outcome-measurement-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/a-population-based-analysis-of-rheumatology-care-patterns-for-inflammatory-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/a-predictive-model-for-progression-to-clinical-arthritis-in-at-risk-individuals-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/a-proposed-clinical-tool-to-identify-high-risk-patients-for-monogenic-lupus-a-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/a-prospective-observational-study-of-disease-severity-and-mortality-in-hispanic-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/a-protocol-for-targeted-b-lymphocyte-depletion-for-the-treatment-of-igg4-related-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/a-qualitative-investigation-of-the-experiences-of-patients-living-with-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/a-qualitative-study-of-facilitators-of-medication-adherence-in-systemic-lupus-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/a-randomized-controlled-educational-study-to-evaluate-an-e-learning-module-to-2024/2026-11-04T00:12:21Z https://currentrheuma.com/studies/a-rare-disease-with-many-faces-a-multicentre-registry-of-igg4-related-disease-in-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/a-real-world-analysis-of-weather-variation-on-disease-activity-and-patient-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/a-retrospective-evaluation-of-glucagon-like-peptide-1-receptor-agonists-in-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/a-secukinumab-dose-escalation-study-in-patients-with-ankylosing-spondylitis-not-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/a-simple-clinically-usable-whole-body-mri-system-of-joint-assessment-in-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/a-single-dose-of-anakinra-for-arresting-familial-mediterranean-fever-attacks-a-2024/2026-11-03T11:13:22Z https://currentrheuma.com/studies/a-stratification-approach-based-on-salivary-gland-ultrasonography-for-assessing-2024/2026-11-03T07:58:52Z https://currentrheuma.com/studies/a-strong-dysregulated-myeloid-component-in-the-epigenetic-landscape-of-systemic-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/a-systematic-review-of-patient-reported-outcome-measures-in-patients-with-anti-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/a-treatment-algorithm-for-familial-mediterranean-fever-patients-with-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/a-validation-of-register-derived-diagnoses-of-interstitial-lung-disease-in-2024/2026-11-04T09:23:05Z https://currentrheuma.com/studies/abatacept-and-non-melanoma-skin-cancer-in-patients-with-rheumatoid-arthritis-a-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/abatacept-and-tofacitinib-in-refractory-sarcoidosis-drug-survival-safety-and-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/abatacept-in-individuals-at-high-risk-of-rheumatoid-arthritis-apippra-a-2024/2026-11-04T09:33:34Z https://currentrheuma.com/studies/abatacept-inhibits-inflammation-onset-rheumatoid-arthritis-individuals-at-high-2024/2026-11-04T09:33:34Z https://currentrheuma.com/studies/aberrant-phenotypes-of-circulating-t-cells-may-be-involved-in-the-onset-of-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/abo-blood-groups-and-increased-risk-for-the-development-of-vascular-involvement-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/accrual-of-organ-damage-and-one-year-mortality-in-systemic-sclerosis-a-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/acetabular-dysplasia-risk-developing-hip-osteoarthritis-within-4-8-years-2024/2026-11-04T00:13:14Z https://currentrheuma.com/studies/achieving-low-lupus-disease-activity-state-systemic-lupus-erythematosus-disease-2024/2026-11-04T00:09:46Z https://currentrheuma.com/studies/activated-phosphoinositide-3-kinase-syndrome-caused-by-pik3cd-mutations-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/activation-circulating-tfh17-cells-associated-activated-naive-double-negative-2-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/acute-coronary-syndrome-in-calcium-pyrophosphate-deposition-disease-patients-a-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/acute-kidney-injury-an-underrecognized-feature-of-vexas-syndrome-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/adamts13-and-insulin-resistance-in-systemic-sclerosis-patients-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/add-on-sirolimus-for-the-treatment-of-mild-or-moderate-systemic-lupus-2024/2026-11-04T09:26:49Z https://currentrheuma.com/studies/added-value-of-the-salivary-gland-ultrasonography-omeract-score-in-the-acr-eular-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/addition-of-constitutional-symptoms-to-the-sledai-2k-improves-overall-disease-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/adeno-associated-virus-type-5-infection-via-pdgfr-is-associated-interstitial-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/adenosine-metabolic-signature-in-circulating-cd4-t-cells-predicts-remission-in-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/adherence-and-treat-to-target-benchmarks-in-older-adults-with-gout-initiating-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/adherence-to-healthy-and-unhealthy-plant-based-diets-and-the-risk-of-gout-2024/2026-11-04T06:21:48Z https://currentrheuma.com/studies/adherence-to-low-dose-methotrexate-in-children-with-juvenile-idiopathic-2024/2026-11-04T06:16:46Z https://currentrheuma.com/studies/adolescent-health-care-needs-and-relationship-to-disease-in-patients-with-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/adult-onset-stills-disease-analysis-of-a-monocentric-cohort-of-patients-2024/2026-11-04T06:09:55Z https://currentrheuma.com/studies/advancing-basic-and-translational-science-highlights-from-the-basic-science-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/advancing-composite-outcome-measures-insights-on-weighting-components-from-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/adverse-cardiovascular-events-in-rheumatoid-arthritis-patients-treated-with-jak-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/age-at-first-fracture-and-later-fracture-risk-in-older-adults-undergoing-2024/2026-11-04T00:16:14Z https://currentrheuma.com/studies/age-dependent-variations-in-kawasaki-disease-incidence-in-japan-2024/2026-11-04T09:34:58Z https://currentrheuma.com/studies/ages-reykjavik-refracture-and-mortality-risk-in-the-elderly-with-osteoporotic-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/agreement-between-child-and-parent-reported-orofacial-symptoms-in-patients-with-2024/2026-11-04T00:05:39Z https://currentrheuma.com/studies/agreement-between-local-and-central-anti-synthetase-antibodies-detection-results-2024/2026-11-04T09:24:09Z https://currentrheuma.com/studies/agreement-between-patient-reported-flares-clinically-significant-flare-status-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/air-pollution-genetic-susceptibility-and-risk-of-incident-systemic-lupus-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/alendronate-preserves-bone-mineral-density-in-adults-with-sickle-cell-disease-2024/2026-11-04T00:13:51Z https://currentrheuma.com/studies/alignment-of-contraception-use-with-the-acr-reproductive-health-guidelines-in-2024/2026-11-04T03:18:08Z https://currentrheuma.com/studies/allogeneic-haematopoietic-stem-cell-transplantation-children-refractory-systemic-2024/2026-11-03T23:51:04Z https://currentrheuma.com/studies/allogeneic-umbilical-cord-derived-mesenchymal-stromal-cells-as-treatment-2024/2026-11-03T23:51:04Z https://currentrheuma.com/studies/allogenic-bone-marrow-derived-mesenchymal-stromal-cell-based-therapy-chronic-low-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/alterations-in-compositional-and-cellular-properties-of-the-subchondral-bone-are-2024/2026-11-04T09:31:04Z https://currentrheuma.com/studies/alterations-of-the-microbiome-across-body-sites-in-systemic-lupus-erythematosus-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/altered-dynamic-functional-network-connectivity-in-rheumatoid-arthritis-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/altered-plasma-levels-and-tissue-expression-of-fibroblast-activation-protein-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/altered-serum-metabolome-as-an-indicator-of-paraneoplasia-or-concomitant-cancer-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/altered-structural-and-functional-homotopic-connectivity-associated-with-2024/2026-11-04T00:09:46Z https://currentrheuma.com/studies/ambulatory-blood-pressure-in-patients-with-rheumatoid-arthritis-association-with-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/american-college-of-rheumatology-and-food-and-drug-administration-summit-summary-2024/2026-11-04T05:52:08Z https://currentrheuma.com/studies/amino-acids-fueling-fibroblast-like-synoviocyte-activation-and-arthritis-by-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/among-people-on-osteoporosis-medication-loss-of-appendicular-or-total-body-lean-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/amplified-type-i-interferon-response-sjogrens-disease-via-ectopic-toll-like-2024/2026-11-04T05:52:08Z https://currentrheuma.com/studies/an-artificial-intelligence-based-gout-management-system-reduced-chronic-kidney-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/an-electronic-health-record-ehr-based-risk-calculator-can-predict-fractures-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/ana-associated-arthritis-clinical-and-biomarker-characterization-of-a-population-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/ana-positive-ana-negative-antiphospholipid-antibody-positive-results-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/analysis-of-5-year-hospitalization-data-of-patients-with-systemic-lupus-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/analysis-of-belimumab-prescription-and-outcomes-in-a-10-year-monocentric-cohort-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/analysis-of-clinical-immunological-characteristics-damage-and-survival-in-300-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/analysis-of-gout-remission-definitions-in-a-randomized-controlled-trial-of-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/analysis-of-risk-factors-and-development-of-a-nomogram-prediction-model-for-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/analysis-of-synovitis-patterns-in-early-ra-supports-the-importance-of-joint-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/anatomical-pattern-of-entheseal-and-synovial-fibroblast-activation-in-patients-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/anatomy-centred-deep-learning-improves-generalisability-and-progression-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/anca-in-patients-with-systemic-lupus-erythematosus-a-cross-sectional-study-in-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/anifrolumab-for-systemic-lupus-erythematosus-with-multi-refractory-skin-disease-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/anifrolumab-in-refractory-systemic-lupus-erythematosus-a-real-world-multicenter-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/anifrolumab-treatment-improves-patient-reported-quality-life-decreases-disease-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/annual-trends-pain-management-modalities-newly-diagnosed-autoimmune-rheumatic-2024/2026-11-04T05:53:11Z https://currentrheuma.com/studies/anti-aquaporin-5-and-anti-poly-u-binding-factor-60kda-protein-antibodies-in-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/anti-carbamylated-protein-antibodies-drive-aec-ii-toward-a-profibrotic-phenotype-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/anti-dsdna-ige-a-potential-non-invasive-test-for-prediction-of-lupus-nephritis-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/anti-fhl1-autoantibodies-in-adult-patients-with-myositis-a-longitudinal-follow-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/anti-histone-and-anti-nucleosome-rather-than-anti-dsdna-antibodies-associate-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/anti-hmgcr-myopathy-diversity-of-clinical-presentations-in-a-national-cohort-in-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/anti-hmgcr-myopathy-estimated-five-fold-higher-incidence-in-polynesian-compared-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/anti-inflammatory-effect-of-high-density-lipoprotein-blunted-by-delivery-of-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/anti-inflammatory-effects-of-infliximab-and-methotrexate-on-peripheral-blood-and-2024/2026-11-04T09:23:05Z https://currentrheuma.com/studies/anti-kif20b-autoantibodies-are-associated-with-cranial-neuropathy-in-systemic-2024/2026-11-04T06:13:45Z https://currentrheuma.com/studies/anti-pentraxin-3-antibodies-and-residual-disease-activity-in-rheumatoid-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/anti-peptide-antibodies-anti-snrk-and-anti-huwe1-antibodies-as-potential-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/anti-sae-dermatomyositis-clinical-and-histologic-characteristics-from-a-2024/2026-11-04T09:24:09Z https://currentrheuma.com/studies/anti-sars-cov-2-mrna-vaccination-among-patients-living-with-sle-in-sweden-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/anti-sp4-and-anti-ccar1-autoantibodies-in-uk-vs-us-patients-with-adult-and-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/antibiotics-in-inflammatory-arthritis-and-background-population-one-year-before-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/antibodies-malondialdehyde-acetaldehyde-adduct-are-associated-prevalent-incident-2024/2026-11-04T05:52:08Z https://currentrheuma.com/studies/antihistamine-use-and-osteoarthritis-or-joint-pain-2024/2026-11-04T03:22:35Z https://currentrheuma.com/studies/antiphospholipid-antibodies-as-potential-predictors-disease-severity-poor-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/antiplatelet-effects-hydroxychloroquine-systemic-lupus-erythematosus-evaluated-2024/2026-11-04T03:18:08Z https://currentrheuma.com/studies/anxiety-and-depression-symptoms-in-adolescents-and-young-adults-with-juvenile-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/apolipoproteins-and-the-risk-of-giant-cell-arteritis-a-nested-case-control-study-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/application-lupus-comprehensive-disease-control-newly-diagnosed-systemic-lupus-2024/2026-11-03T08:01:42Z https://currentrheuma.com/studies/application-of-the-2023-acr-eular-antiphospholipid-syndrome-classification-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/application-vascular-index-based-superb-microvascular-imaging-technique-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/appraisal-of-quality-and-analysis-of-the-similarities-and-differences-between-2024/2026-11-04T09:31:04Z https://currentrheuma.com/studies/approaches-and-outcomes-of-adalimumab-discontinuation-in-patients-with-well-2024/2026-11-04T00:12:21Z https://currentrheuma.com/studies/are-gout-patients-with-negative-dual-energy-computed-tomography-for-monosodium-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/are-outcomes-exercise-therapy-patient-education-program-osteoarthritis-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/are-the-effects-of-resistance-exercise-on-pain-and-function-in-knee-and-hip-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/are-ultrasound-salivary-parenchymal-lesions-more-severe-in-primary-sjogren-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/area-level-socioeconomic-status-impacts-health-care-visit-frequency-australian-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/arrhythmia-in-patients-with-systemic-sclerosis-incidence-risk-factors-and-impact-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/arthralgia-with-risk-of-progression-to-psoriatic-arthritis-role-of-clinical-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/arthritis-in-patients-with-very-early-systemic-sclerosis-a-comprehensive-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/arthritis-progressors-have-a-decreased-frequency-of-circulating-autoreactive-t-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/arthroplasty-rates-and-risk-in-familial-mediterranean-fever-patients-a-large-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/arthroscopy-has-a-higher-discriminative-capacity-than-mri-in-detecting-mild-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/artificial-intelligence-enhanced-opportunistic-screening-of-osteoporosis-in-ct-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/asas-consensus-definition-of-early-axial-spondyloarthritis-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/assay-for-interferon-gamma-release-as-a-novel-marker-in-pediatric-patients-with-2024/2026-11-04T03:21:42Z https://currentrheuma.com/studies/assessing-competencies-needs-satisfaction-transition-pediatric-adult-health-care-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/assessing-domain-match-feasibility-candidate-instruments-matching-omeract-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/assessing-igg4-related-autoimmune-pancreatitis-contrast-enhanced-ultrasonography-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/assessing-methotrexate-adherence-in-juvenile-idiopathic-arthritis-using-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/assessing-patient-values-and-preferences-to-inform-the-2023-american-college-of-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/assessing-the-association-of-epigenetic-age-acceleration-with-osteoarthritis-in-2024/2026-11-04T09:31:04Z https://currentrheuma.com/studies/assessing-the-causal-relationship-between-plasma-proteins-and-osteoporosis-novel-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/assessing-the-efficacy-of-anticoagulation-therapy-in-the-treatment-of-vascular-2024/2026-11-03T11:13:22Z https://currentrheuma.com/studies/assessing-the-impact-of-health-care-access-on-the-severity-of-low-back-pain-by-2024/2026-11-04T02:58:58Z https://currentrheuma.com/studies/assessing-the-impact-of-the-ipeer2peer-program-for-adolescents-with-juvenile-2024/2026-11-04T00:12:21Z https://currentrheuma.com/studies/assessing-the-quality-of-forced-vital-capacity-measurement-in-patients-with-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/assessing-the-sensitivity-and-specificity-of-myositis-specific-and-associated-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/assessment-of-damage-in-takayasus-arteritis-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/assessment-of-enthesopathy-in-conventional-pelvis-radiography-another-tool-for-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/assessment-of-foot-impairment-in-systemic-sclerosis-a-cross-sectional-study-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/assessment-of-the-role-of-high-density-lipoproteins-and-their-immunomodulatory-2024/2026-11-04T03:18:08Z https://currentrheuma.com/studies/assessment-renal-response-tunisian-proliferative-lupus-nephritis-under-three-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/association-between-25-hydroxyvitamin-d-levels-and-adverse-pregnancy-outcomes-in-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/association-between-ankylosing-spondylitis-and-neurodegenerative-diseases-2024/2026-11-04T00:06:14Z https://currentrheuma.com/studies/association-between-antibiotic-use-and-the-risk-of-rheumatoid-arthritis-a-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/association-between-antiphospholipid-antibodies-diffuse-alveolar-haemorrhage-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/association-between-body-weight-and-tocilizumab-effectiveness-in-rheumatoid-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/association-between-colchicine-use-and-adverse-cardiovascular-events-in-patients-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/association-between-combined-exposure-to-ambient-air-pollutants-genetic-risk-and-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/association-between-depression-and-anxiety-and-inability-to-achieve-remission-in-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/association-between-discontinuity-of-care-and-patient-trust-in-the-usual-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/association-between-disease-modifying-antirheumatic-drugs-rheumatoid-arthritis-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/association-between-hyperuricemia-and-ultrasound-detected-hand-synovitis-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/association-between-interleukin-12-p40-subunit-and-risk-of-primary-sjogrens-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/association-between-musculoskeletal-sonographic-features-and-response-to-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/association-between-physical-activity-and-mortality-in-patients-with-2024/2026-11-04T00:13:51Z https://currentrheuma.com/studies/association-between-proton-pump-inhibitors-and-the-risk-of-intestinal-behcet-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/association-between-radiographic-progression-functional-impairment-markers-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/association-between-renal-function-fracture-incidence-during-treatment-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/association-between-sinusitis-and-incident-rheumatic-diseases-a-population-based-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/association-between-socioeconomic-deprivation-and-bone-health-status-in-the-uk-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/association-between-synovial-tissue-damage-and-pain-in-late-stage-knee-2024/2026-11-04T03:22:35Z https://currentrheuma.com/studies/association-between-thyroid-function-and-osteoarthritis-a-population-based-2024/2026-11-04T00:13:14Z https://currentrheuma.com/studies/association-biochemical-markers-bone-marrow-lesion-changes-imaging-data-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/association-bone-fracture-30-year-body-mass-index-bmi-trajectories-findings-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/association-catechol-o-methyltransferase-val158met-polymorphism-fibromyalgia-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/association-clinical-components-distal-interphalangeal-joint-synovio-entheseal-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/association-clinical-response-criteria-disease-activity-levels-axial-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/association-depressive-symptoms-incident-fractures-japan-public-health-center-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/association-historical-redlining-present-day-racialised-economic-segregation-2024/2026-11-03T23:51:04Z https://currentrheuma.com/studies/association-lupus-low-disease-activity-state-remission-reduced-organ-damage-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/association-nirmatrelvir-ritonavir-post-acute-sequelae-mortality-who-are-2024/2026-11-03T23:51:04Z https://currentrheuma.com/studies/association-nociplastic-neuropathic-pain-components-presence-residual-symptoms-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/association-of-ankylosing-spondylitis-with-the-risk-of-cancer-a-meta-analysis-of-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/association-of-anti-hmgcr-antibodies-of-the-igm-isotype-with-refractory-immune-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/association-of-anti-ro-52-antibodies-with-occurrence-of-interstitial-lung-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/association-of-autoantibody-concentrations-and-trajectories-with-lupus-nephritis-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/association-of-c-677-c-t-rs1801133-and-c-1298-a-c-rs1801131-mthfr-genetic-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/association-of-cardiovascular-outcomes-with-low-dose-glucocorticoid-prescription-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/association-of-combined-anti-ro52-trim21-and-anti-ro60-ssa-antibodies-with-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/association-of-combined-healthy-lifestyle-factors-with-incident-osteoporosis-in-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/association-of-disease-activity-with-depression-and-anxiety-in-systemic-lupus-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/association-of-genetic-variation-on-x-chromosome-with-systemic-lupus-2024/2026-11-04T09:26:49Z https://currentrheuma.com/studies/association-of-gut-commensal-translocation-with-autoantibody-production-in-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/association-of-infant-breastfeeding-and-juvenile-spondyloarthritis-a-case-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/association-of-muscle-quality-and-pain-in-adults-with-symptomatic-knee-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/association-of-muscle-quantity-and-quality-with-knee-extension-strength-in-knee-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/association-of-non-alcoholic-fatty-liver-disease-with-self-reported-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/association-of-past-smoking-status-with-gout-in-maori-people-in-aotearoa-new-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/association-of-phenotypic-frailty-and-hand-grip-strength-with-telomere-length-in-2024/2026-11-04T09:26:49Z https://currentrheuma.com/studies/association-of-proton-density-fat-fraction-with-osteoporosis-a-systematic-review-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/association-of-rare-and-common-genetic-variants-in-mocos-with-inadequate-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/association-of-rare-single-nucleotide-variant-muc5b-rs35705950-with-interstitial-2024/2026-11-03T10:53:39Z https://currentrheuma.com/studies/association-of-serum-interferon-alpha-2a-levels-with-disease-severity-and-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/association-of-serum-myeloperoxidase-with-metabolic-syndrome-and-adverse-lipid-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/association-of-serum-soluble-transferrin-receptor-concentration-with-markers-of-2024/2026-11-04T09:22:05Z https://currentrheuma.com/studies/association-of-somatic-tet2-mutations-with-giant-cell-arteritis-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/association-of-sustained-lupus-low-disease-activity-state-with-improved-outcomes-2024/2026-11-04T05:53:11Z https://currentrheuma.com/studies/association-of-the-apollo-wearable-with-fatigue-raynaud-phenomenon-and-quality-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/association-of-the-multi-biomarker-disease-activity-score-with-arterial-18-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/association-of-validated-patient-reported-outcome-measures-with-patients-self-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/association-of-weight-loss-and-weight-gain-with-structural-defects-and-pain-in-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/association-outdoor-temperature-self-reported-raynauds-phenomenon-severity-2024/2026-11-04T02:58:58Z https://currentrheuma.com/studies/association-patient-hospital-level-predictors-patterns-initial-treatment-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/association-rheumatoid-factor-anti-citrullinated-protein-antibodies-shared-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/association-serum-alkaline-phosphatase-levels-bone-mineral-density-osteoporosis-2024/2026-11-04T00:13:51Z https://currentrheuma.com/studies/association-serum-biomarkers-radiographic-knee-osteoarthritis-knee-pain-function-2024/2026-11-04T03:22:35Z https://currentrheuma.com/studies/association-vasomotor-symptoms-fracture-risk-bone-mineral-density-postmenopausal-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/associations-between-6-minute-walk-distance-and-physiologic-measures-and-2024/2026-11-03T10:53:39Z https://currentrheuma.com/studies/associations-between-biomarkers-and-skeletal-muscle-function-in-individuals-with-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/associations-between-life-course-longitudinal-growth-and-hip-shapes-at-ages-60-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/associations-between-loneliness-disease-activity-disease-impact-inflammatory-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/associations-between-new-obesity-indices-and-abnormal-bone-density-in-type-2-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/associations-between-plasma-metabolism-associated-proteins-future-development-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/associations-between-rheumatoid-arthritis-clinical-factors-and-synovial-cell-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/associations-between-static-foot-posture-dynamic-shoe-plantar-foot-forces-knee-2024/2026-11-04T03:22:35Z https://currentrheuma.com/studies/associations-between-tca-cycle-plasma-metabolites-and-fatigue-in-black-females-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/associations-between-thiazolidinediones-use-and-incidence-of-rheumatoid-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/associations-between-ultra-distal-forearm-bone-mineral-density-and-incident-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/associations-of-galectin-3-levels-with-measures-of-vascular-disease-in-patients-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/associations-of-inflammatory-and-metabolic-biomarkers-with-incident-erosive-hand-2024/2026-11-04T09:31:04Z https://currentrheuma.com/studies/associations-of-pain-sensitivity-and-conditioned-pain-modulation-with-physical-2024/2026-11-04T06:17:41Z https://currentrheuma.com/studies/associations-of-residential-greenness-with-bone-mineral-density-and-osteoporosis-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/atlas-for-the-ct-syndesmophyte-score-ctss-in-patients-with-axial-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/attainment-of-eular-era-edta-targets-of-therapy-with-current-immunosuppressive-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/attainment-remission-low-disease-activity-after-treatment-belimumab-systemic-2024/2026-11-04T02:58:58Z https://currentrheuma.com/studies/autoantibodies-and-damage-in-patients-with-idiopathic-inflammatory-myopathies-a-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/autoantibodies-cutaneous-subset-and-immunosuppressants-contribute-to-the-cancer-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/autoantibodies-targeting-nephrin-in-podocytopathies-2024/2026-11-04T06:21:03Z https://currentrheuma.com/studies/autoantibodies-to-joint-related-peptides-as-predictive-markers-in-early-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/autoantibodies-to-nuclear-valosin-containing-protein-like-protein-systemic-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/autoantibodies-towards-hfe-and-syt5-in-anti-neutrophil-cytoplasm-antibody-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/autoimmune-inner-ear-disease-associated-with-antiphospholipid-antibodies-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/autoimmune-sequelae-after-delta-or-omicron-variant-sars-cov-2-infection-in-a-2024/2026-11-04T03:25:32Z https://currentrheuma.com/studies/autoinflammatory-syndromes-mimicking-behcets-disease-with-gastrointestinal-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/autologous-haematopoiesis-stem-cell-transplantation-ahsct-for-treatment-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/automatic-knee-osteoarthritis-severity-grading-based-on-x-ray-images-using-a-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/avacopan-combined-cyclophosphamide-rituximab-induction-therapy-severe-anca-2024/2026-11-03T04:32:44Z https://currentrheuma.com/studies/avacopan-for-anti-neutrophil-cytoplasm-antibodies-associated-vasculitis-a-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/average-daily-glucocorticoid-dose-number-prescription-days-cumulative-dose-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/azathioprine-metabolite-levels-and-outcomes-during-pregnancies-with-rheumatic-2024/2026-11-04T09:26:49Z https://currentrheuma.com/studies/b-cell-depletion-after-treatment-with-rituximab-predicts-relapse-of-igg4-related-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/b-cell-receptor-repertoire-analysis-in-primary-sjogrens-syndrome-salivary-glands-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/b-vitamins-and-bone-health-a-meta-analysis-with-trial-sequential-analysis-of-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/baricitinib-for-refractory-takayasu-arteritis-a-prospective-cohort-study-in-a-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/barriers-and-facilitators-to-application-of-treat-to-target-management-in-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/barriers-and-facilitators-to-medical-care-retention-for-pediatric-systemic-lupus-2024/2026-11-04T06:16:46Z https://currentrheuma.com/studies/barriers-facilitators-and-preferences-for-mental-health-services-among-patients-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/barriers-to-facilitators-of-and-interventions-to-support-treat-to-target-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/barriers-to-total-joint-arthroplasty-a-comparison-of-high-poverty-and-low-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/baseline-absolute-monocyte-count-predicts-lung-function-decline-systemic-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/baseline-and-2-year-differences-in-spinal-symptoms-and-spinal-and-hip-mobility-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/baseline-dual-energy-computed-tomography-urate-volume-predicts-fulfillment-of-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/bayesian-model-analyse-association-comorbidities-biosimilar-treatment-retention-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/bcma-cd19-compound-car-t-cells-for-systemic-lupus-erythematosus-a-phase-1-open-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/bdmard-can-prevent-the-progression-of-aa-amyloidosis-to-end-stage-renal-disease-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/belimumab-safety-in-adult-and-paediatric-chinese-patients-with-systemic-lupus-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/benefits-early-late-initiation-intravenous-immunoglobulin-treatment-anti-3-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/benralizumab-versus-mepolizumab-for-eosinophilic-granulomatosis-with-2024/2026-11-04T09:33:11Z https://currentrheuma.com/studies/best-practice-recommendations-for-clinical-psychological-interventions-in-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/beyond-diagnosis-exploring-the-significance-of-igg4-plasma-cell-count-through-2024/2026-11-04T03:15:15Z https://currentrheuma.com/studies/beyond-pain-the-influence-of-psychological-factors-on-functional-status-in-2024/2026-11-04T06:11:16Z https://currentrheuma.com/studies/beyond-paraneoplastic-neurological-syndromes-anti-neuronal-antibodies-in-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/bicaudal-d2-autoantibodies-are-highly-specific-for-systemic-sclerosis-2024/2026-11-04T06:09:55Z https://currentrheuma.com/studies/bimekizumab-provided-rapid-improvements-patient-reported-symptoms-health-related-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/bimekizumab-treatment-active-axial-spondyloarthritis-52-week-efficacy-safety-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/bimekizumab-treatment-active-psoriatic-arthritis-prior-inadequate-response-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/biological-hallmarks-of-systemic-sclerosis-are-present-in-the-skin-and-serum-of-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/biological-use-influences-the-impact-of-inflammation-on-risk-of-major-adverse-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/biomarker-analysis-from-the-phase-2b-randomized-placebo-controlled-trial-of-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/biomarker-changes-in-response-to-tofacitinib-treatment-in-patients-with-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/biomarkers-in-psoriasis-and-psoriatic-arthritis-where-are-we-now-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/biomarkers-reflecting-disturbed-gut-barrier-under-treatment-with-tnf-inhibitors-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/biomechanical-determinants-of-rheumatoid-arthritis-severity-and-excess-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/birth-weight-and-birth-length-affect-future-fracture-risk-differently-in-men-and-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/bisphosphonate-drug-holidays-in-osteoporosis-according-to-fracture-risk-profile-2024/2026-11-04T00:13:51Z https://currentrheuma.com/studies/blood-based-biomarkers-of-neuronal-and-glial-injury-in-active-major-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/blood-brain-barrier-permeability-and-astrocyte-derived-extracellular-vesicles-in-2024/2026-11-04T06:16:46Z https://currentrheuma.com/studies/blood-pressure-changes-during-methotrexate-treatment-results-from-a-randomized-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/blood-rna-sequencing-across-the-continuum-of-ana-positive-autoimmunity-reveals-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/body-mass-index-is-associated-with-health-related-quality-of-life-and-disease-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/bone-health-and-physical-activity-in-adolescents-with-juvenile-idiopathic-2024/2026-11-04T06:16:46Z https://currentrheuma.com/studies/brain-functional-alternation-in-patients-with-systemic-sclerosis-a-resting-state-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/brain-white-matter-microstructural-alterations-behcets-syndrome-correlate-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/breakout-session-and-report-back-collaboration-of-rheumatologists-and-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/brentuximab-vedotin-for-skin-involvement-in-refractory-diffuse-cutaneous-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/british-society-for-rheumatology-guideline-on-management-of-adult-and-juvenile-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/building-the-oachangemap-to-improve-the-service-delivery-of-the-new-south-wales-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/c-reactive-protein-albumin-ratio-as-prognostic-tool-predicting-intravenous-2024/2026-11-04T06:16:46Z https://currentrheuma.com/studies/c-reactive-protein-thresholds-for-discriminating-active-disease-in-axial-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/c-reactive-protein-thresholds-for-discriminating-active-disease-in-psoriatic-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/caffeine-improves-systemic-lupus-erythematosus-endothelial-dysfunction-by-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/calprotectin-impairs-platelet-survival-in-patients-with-primary-antiphospholipid-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/can-nailfold-capillaroscopy-findings-be-a-marker-for-uveitis-in-behcets-syndrome-2024/2026-11-03T11:13:22Z https://currentrheuma.com/studies/can-rheumatologists-unequivocally-diagnose-axial-spondyloarthritis-chronic-back-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/can-simple-0-10-rheumetric-physician-estimate-inflammatory-activity-docinf-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/can-the-dose-of-belimumab-be-reduced-in-patients-with-systemic-lupus-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/can-we-predict-kidney-involvement-in-patients-with-systemic-lupus-erythematosus-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/canadian-rheumatology-association-spondyloarthritis-research-consortium-canada-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/canakinumab-treatment-real-world-evidence-3-monogenic-periodic-fever-syndromes-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/cancer-associated-myositis-before-and-after-the-covid-19-pandemic-onset-a-2024/2026-11-04T09:24:09Z https://currentrheuma.com/studies/cancer-incidence-and-outcome-for-patients-with-rheumatoid-arthritis-a-long-term-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/cancer-risk-and-mortality-in-hospitalized-patients-with-idiopathic-inflammatory-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/cancer-risk-with-tocilizumab-sarilumab-abatacept-and-rituximab-treatment-in-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/candidate-biomarkers-for-response-to-treatment-in-psoriatic-disease-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/capi-score-a-quantitative-algorithm-for-identifying-disease-patterns-in-nailfold-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/capturing-the-range-of-disease-involvement-in-localized-scleroderma-the-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/cardiac-involvement-in-eosinophilic-granulomatosis-with-polyangiitis-acute-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/cardiac-involvement-in-systemic-lupus-erythematosus-interest-of-2d-global-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/cardiac-involvement-in-the-catastrophic-antiphospholipid-syndrome-caps-lessons-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/cardiovascular-events-during-pregnancy-implications-for-adverse-pregnancy-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/cardiovascular-events-gout-initiating-urate-lowering-therapy-or-without-2024/2026-11-03T23:51:04Z https://currentrheuma.com/studies/cardiovascular-health-metrics-all-cause-mortality-osteoarthritis-inflammatory-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/cardiovascular-risk-according-to-genetic-predisposition-to-gout-lifestyle-and-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/cardiovascular-risk-factors-complications-systemic-lupus-erythematosus-without-2024/2026-11-04T09:26:49Z https://currentrheuma.com/studies/cardiovascular-safety-class-jak-inhibitors-or-tocilizumab-compared-tnf-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/carotid-artery-ultrasonography-and-shear-wave-elastography-in-takayasus-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/cartilage-destruction-in-early-rheumatoid-arthritis-patients-correlates-with-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/causal-associations-of-osteoporosis-with-stroke-a-bidirectional-mendelian-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/causal-factors-for-osteoarthritis-a-scoping-review-of-mendelian-randomization-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/causal-relationship-between-731-immune-cell-immunophenotypes-and-giant-cell-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/causal-relationship-between-rheumatoid-arthritis-and-bronchiectasis-a-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/causal-relationship-between-serum-metabolites-and-juvenile-idiopathic-arthritis-2024/2026-11-04T06:16:46Z https://currentrheuma.com/studies/causal-relationship-between-systemic-lupus-erythematosus-primary-liver-cirrhosis-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/causes-and-predictors-of-death-among-finnish-patients-with-systemic-sclerosis-2024/2026-11-04T06:09:55Z https://currentrheuma.com/studies/ccr4-tfh2-cells-specifically-produce-il-4-driving-the-pathological-reaction-in-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/cd-99-g1-neutrophils-modulate-osteogenic-differentiation-of-mesenchymal-stem-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/cd19-car-t-cell-therapy-in-autoimmune-disease-a-case-series-with-follow-up-2024/2026-11-04T09:33:11Z https://currentrheuma.com/studies/cd19-targeting-car-t-cell-therapy-in-patients-with-diffuse-systemic-sclerosis-a-2024/2026-11-03T23:51:04Z https://currentrheuma.com/studies/cd4-cd8-low-t-cell-clonal-expansion-dependent-on-costimulation-in-patients-with-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/cd44-is-associated-with-muscle-inflammation-in-polymyositis-and-skin-damage-in-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/cd7-activation-regulates-cytotoxicity-driven-pathology-in-systemic-sclerosis-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/cd8-tissue-resident-memory-t-cells-are-expanded-in-primary-sjogrens-disease-and-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/cell-integrated-serum-induced-signalling-patterns-can-differentiate-between-hand-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/cenerimod-sphingosine-1-phosphate-receptor-modulator-placebo-moderate-severe-2024/2026-11-03T23:51:04Z https://currentrheuma.com/studies/cervicothoracic-volumetric-bone-mineral-density-assessed-by-opportunistic-qct-2024/2026-11-04T00:13:51Z https://currentrheuma.com/studies/change-in-different-classes-of-chronic-back-pain-suspicious-of-axial-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/changes-and-associations-between-synovial-fluid-and-magnetic-resonance-imaging-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/changes-at-presentation-in-patients-with-early-rheumatoid-arthritis-a-24-year-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/changes-characteristics-initiating-discontinuing-advanced-therapies-rheumatoid-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/changes-in-alcohol-intake-and-serum-urate-changes-longitudinal-analyses-of-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/changes-in-serum-cholesterol-loading-capacity-are-linked-to-coronary-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/changes-in-type-vi-collagen-degradation-reflect-clinical-response-to-treatment-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/changes-incidence-prevalence-systemic-lupus-erythematosus-between-1990-2020-2024/2026-11-04T03:18:08Z https://currentrheuma.com/studies/changes-of-cerebral-structure-and-perfusion-in-subtypes-of-systemic-sclerosis-a-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/characterisation-and-outcomes-of-different-subsets-of-low-disease-activity-2024/2026-11-04T03:18:08Z https://currentrheuma.com/studies/characterisation-of-airway-disease-associated-with-sjogren-disease-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/characterisation-of-myeloid-cells-in-circulation-and-synovial-fluid-of-patients-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/characterised-intron-retention-profiles-in-muscle-tissue-of-idiopathic-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/characteristic-features-late-onset-systemic-lupus-erythematosus-observational-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/characteristics-and-clustering-analysis-of-peripheral-blood-lymphocyte-subsets-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/characteristics-and-outcomes-of-biopsy-proven-lupus-nephritis-in-the-eastern-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/characteristics-and-prognosis-of-elderly-onset-antiphospholipid-syndrome-an-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/characteristics-associated-with-patient-reported-treatment-success-in-psoriatic-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/characteristics-disease-course-untreated-interstitial-lung-disease-associated-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/characteristics-of-and-risk-factors-for-covid-19-breakthrough-infections-in-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/characteristics-of-the-synovial-microenvironment-and-synovial-mesenchymal-stem-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/characterization-of-genetic-landscape-and-novel-inflammatory-biomarkers-in-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/characterizing-neurobiological-mechanisms-action-exercise-cognitive-behavioral-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/characterizing-nonarticular-pain-at-early-rheumatoid-arthritis-diagnosis-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/chatgpt4s-proficiency-in-addressing-patients-questions-on-systemic-lupus-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/chemokine-cxcl9-a-marker-of-inflammaging-is-associated-with-changes-of-muscle-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/chemokine-receptor-cxcr4-based-positron-emission-tomography-imaging-in-systemic-2024/2026-11-03T10:53:39Z https://currentrheuma.com/studies/childhood-adverse-experiences-and-clinical-manifestations-in-women-with-systemic-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/childhood-arthritis-rheumatology-research-alliance-biologic-disease-modifying-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/childhood-onset-systemic-lupus-erythematosus-a-descriptive-and-comparative-study-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/childhood-onset-versus-adult-onset-takayasu-arteritis-a-study-of-239-patients-2024/2026-11-04T00:06:14Z https://currentrheuma.com/studies/children-systemic-lupus-erythematosus-associated-pancreatitis-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/children-with-type-i-interferonopathy-commonalities-and-diversities-in-a-large-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/choroidal-vascularity-analysis-in-patients-with-juvenile-idiopathic-arthritis-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/chronic-abdominal-aortic-occlusive-disease-related-to-antiphospholipid-syndrome-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/chronic-kidney-disease-in-patients-with-psoriatic-arthritis-a-cohort-study-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/circulating-cell-free-dna-promotes-inflammation-in-dermatomyositis-patients-with-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/circulating-extracellular-vesicles-in-systemic-lupus-erythematosus-2024/2026-11-04T03:18:08Z https://currentrheuma.com/studies/circulating-interleukin-17a-and-other-inflammatory-proteins-may-predict-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/circulating-neutrophil-extracellular-trap-remnants-as-a-biomarker-to-predict-2024/2026-11-04T09:26:49Z https://currentrheuma.com/studies/circulating-tfh-cells-are-differentially-modified-by-abatacept-or-tnf-blockers-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/classifying-multimorbidity-using-drug-concepts-via-the-rx-risk-comorbidity-index-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/clinical-algorithm-model-based-on-cfdna-to-predict-sle-disease-activity-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/clinical-and-imaging-outcomes-of-different-phenotypes-of-axial-spondyloarthritis-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/clinical-biological-prognostic-characteristics-of-patients-with-immune-mediated-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/clinical-characteristics-adolescents-juvenile-idiopathic-arthritis-transitioning-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/clinical-characteristics-and-clinical-risk-model-of-the-lower-gastrointestinal-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/clinical-characteristics-and-outcomes-of-polyarteritis-nodosa-an-international-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/clinical-characteristics-and-prognosis-of-interstitial-lung-disease-in-systemic-2024/2026-11-04T00:12:21Z https://currentrheuma.com/studies/clinical-characteristics-and-prognostic-factor-in-juvenile-dermatomyositis-data-2024/2026-11-04T03:21:42Z https://currentrheuma.com/studies/clinical-characteristics-cryopyrin-associated-periodic-syndrome-long-term-real-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/clinical-characteristics-hypertrophic-cranial-pachymeningitis-granulomatosis-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/clinical-characteristics-of-adolescent-onset-gout-in-chinese-a-hospital-based-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/clinical-characteristics-of-anti-synthetase-syndrome-analysis-from-the-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/clinical-characteristics-of-idiopathic-inflammatory-myopathies-patients-with-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/clinical-consequences-infliximab-immunogenicity-effect-proactive-therapeutic-2024/2026-11-04T09:04:37Z https://currentrheuma.com/studies/clinical-course-of-paediatric-onset-behcets-disease-in-young-adulthood-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/clinical-demographic-factors-determining-patient-fracture-risk-decision-point-2024/2026-11-04T00:13:51Z https://currentrheuma.com/studies/clinical-enthesitis-in-patient-with-psoriatic-arthritis-a-systematic-literature-2024/2026-11-04T00:06:14Z https://currentrheuma.com/studies/clinical-features-and-recurrence-predictors-of-histiocytic-necrotizing-2024/2026-11-04T06:16:46Z https://currentrheuma.com/studies/clinical-features-and-two-year-outcomes-in-systemic-lupus-erythematosus-patients-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/clinical-features-fallers-non-fallers-finding-best-performing-combinations-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/clinical-features-immunogenetic-risk-factors-associated-additional-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/clinical-features-of-guillain-barre-syndrome-and-chronic-inflammatory-2024/2026-11-04T00:09:46Z https://currentrheuma.com/studies/clinical-features-of-patients-with-systemic-sclerosis-positive-for-anti-ss-a-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/clinical-health-related-quality-of-life-and-gait-differences-among-obesity-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/clinical-histologic-and-prognostic-features-of-clinically-amyopathic-2024/2026-11-04T09:24:09Z https://currentrheuma.com/studies/clinical-immunologic-and-genetic-characteristics-in-patients-with-syndrome-of-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/clinical-information-on-imaging-referrals-for-suspected-or-known-axial-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/clinical-management-of-lupus-in-the-united-states-a-claims-based-analysis-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/clinical-manifestations-treatment-and-prognosis-of-juvenile-idiopathic-arthritis-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/clinical-outcomes-healthcare-resource-utilization-igg4-related-disease-claims-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/clinical-outcomes-in-cancer-patients-with-immune-checkpoint-inhibitor-induced-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/clinical-outcomes-of-patients-receiving-long-term-fondaparinux-for-thrombotic-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/clinical-phenotypes-and-therapeutic-outcomes-in-enteropathic-arthritis-a-2024/2026-11-03T08:01:42Z https://currentrheuma.com/studies/clinical-phenotypes-of-sarcoidosis-using-cluster-analysis-a-spanish-population-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/clinical-practice-pattern-pneumocystis-pneumonia-prophylaxis-systemic-lupus-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/clinical-presentation-care-pathways-and-delays-in-access-to-specialized-care-in-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/clinical-relevance-of-positively-determined-myositis-antibodies-in-rheumatology-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/clinical-significance-of-serum-soluble-scavenger-receptor-cd163-in-patients-with-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/clinical-spectrum-and-outcome-of-takayasus-arteritis-in-children-2024/2026-11-04T06:10:35Z https://currentrheuma.com/studies/clinical-spectrum-of-and-outcomes-for-indian-children-with-deficiency-of-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/clinical-stratification-of-1318-primary-sjogrens-syndrome-patients-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/clinical-subclinical-atherosclerosis-systemic-sclerosis-observational-2024/2026-11-04T03:15:15Z https://currentrheuma.com/studies/clinical-trajectories-of-hand-function-impairment-in-systemic-sclerosis-an-unmet-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/clinical-trial-eligibility-of-a-real-world-connective-tissue-disease-cohort-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/clinical-validation-digitally-acquired-clinical-data-machine-learning-models-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/clinical-value-of-diagnosing-ischaemic-stroke-in-patients-with-takayasus-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/clinically-relevant-differences-between-primary-raynauds-phenomenon-and-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/clinically-relevant-differences-in-spinal-mobility-related-to-daytime-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/clinically-suspect-arthralgia-and-rheumatoid-arthritis-patients-perceptions-of-2024/2026-11-04T06:10:35Z https://currentrheuma.com/studies/clinicopathological-characteristics-of-severe-aortic-valve-regurgitation-caused-2024/2026-11-03T11:13:22Z https://currentrheuma.com/studies/clonal-haematopoiesis-across-the-age-spectrum-of-vasculitis-patients-with-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/clonal-t-cell-populations-scarcely-impair-patients-with-rheumatic-diseases-a-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/cluster-analysis-identifies-differential-impact-disease-activity-severity-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/cluster-analysis-of-clinical-manifestations-assigns-systemic-lupus-erythematosus-2024/2026-11-04T03:14:48Z https://currentrheuma.com/studies/coexistence-diabetes-hypertension-obesity-is-associated-worse-pain-outcomes-2024/2026-11-04T06:17:41Z https://currentrheuma.com/studies/cognitive-impairment-in-a-colombian-cohort-of-patients-with-systemic-lupus-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/cohort-study-of-serological-biomarkers-for-interstitial-lung-disease-in-patients-2024/2026-11-04T00:05:39Z https://currentrheuma.com/studies/collaborative-model-care-between-orthopaedics-allied-healthcare-professionals-2024/2026-11-04T06:17:41Z https://currentrheuma.com/studies/colour-changes-in-the-feet-a-sign-of-autonomic-symptoms-in-systemic-sclerosis-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/combination-of-anti-ssa-ro60-and-anti-dsdna-serotype-is-predictive-of-belimumab-2024/2026-11-04T06:13:45Z https://currentrheuma.com/studies/combination-of-cytoplasmic-and-nuclear-patterns-on-hep-2-antinuclear-antibody-is-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/combination-of-scavenger-receptor-a-with-anti-cyclic-citrullinated-peptide-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/combinations-immunomodulatory-agents-prevention-uveitis-relapse-severe-behcets-2024/2026-11-04T02:58:58Z https://currentrheuma.com/studies/combined-inhibition-of-il-1-il-33-and-il-36-signalling-by-targeting-il1rap-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/combined-radiographic-and-us-evaluations-to-decipher-joint-involvement-in-the-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/combined-use-qrisk3-score2-increases-identification-ankylosing-spondylitis-at-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/combining-patient-reported-outcome-measures-to-screen-for-active-disease-in-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/come-rain-or-shine-is-weather-a-risk-factor-for-musculoskeletal-pain-a-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/common-seasonal-pathogens-and-epidemiology-of-henoch-schonlein-purpura-among-2024/2026-11-04T06:21:48Z https://currentrheuma.com/studies/comorbidities-in-early-psoriatic-arthritis-data-from-the-metabolic-disturbances-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/comorbidity-burden-on-mortality-in-patients-with-systemic-sclerosis-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/comorbidity-clusters-in-patients-with-rheumatoid-arthritis-identify-a-patient-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/comorbidity-in-incident-rheumatoid-arthritis-a-nationwide-case-control-study-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/comparative-analysis-arterial-involvement-predominant-cranial-isolated-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/comparative-early-effectiveness-across-14-psa-drugs-and-5-classes-of-psa-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/comparative-effectiveness-and-persistence-of-sb4-and-reference-etanercept-in-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/comparative-effectiveness-cardiovascular-safety-romosozumab-teriparatide-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/comparative-effectiveness-different-placebos-comparator-groups-hand-2024/2026-11-04T06:17:41Z https://currentrheuma.com/studies/comparative-effectiveness-of-disease-modifying-antirheumatic-drugs-for-patients-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/comparative-effectiveness-second-tumor-necrosis-factor-inhibitor-non-tumor-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/comparative-effectiveness-tofacitinib-tumour-necrosis-factor-inhibitors-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/comparative-effects-of-biological-and-targeted-synthetic-dmards-on-incident-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/comparative-efficacy-and-safety-of-bimekizumab-in-psoriatic-arthritis-a-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/comparative-risk-of-gout-flares-when-initiating-or-escalating-various-urate-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/comparative-risk-of-incident-and-recurrent-acute-anterior-uveitis-across-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/comparing-clinical-features-between-males-and-females-with-vexas-syndrome-data-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/comparing-construct-validity-measurement-instruments-pain-stiffness-axial-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/comparing-dapsa-dapsa28-and-das28-crp-in-patients-with-psoriatic-arthritis-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/comparing-immunogenicity-safety-following-transition-reference-rituximab-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/comparing-outcomes-early-active-rheumatoid-arthritis-initially-treated-inpatient-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/comparing-rituximab-cyclophosphamide-induction-therapy-childhood-onset-anti-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/comparing-the-safety-and-efficacy-of-nintedanib-starting-dose-in-patients-with-2024/2026-11-04T06:09:55Z https://currentrheuma.com/studies/comparison-asas-health-index-classified-as-radiographic-axial-spondyloarthritis-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/comparison-clinical-serological-features-thrombotic-antiphospholipid-syndrome-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/comparison-effect-treatment-nsaids-added-anti-tnf-therapy-anti-tnf-therapy-alone-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/comparison-efficacy-safety-proposed-biosimilar-msb11456-tocilizumab-reference-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/comparison-established-preliminarily-proposed-asas-mri-working-group-cut-offs-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/comparison-of-a-handheld-ultrasound-device-with-cart-based-ultrasound-for-the-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/comparison-of-active-tuberculosis-occurrence-associated-with-janus-kinase-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/comparison-of-anti-il-6-receptor-and-jak-inhibitors-in-patients-with-rheumatoid-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/comparison-of-attainment-and-protective-effects-of-lupus-low-disease-activity-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/comparison-of-cognitive-performance-measures-in-individuals-with-systemic-lupus-2024/2026-11-04T06:13:45Z https://currentrheuma.com/studies/comparison-of-efficacy-of-continuous-mycophenolate-mofetil-with-sequential-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/comparison-of-gout-flares-with-the-initiation-of-treat-to-target-allopurinol-and-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/comparison-of-late-onset-and-non-late-onset-systemic-lupus-erythematosus-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/comparison-of-methotrexate-and-azathioprine-as-the-first-line-steroid-sparing-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/comparison-of-radiological-and-functional-outcomes-of-conservative-treatment-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/comparison-of-retention-of-biologics-in-japanese-patients-with-elderly-onset-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/comparison-of-rituximab-efficacy-in-treatment-naive-and-refractory-inflammatory-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/comparison-of-serum-exosome-mirna-from-patients-with-raynauds-phenomenon-with-2024/2026-11-04T03:15:15Z https://currentrheuma.com/studies/comparison-of-the-efficacy-of-janus-kinase-inhibitors-and-adalimumab-in-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/comparison-of-three-physician-global-assessment-instruments-in-systemic-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/comparison-of-weight-loss-interventions-in-overweight-and-obese-adults-with-knee-2024/2026-11-04T03:22:35Z https://currentrheuma.com/studies/comparison-sle-risk-probability-index-slerpi-scale-against-european-league-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/comparison-systemic-lupus-international-collaborating-clinics-2012-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/comparison-voclosporin-based-triple-immunosuppressive-therapy-high-dose-2024/2026-11-04T00:09:46Z https://currentrheuma.com/studies/comprehensive-analysis-trends-inequalities-rheumatoid-arthritis-burden-women-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/comprehensive-relationship-between-combined-anti-inflammatory-healthy-diets-all-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/compression-ratio-a-novel-method-to-quantify-compressibility-as-a-diagnostic-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/computable-phenotype-for-real-world-data-driven-retrospective-identification-of-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/concomitant-sjogrens-disease-as-a-biomarker-for-treatment-effectiveness-in-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/concordance-and-agreement-between-different-activity-scores-in-polymyalgia-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/consensus-on-the-definitions-and-descriptions-of-the-domains-of-the-omeract-core-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/consensus-on-transition-care-for-juvenile-idiopathic-arthritis-a-delphi-study-2024/2026-11-04T00:12:21Z https://currentrheuma.com/studies/conservative-treatments-in-the-management-of-acute-painful-vertebral-compression-2024/2026-11-04T03:25:32Z https://currentrheuma.com/studies/considering-belimumab-during-pregnancy-a-more-viable-option-over-time-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/construct-validity-promis-pain-interference-fatigue-physical-function-as-patient-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/construct-validity-responsiveness-asas-health-index-assessed-two-longitudinal-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/consumption-of-total-and-specific-alcoholic-beverages-and-long-term-risk-of-gout-2024/2026-11-04T03:25:32Z https://currentrheuma.com/studies/continued-jak-inhibitor-treatment-risk-recurrent-herpes-zoster-reactivation-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/contribution-of-inflammation-markers-and-quantitative-sensory-testing-qst-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/contribution-of-left-ventricular-diastolic-dysfunction-to-survival-and-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/contributors-to-organ-damage-in-childhood-lupus-corticosteroid-use-and-disease-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/convergence-and-divergence-in-kawasaki-disease-and-multisystem-inflammatory-2024/2026-11-04T06:11:16Z https://currentrheuma.com/studies/coronary-artery-calcification-progression-in-patients-with-systemic-lupus-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/coronary-artery-calcium-and-atherosclerotic-cardiovascular-disease-risk-scores-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/correction-omega-3-fatty-acid-deficiency-improvement-disease-activity-systemic-2024/2026-11-04T03:18:08Z https://currentrheuma.com/studies/correlation-between-circulating-cell-free-mitochondrial-dna-content-severity-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/correlation-between-the-changes-of-brain-amplitude-of-low-frequency-fluctuation-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/correlation-between-the-oxygenation-status-of-extrasynovial-tissue-in-the-wrist-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/correlation-high-resolution-computed-tomography-immunological-bronchoalveolar-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/correlation-of-professional-antigen-presenting-tbet-cd11c-b-cells-with-bone-2024/2026-11-04T05:52:08Z https://currentrheuma.com/studies/corticosteroid-injections-and-risk-of-fracture-2024/2026-11-04T06:21:48Z https://currentrheuma.com/studies/cost-effectiveness-intervention-thresholds-for-romosozumab-and-teriparatide-in-2024/2026-11-04T00:13:51Z https://currentrheuma.com/studies/cost-effectiveness-of-biosimilars-vs-leflunomide-in-patients-with-rheumatoid-2024/2026-11-04T06:21:48Z https://currentrheuma.com/studies/cost-effectiveness-of-community-based-diet-and-exercise-for-patients-with-knee-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/cost-effectiveness-of-frax-based-intervention-thresholds-for-management-of-2024/2026-11-04T00:13:51Z https://currentrheuma.com/studies/cost-effectiveness-of-romosozumab-for-the-treatment-of-postmenopausal-women-with-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/cost-effectiveness-osteoporosis-medications-preventing-periprosthetic-fractures-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/cost-related-medication-behaviors-for-patients-with-and-without-systemic-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/cost-utility-analysis-of-longstanding-exercise-therapy-versus-usual-care-in-2024/2026-11-04T00:05:39Z https://currentrheuma.com/studies/cost-utility-of-tofacitinib-in-the-treatment-of-moderate-to-severe-rheumatoid-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/could-tocilizumab-be-used-in-familial-mediterranean-fever-a-systematic-review-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/counteracting-tryptophan-metabolism-alterations-as-a-new-therapeutic-strategy-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/covid-19-vaccinations-and-infections-among-individuals-with-systemic-sclerosis-a-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/critical-peripheral-ischemia-higher-prevalence-in-indian-systemic-lupus-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/cross-sectional-studies-of-the-causal-link-between-asthma-and-osteoporosis-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/cryoneurolysis-radiofrequency-ablation-outcome-pain-experience-chronic-low-back-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/ct-based-comprehensive-scoring-system-for-assessing-hip-arthropathy-in-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/ct-image-based-biomarkers-for-opportunistic-screening-of-osteoporotic-fractures-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/ct-informs-detection-and-treatment-options-in-rheumatoid-arthritis-complicated-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/current-smoking-is-related-to-severe-damage-in-systemic-lupus-erythematosus-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/current-treatment-in-macrophage-activation-syndrome-worldwide-a-systematic-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/cut-offs-disease-activity-states-axial-spondyloarthritis-ankylosing-spondylitis-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/cutaneous-vasculitis-in-systemic-lupus-erythematosus-epidemiology-and-risk-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/cxcl9-may-serve-as-a-potential-biomarker-for-primary-sjogrens-syndrome-with-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/cytomegalovirus-infection-and-disease-in-systemic-lupus-erythematosus-patients-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/cytotoxic-cx3cr1-t-cells-drive-vascular-inflammation-in-giant-cell-arteritis-but-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/damage-index-antiphospholipid-syndrome-diaps-antiphospholipid-syndrome-alliance-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/damage-large-systemic-lupus-erythematosus-cohort-spanish-society-rheumatology-2024/2026-11-04T03:18:08Z https://currentrheuma.com/studies/damaged-bone-microarchitecture-trabecular-bone-score-tbs-low-appendicular-muscle-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/dancing-with-disorder-chorea-an-unusual-and-neglected-manifestation-of-2024/2026-11-04T00:09:46Z https://currentrheuma.com/studies/danish-translation-and-cultural-adaptation-of-the-psoriatic-arthritis-2024/2026-11-04T09:23:05Z https://currentrheuma.com/studies/data-driven-subclassification-of-anca-associated-vasculitis-model-based-2024/2026-11-04T02:58:58Z https://currentrheuma.com/studies/data-quality-and-patient-characteristics-in-european-anca-associated-vasculitis-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/de-novo-manifestations-during-adalimumab-treatment-in-behcets-syndrome-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/deciding-to-attend-the-emergency-department-experiences-of-patients-with-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/decision-aid-led-tapering-of-biologic-and-targeted-synthetic-disease-modifying-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/declining-incidence-systemic-lupus-erythematosus-norway-1999-2017-data-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/decreased-expression-of-nat10-in-peripheral-blood-mononuclear-cells-from-new-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/deep-immunophenotyping-reveals-that-autoimmune-autoinflammatory-disorders-are-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/deep-learning-based-classification-of-erosion-synovitis-and-osteitis-in-hand-mri-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/deep-learning-ct-imaging-algorithm-detect-usual-interstitial-pneumonia-pattern-2024/2026-11-03T10:53:39Z https://currentrheuma.com/studies/deep-learning-enables-automatic-detection-of-joint-damage-progression-in-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/deep-learning-in-the-precise-assessment-of-primary-sjogrens-syndrome-based-on-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/defects-in-b-lymphopoiesis-and-b-cell-maturation-underlie-prolonged-b-cell-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/deficiency-of-peripheral-cla-tregs-and-clinical-relevance-in-behcets-syndrome-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/defining-cause-of-death-in-a-contemporary-cohort-with-anca-associated-vasculitis-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/defining-criteria-for-disease-activity-states-in-juvenile-dermatomyositis-based-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/defining-criteria-for-disease-activity-states-in-systemic-juvenile-idiopathic-2024/2026-11-04T05:52:08Z https://currentrheuma.com/studies/defining-domains-developing-consensus-based-definitions-for-foundational-domains-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/defining-the-minimal-important-change-and-meaningful-change-value-of-the-disease-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/definition-of-rheumatoid-arthritis-flare-based-on-sdai-and-cdai-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/definitions-of-and-instruments-for-disease-activity-remission-and-relapse-in-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/definitions-of-rheumatoid-arthritis-flare-and-how-they-relate-to-patients-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/delay-in-fibromyalgia-diagnosis-and-its-impact-on-the-severity-and-outcome-a-2024/2026-11-04T06:11:16Z https://currentrheuma.com/studies/demographics-and-clinical-features-associated-with-abnormal-small-bowel-motility-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/denosumab-and-the-risk-of-diabetes-in-patients-treated-for-osteoporosis-2024/2026-11-04T09:34:58Z https://currentrheuma.com/studies/denosumab-vs-bisphosphonates-in-primary-osteoporosis-a-meta-analysis-of-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/depression-anxiety-and-cognitive-function-in-persons-with-inflammatory-rheumatic-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/deregulation-in-adult-iga-vasculitis-skin-as-the-basis-for-the-discovery-of-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/dermal-cellular-senescence-and-endmt-in-patients-with-systemic-sclerosis-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/description-of-a-novel-splice-site-variant-in-uba1-gene-causing-vexas-syndrome-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/description-of-self-efficacy-for-managing-symptoms-and-emotions-in-a-large-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/description-of-the-characteristics-of-the-nailfold-capillary-structure-in-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/detecting-new-erosions-in-rheumatoid-arthritis-over-one-year-radiography-and-2024/2026-11-04T00:06:14Z https://currentrheuma.com/studies/detection-decline-pulmonary-function-systemic-sclerosis-associated-interstitial-2024/2026-11-03T23:51:04Z https://currentrheuma.com/studies/detection-of-anti-calreticulin-antibody-in-the-sera-of-chinese-patients-with-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/detection-of-genetic-mutations-underlying-early-onset-systemic-lupus-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/detection-of-hypophosphatasia-in-hospitalised-adults-in-rheumatology-and-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/detection-of-inflammation-by-whole-body-mri-in-young-people-with-juvenile-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/detection-of-interstitial-lung-disease-in-rheumatoid-arthritis-by-thoracic-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/determinants-associated-with-the-prescription-of-a-first-biologic-therapy-in-2024/2026-11-04T03:14:48Z https://currentrheuma.com/studies/determinants-of-radiographic-progression-in-early-psoriatic-arthritis-insights-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/determinants-of-self-management-behavior-in-gout-a-scoping-review-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/determination-combined-effects-asian-herbal-medicine-calcium-or-vitamin-d-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/determination-of-the-factors-associated-with-antigen-specific-cd4-t-cell-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/determination-of-the-most-appropriate-acr-response-definition-for-contemporary-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/determining-patient-and-carer-priorities-in-inclusion-body-myositis-a-patient-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/deucravacitinib-a-selective-tyk2-inhibitor-in-psoriatic-arthritis-achievement-of-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/developing-a-novel-surgical-care-access-score-for-patients-with-osteoarthritis-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/developing-fracture-liaison-service-framework-based-on-comparative-analysis-and-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/development-and-evaluation-of-a-text-analytics-algorithm-for-automated-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/development-and-evaluation-of-shared-decision-making-tools-in-rheumatology-a-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/development-and-external-validation-of-a-prediction-model-for-interstitial-lung-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/development-and-initial-validation-of-parent-and-child-versions-of-the-juvenile-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/development-and-initial-validation-of-the-novel-scleroderma-clinical-trials-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/development-and-internal-external-cross-validation-of-a-patient-reported-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/development-and-internal-validation-of-a-clinical-and-genetic-risk-score-for-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/development-and-validation-of-a-new-tool-for-assessment-of-trainees-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/development-and-validation-of-a-nomogram-for-predicting-the-interstitial-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/development-and-validation-of-a-pediatric-internationally-agreed-ultrasound-knee-2024/2026-11-04T00:12:21Z https://currentrheuma.com/studies/development-and-validation-of-a-risk-scoring-system-to-identify-patients-with-2024/2026-11-04T06:13:45Z https://currentrheuma.com/studies/development-and-validation-of-a-self-updating-gout-register-from-electronic-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/development-diagnostic-prediction-model-giant-cell-arteritis-sequential-2024/2026-11-04T09:04:37Z https://currentrheuma.com/studies/development-international-consensus-standardised-image-acquisition-protocol-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/development-of-a-core-domain-set-for-ankle-osteoarthritis-an-international-2024/2026-11-04T03:22:35Z https://currentrheuma.com/studies/development-of-a-machine-learning-model-to-predict-the-use-of-surgery-in-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/development-of-a-measuring-app-for-systemic-sclerosis-related-digital-ulceration-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/development-of-a-multivariable-prediction-model-for-progression-of-systemic-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/development-of-a-predictive-model-for-systemic-lupus-erythematosus-incidence-2024/2026-11-04T00:09:46Z https://currentrheuma.com/studies/development-of-a-web-based-ecological-momentary-assessment-tool-to-measure-day-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/development-of-an-ultrasound-imaging-atlas-for-grading-osteoarthritis-in-the-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/development-of-autoimmune-diseases-among-children-with-pediatric-acute-onset-2024/2026-11-04T03:25:32Z https://currentrheuma.com/studies/development-of-differential-diagnostic-models-for-distinguishing-between-limb-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/development-of-the-2023-acr-eular-antiphospholipid-syndrome-classification-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/development-of-the-american-college-of-rheumatology-patient-reported-outcome-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/development-of-the-takayasu-arteritis-integrated-disease-activity-index-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/development-paediatric-society-african-league-against-rheumatism-paflar-jia-2024/2026-11-04T03:21:42Z https://currentrheuma.com/studies/development-rheumatoid-arthritis-after-methotrexate-anticitrullinated-protein-2024/2026-11-04T02:58:58Z https://currentrheuma.com/studies/diagnosing-a-child-presenting-with-symptoms-suggesting-sjogrens-disease-a-tool-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/diagnosis-challenges-in-inception-cohorts-in-axial-spondyloarthritis-the-case-of-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/diagnosis-of-giant-cell-arteritis-by-18f-fdg-pet-ct-in-patients-on-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/diagnostic-accuracy-axial-spondyloarthritis-systematic-evaluation-role-clinical-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/diagnostic-accuracy-of-artificial-intelligence-models-in-detecting-osteoporosis-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/diagnostic-accuracy-of-hip-joint-ultrasound-for-detection-of-calcium-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/diagnostic-accuracy-of-raman-spectroscopy-integrated-with-polarized-light-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/diagnostic-accuracy-of-serum-biomarkers-to-identify-giant-cell-arteritis-in-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/diagnostic-delay-in-patients-from-the-international-map-of-axial-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/diagnostic-pathway-and-treatment-preferences-for-systemic-lupus-erythematosus-a-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/diagnostic-performance-of-radiomics-for-predicting-osteoporosis-in-adults-a-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/diagnostic-value-of-a-novel-salivary-gland-ultrasound-scoring-system-in-igg4-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/diagnostic-value-of-minor-salivary-gland-biopsy-for-sjogrens-syndrome-in-2024/2026-11-04T00:06:14Z https://currentrheuma.com/studies/dietary-inflammatory-index-magnetic-resonance-imaging-detected-knee-structural-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/differences-in-femoral-fracture-localizations-in-men-and-women-in-switzerland-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/differences-in-reproductive-health-discussions-in-an-urban-hispanic-population-2024/2026-11-04T09:26:49Z https://currentrheuma.com/studies/differences-in-the-autoantibody-phenotypes-and-long-term-outcomes-between-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/different-bone-health-progression-patterns-and-early-stage-risk-marker-in-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/different-disease-activity-trajectories-early-axial-spondyloarthritis-lead-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/different-giant-cell-arteritis-phenotypes-may-present-distinct-types-of-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/different-immunologic-profiles-are-associated-with-distinct-clinical-phenotypes-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/different-patterns-of-longitudinal-changes-in-antinuclear-antibodies-titers-in-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/different-phenotypic-manifestations-between-brazilian-and-japanese-anti-mda5-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/different-subtypes-cam-morphology-as-defined-statistical-shape-modeling-their-2024/2026-11-04T03:22:35Z https://currentrheuma.com/studies/difficult-to-treat-concept-in-psoriatic-arthritis-analysis-of-2-potential-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/difficult-to-treat-psoriatic-arthritis-d2t-psa-a-scoping-literature-review-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/diffusion-tensor-imaging-of-vastus-lateralis-in-patients-with-inflammatory-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/digital-biomarkers-for-psoriatic-arthritis-a-qualitative-focus-group-study-on-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/digital-health-program-improves-quality-of-life-in-rheumatoid-arthritis-a-2024/2026-11-04T09:24:09Z https://currentrheuma.com/studies/digital-ulcers-systemic-sclerosis-are-strongly-associated-digital-arterial-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/diminished-expression-ubiquitin-proteasome-system-early-treatment-naive-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/diminished-vibration-perception-greater-pressure-pain-sensitivity-are-associated-2024/2026-11-04T06:17:41Z https://currentrheuma.com/studies/disability-related-to-the-upper-extremities-in-early-rheumatoid-arthritis-long-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/discovery-novel-missense-variant-nlrp3-causing-atypical-cryopyrin-associated-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/discovery-of-calcite-as-a-new-pro-inflammatory-calcium-containing-crystal-in-2024/2026-11-04T06:17:41Z https://currentrheuma.com/studies/disease-activity-and-quality-of-life-in-patients-with-systemic-lupus-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/disease-activity-drives-divergent-epigenetic-and-transcriptomic-reprogramming-of-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/disease-activity-guided-dose-optimization-including-discontinuation-tnf-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/disease-activity-trajectories-from-childhood-to-adulthood-in-the-population-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/disease-activity-trajectories-in-juvenile-dermatomyositis-from-childhood-to-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/disease-characteristics-medications-use-idiopathic-inflammatory-myopathy-multi-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/disease-evolution-and-organ-damage-accrual-in-patients-with-stable-uctd-a-long-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/disease-flares-with-baricitinib-dose-reductions-and-development-of-flare-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/disease-modifying-antirheumatic-drugs-risk-incident-interstitial-lung-disease-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/disease-modifying-drugs-for-adult-onset-rheumatoid-arthritis-2024/2026-11-04T09:34:04Z https://currentrheuma.com/studies/disease-response-in-rheumatoid-arthritis-across-four-biologic-therapies-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/disease-tailored-brief-intervention-for-alcohol-use-among-youths-with-chronic-2024/2026-11-04T03:25:32Z https://currentrheuma.com/studies/disentangling-riddle-systemic-lupus-erythematosus-antiphospholipid-syndrome-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/disparities-between-rural-and-urban-communities-response-to-18-months-of-diet-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/disparities-in-time-to-diagnosis-of-radiographic-axial-spondyloarthritis-2024/2026-11-03T17:30:27Z https://currentrheuma.com/studies/disruption-of-memory-b-cell-trafficking-by-belimumab-in-patients-with-systemic-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/distinct-clinical-trajectories-of-gastrointestinal-progression-among-patients-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/distinct-features-of-anca-associated-hypertrophic-pachymeningitis-compared-with-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/distinct-features-of-trisomy-8-associated-autoinflammatory-disease-from-behcets-2024/2026-11-03T11:13:22Z https://currentrheuma.com/studies/distinct-phenotype-and-prognosis-of-immune-mediated-necrotizing-myopathy-based-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/distinct-uric-acid-trajectories-are-associated-with-incident-cardiac-conduction-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/distinctive-clinical-traits-of-lupus-related-myocarditis-a-multicentre-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/distinctive-profile-of-monomeric-and-polymeric-anti-ssa-ro52-immunoglobulin-a1-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/diurnal-production-of-cortisol-and-prediction-of-treatment-response-in-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/diversity-and-epitope-spreading-of-anti-rna-polymerase-iii-antibodies-in-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/diving-deep-into-lupus-gastrointestinal-involvement-insights-from-the-oman-lupus-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/do-existing-magnetic-resonance-imaging-definitions-knee-osteoarthritis-identify-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/do-functionality-strength-vascularization-inflammatory-biopsychosocial-status-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/do-novel-inflammation-biomarkers-arising-from-routine-complete-blood-count-play-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/do-quality-of-life-and-work-productivity-change-in-early-axial-spondyloarthritis-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/do-sms-e-mail-reminders-increase-influenza-vaccination-rheumatoid-arthritis-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/doctor-artificial-intelligence-patient-physician-evaluation-large-language-model-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/does-adding-single-nucleotide-polymorphisms-risk-algorithms-improve-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/does-high-hepatic-bioavailability-enhance-the-effect-of-oral-compared-to-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/does-higher-compliance-american-college-sports-medicine-exercise-prescription-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/does-regression-skin-thickening-predict-improvement-internal-organ-involvement-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/does-standard-proteinuria-cut-off-renal-biopsy-lupus-nephritis-as-per-current-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/does-therapy-with-immunosuppressive-drugs-improve-gastrointestinal-symptoms-in-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/does-tocilizumab-eliminate-inflammation-in-gca-a-cohort-study-on-repeated-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/dose-response-relationship-between-alcohol-consumption-and-gout-risk-do-subtypes-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/drug-effectiveness-of-2nd-and-3rd-tnf-inhibitors-in-psoriatic-arthritis-2024/2026-11-04T06:10:35Z https://currentrheuma.com/studies/drug-induced-liver-injury-related-to-avacopan-therapy-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/drug-survival-analysis-etanercept-compared-monoclonal-antibody-tumour-necrosis-2024/2026-11-04T03:14:15Z https://currentrheuma.com/studies/drug-survival-predictor-factors-discontinuation-first-line-biologic-therapy-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/dual-mpo-pr3-anca-positivity-and-vasculitis-insights-from-a-7-cases-study-and-an-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/dupilumab-for-refractory-chronic-rhinosinusitis-in-eosinophilic-granulomatosis-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/duration-effect-treatment-methotrexate-intolerance-juvenile-idiopathic-arthritis-2024/2026-11-04T00:12:21Z https://currentrheuma.com/studies/dwi-scrolling-artery-sign-for-the-diagnosis-of-giant-cell-arteritis-a-pattern-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/dynamic-change-in-red-cell-distribution-width-as-a-predictor-for-short-time-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/dynamics-inflammation-associated-plasma-proteins-following-faecal-microbiota-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/dynamics-of-the-gut-microbiome-in-individuals-at-risk-of-rheumatoid-arthritis-a-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/dysregulation-of-circulating-collagen-turnover-markers-in-very-early-systemic-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/dystrophic-calcinosis-structural-and-morphological-composition-and-evaluation-of-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/early-clinical-response-associates-with-long-term-outcomes-with-ixekizumab-in-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/early-identification-of-macrophage-activation-syndrome-secondary-to-systemic-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/early-identification-of-rheumatoid-arthritis-does-it-induce-treatment-related-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/early-life-famine-exposure-and-risk-of-osteoporosis-and-low-bone-mineral-density-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/early-methotrexate-treatment-for-psoriatic-arthritis-prevention-in-psoriasis-2024/2026-11-04T00:06:14Z https://currentrheuma.com/studies/early-monitoring-of-anti-infliximab-antibodies-by-drug-tolerant-assay-predicts-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/early-rheumatoid-arthritis-anticitrullinated-peptide-antibodies-associate-low-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/early-stage-established-knee-osteoarthritis-comparative-observational-prevalence-2024/2026-11-04T00:13:14Z https://currentrheuma.com/studies/early-subclinical-macular-disease-in-asymptomatic-patients-with-primary-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/economic-burden-of-systemic-lupus-erythematosus-and-lupus-nephritis-in-france-a-2024/2026-11-04T00:06:14Z https://currentrheuma.com/studies/economic-evaluation-of-a-trial-exploring-the-effects-of-a-web-based-support-tool-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/educational-gradient-in-hip-fracture-incidence-in-norway-the-norwegian-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/effect-apremilast-hand-whole-body-mri-assessments-inflammation-psoriatic-2024/2026-11-03T23:51:04Z https://currentrheuma.com/studies/effect-baduanjin-qigong-transcranial-direct-current-stimulation-quality-sleep-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/effect-intravenous-zoledronic-acid-total-knee-replacement-symptomatic-knee-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/effect-modification-of-cancer-on-the-association-between-dysphagia-and-mortality-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/effect-of-a-billing-code-to-reimburse-nurse-supported-rheumatology-care-on-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/effect-of-age-on-rheumatic-immune-related-adverse-events-experience-from-the-2024/2026-11-03T17:30:27Z https://currentrheuma.com/studies/effect-of-ambrisentan-in-patients-with-systemic-sclerosis-and-mild-pulmonary-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/effect-of-bimekizumab-on-patient-reported-disease-impact-in-patients-with-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/effect-of-biologic-agents-and-inflammation-on-lipid-levels-and-cardiovascular-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/effect-of-collagen-supplementation-on-knee-osteoarthritis-an-updated-systematic-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/effect-of-exercise-training-on-heath-quality-of-life-exercise-capacity-in-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/effect-of-fibromyalgia-on-demographic-biochemical-metabolic-and-inflammatory-2024/2026-11-04T06:11:16Z https://currentrheuma.com/studies/effect-of-gender-and-age-on-bdmard-efficacy-for-axial-spondyloarthritis-patients-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/effect-of-heated-mittens-on-physical-hand-function-in-people-with-hand-2024/2026-11-04T00:15:50Z https://currentrheuma.com/studies/effect-of-high-intensity-interval-training-in-physiotherapy-primary-care-for-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/effect-of-hydroxychloroquine-on-pregnancy-outcome-in-patients-with-sle-a-2024/2026-11-04T00:09:46Z https://currentrheuma.com/studies/effect-of-isometric-quadriceps-exercise-on-local-microcirculation-of-the-2024/2026-11-04T06:17:41Z https://currentrheuma.com/studies/effect-of-online-training-on-the-reliability-of-assessing-sacroiliac-joint-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/effect-of-recent-antirheumatic-drug-on-features-of-rheumatoid-arthritis-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/effect-of-systemic-lupus-erythematosus-on-the-ovarian-reserve-a-systematic-2024/2026-11-04T06:10:35Z https://currentrheuma.com/studies/effect-of-tnf-blockers-on-reducing-the-risk-of-dementia-in-rheumatoid-arthritis-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/effect-of-using-the-simple-erosion-narrowing-score-or-sharp-van-der-heijde-score-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/effect-respiratory-muscle-training-respiratory-muscle-strength-diaphragm-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/effect-secukinumab-adalimumab-biosimilar-radiographic-progression-radiographic-2024/2026-11-04T05:52:08Z https://currentrheuma.com/studies/effect-shared-decision-making-trust-physicians-management-systemic-lupus-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/effectiveness-and-safety-of-adalimumab-compared-with-leflunomide-in-patients-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/effectiveness-and-safety-of-bisphosphonates-in-inflammatory-bone-disorders-a-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/effectiveness-and-safety-of-canakinumab-in-cryopyrin-associated-periodic-2024/2026-11-04T03:21:42Z https://currentrheuma.com/studies/effectiveness-and-safety-of-mycophenolate-mofetil-and-rituximab-combination-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/effectiveness-fracture-liaison-service-reducing-risk-secondary-fragility-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/effectiveness-ixekizumab-over-24-months-different-clinical-scenarios-psoriatic-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/effectiveness-jak-inhibitors-compared-biologic-disease-modifying-antirheumatic-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/effectiveness-longstanding-exercise-therapy-compared-usual-care-people-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/effectiveness-methotrexate-bridging-glucocorticoids-or-without-early-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/effectiveness-of-an-ehealth-delivered-program-to-empower-people-with-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/effectiveness-of-intravenous-methylprednisolone-pulse-in-patients-with-severe-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/effectiveness-of-janus-kinase-inhibitors-in-relapsing-giant-cell-arteritis-in-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/effectiveness-of-patient-education-on-the-quality-of-life-of-patients-with-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/effectiveness-of-pharmacological-therapies-for-fibromyalgia-syndrome-in-adults-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/effectiveness-of-pneumococcal-vaccination-in-adults-with-common-immune-mediated-2024/2026-11-04T02:58:58Z https://currentrheuma.com/studies/effectiveness-of-secukinumab-in-radiographic-and-non-radiographic-axial-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/effectiveness-of-sequential-lines-of-biologic-and-targeted-small-molecule-drugs-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/effectiveness-safety-intra-articular-interventions-knee-hip-osteoarthritis-based-2024/2026-11-04T03:22:35Z https://currentrheuma.com/studies/effects-neuromuscular-control-strengthening-exercises-mri-measured-thigh-tissue-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/effects-of-a-resilience-building-energy-management-program-on-fatigue-and-other-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/effects-of-biologics-on-temporomandibular-joint-inflammation-in-juvenile-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/effects-of-employees-living-with-an-arthritis-on-sickness-absence-and-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/effects-of-exercise-based-interventions-on-inflammatory-markers-in-patients-with-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/effects-of-interleukin-6-signal-inhibition-on-treg-subpopulations-and-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/effects-of-radiotherapy-for-malignancy-in-systemic-sclerosis-a-systematic-review-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/effects-of-social-vulnerability-and-environmental-burden-on-care-fragmentation-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/effects-of-systemic-lupus-erythematosus-on-the-brain-a-systematic-review-of-2024/2026-11-04T03:18:08Z https://currentrheuma.com/studies/effects-of-two-years-of-covid-19-pandemic-on-individuals-with-fibromyalgia-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/effects-of-upadacitinib-on-enthesitis-in-patients-with-psoriatic-arthritis-a-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/effects-suppressing-inflammation-tofacitinib-may-simultaneously-improve-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/effects-tapering-conventional-synthetic-disease-modifying-antirheumatic-drugs-2024/2026-11-04T05:53:11Z https://currentrheuma.com/studies/efficacy-and-glucocorticoid-sparing-of-dupilumab-in-igg4-related-disease-a-case-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/efficacy-and-safety-of-abatacept-in-preclinical-rheumatoid-arthritis-a-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/efficacy-and-safety-of-biologic-drugs-in-stills-disease-a-systematic-review-and-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/efficacy-and-safety-of-canakinumab-in-systemic-juvenile-idiopathic-arthritis-the-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/efficacy-and-safety-of-collagen-derivatives-for-osteoarthritis-a-trial-2024/2026-11-04T09:31:04Z https://currentrheuma.com/studies/efficacy-and-safety-of-filgotinib-in-patients-with-moderately-active-rheumatoid-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/efficacy-and-safety-of-filgotinib-in-patients-with-rheumatoid-arthritis-week-156-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/efficacy-and-safety-of-first-line-biological-dmards-in-rheumatoid-arthritis-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/efficacy-and-safety-of-guselkumab-in-patients-with-active-lupus-nephritis-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/efficacy-and-safety-of-iguratimod-combined-with-celecoxib-in-active-axial-2024/2026-11-04T06:09:55Z https://currentrheuma.com/studies/efficacy-and-safety-of-intravenous-secukinumab-for-the-treatment-of-active-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/efficacy-and-safety-of-intravenous-secukinumab-in-patients-with-active-axial-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/efficacy-and-safety-of-neridronate-in-paediatric-type-i-complex-regional-pain-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/efficacy-and-safety-of-targeted-therapies-in-vexas-syndrome-retrospective-study-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/efficacy-and-safety-of-treat-to-target-strategy-studies-in-rheumatic-diseases-a-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/efficacy-and-safety-of-upadacitinib-or-elsubrutinib-alone-or-in-combination-for-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/efficacy-and-safety-study-of-targeted-small-molecule-drugs-in-the-treatment-of-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/efficacy-baricitinib-moderate-severe-rheumatoid-arthritis-up-6-5-years-treatment-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/efficacy-of-different-exercises-in-women-with-fibromyalgia-syndrome-a-randomised-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/efficacy-of-initial-combination-with-belimumab-in-newly-diagnosed-childhood-2024/2026-11-04T00:09:46Z https://currentrheuma.com/studies/efficacy-of-methylprednisolone-in-very-early-systemic-sclerosis-results-of-the-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/efficacy-of-n-acetylcysteine-for-treating-dryness-symptoms-of-sjogrens-disease-2024/2026-11-04T03:15:15Z https://currentrheuma.com/studies/efficacy-of-physiotherapy-treatment-in-medium-and-long-term-in-adults-with-2024/2026-11-04T06:11:16Z https://currentrheuma.com/studies/efficacy-safety-and-optimal-intervention-of-belimumab-for-proliferative-lupus-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/efficacy-safety-candidate-biosimilar-ct-p41-reference-denosumab-double-blind-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/efficacy-safety-ct-p47-reference-tocilizumab-32-week-results-randomised-active-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/efficacy-safety-culture-expanded-mesenchymal-stromal-cell-therapy-treatment-4-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/efficacy-safety-diffusion-based-extended-release-fluticasone-propionate-intra-2024/2026-11-03T23:51:04Z https://currentrheuma.com/studies/efficacy-safety-infliximab-or-adalimumab-severe-mucocutaneous-behcets-syndrome-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/efficacy-safety-monoclonal-antibody-ak111-treatment-active-ankylosing-2024/2026-11-03T08:01:42Z https://currentrheuma.com/studies/efficacy-safety-pharmacological-treatment-psoriatic-arthritis-systematic-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/efficacy-safety-pharmacological-treatments-autoimmune-disease-associated-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/efficacy-safety-remibrutinib-selective-potent-oral-btk-inhibitor-sjogrens-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/efficacy-safety-sequential-therapy-subcutaneous-belimumab-one-cycle-rituximab-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/efficacy-safety-sodium-glucose-cotransporter-2-inhibitors-primary-prevention-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/efficacy-safety-step-down-regimen-low-dosage-glucocorticoids-combined-early-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/efficacy-safety-therapies-stills-disease-macrophage-activation-syndrome-mas-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/efficacy-safety-tofacitinib-ankylosing-spondylitis-baseline-c-reactive-protein-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/efficacy-safety-tofacitinib-open-label-long-term-extension-psoriatic-arthritis-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/efficacy-safety-upadacitinib-active-ankylosing-spondylitis-refractory-biologic-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/efficacy-safety-upadacitinib-rheumatoid-arthritis-inadequate-response-or-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/efficacy-versus-effectiveness-the-horizon-pivotal-fracture-trial-and-its-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/electrocardiographic-corrected-qt-interval-qt-dispersion-abnormalities-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/elevated-fcy-receptor-expression-augments-pro-inflammatory-macrophage-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/elevated-neutrophil-extracellular-traps-in-systemic-sclerosis-associated-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/elevated-serum-interferon-2-associates-with-activity-and-flare-risk-in-juvenile-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/elevated-serum-uric-acid-is-a-predictor-of-pulmonary-artery-involvement-and-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/elicitation-of-expert-prior-opinion-to-design-the-barjdm-trial-in-juvenile-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/emapalumab-treatment-rheumatologic-disease-associated-hemophagocytic-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/endoplasmic-reticulum-aminopeptidase-2-regulates-cd4-t-cells-pyroptosis-in-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/endpoints-and-outcomes-for-localized-scleroderma-morphea-a-scoping-literature-2024/2026-11-04T03:21:42Z https://currentrheuma.com/studies/enhanced-fracture-risk-prediction-a-novel-multi-trait-genetic-approach-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/enhanced-medullary-and-extramedullary-granulopoiesis-sustain-the-inflammatory-2024/2026-11-04T09:26:49Z https://currentrheuma.com/studies/enhanced-surveillance-for-the-detection-of-psoriatic-arthritis-in-a-uk-primary-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/enhanced-type-1-interferon-signature-in-axial-spondyloarthritis-patients-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/enhancement-of-intracellular-cholesterol-efflux-in-chondrocytes-leading-to-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/enhancing-current-guidance-for-psoriatic-arthritis-and-its-comorbidities-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/enhancing-diagnosis-of-gout-with-deep-learning-in-dual-energy-computed-2024/2026-11-03T10:53:39Z https://currentrheuma.com/studies/enrichment-of-rare-variants-of-hemophagocytic-lymphohistiocytosis-genes-in-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/enrolment-of-the-first-paediatric-cohort-into-the-australian-lupus-registry-and-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/enthesitis-european-registry-based-cohort-psoriatic-arthritis-treated-tumour-2024/2026-11-04T06:09:55Z https://currentrheuma.com/studies/eosinophilic-giant-cell-arteritis-a-different-subset-of-disease-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/epidemiological-characteristics-of-patients-with-juvenile-dermatomyositis-in-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/epidemiological-immunological-and-treatment-response-profile-of-patients-with-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/epidemiological-trends-in-psoriatic-arthritis-a-comprehensive-population-based-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/epidemiology-and-clinical-characteristics-of-biopsy-confirmed-adult-onset-iga-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/epidemiology-of-anca-vasculitis-in-northern-spain-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/epidemiology-of-hip-fractures-in-thailand-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/epidemiology-of-isolated-cutaneous-lupus-erythematosus-in-the-multiethnic-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/epidemiology-of-sle-in-italy-an-observational-study-using-a-primary-care-2024/2026-11-04T06:13:45Z https://currentrheuma.com/studies/epigenetic-regulatory-axis-mir22-tet3-mtrnr2l2-represses-fibroblast-like-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/epigenomic-differences-between-osteoarthritis-grades-in-primary-cartilage-2024/2026-11-04T03:22:35Z https://currentrheuma.com/studies/erg-regulates-lymphatic-vessel-specification-genes-and-its-deficiency-impairs-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/erosion-regression-in-patients-with-rheumatoid-arthritis-after-upadacitinib-a-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/erosions-t1-weighted-magnetic-resonance-imaging-radiography-sacroiliac-joints-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/erosive-hand-osteoarthritis-and-sarcopenia-data-from-osteoarthritis-initiative-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/erosive-progression-by-high-resolution-peripheral-quantitative-computed-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/escalation-to-biologics-after-methotrexate-among-us-veterans-with-rheumatoid-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/essential-fatty-acids-and-osteoarthritis-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/established-and-novel-insights-to-guide-cancer-assessment-in-patients-with-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/establishing-consensus-recommendations-long-term-osteoporosis-care-who-have-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/establishment-and-analysis-of-a-novel-diagnostic-model-for-systemic-juvenile-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/estimated-prevalence-incidence-and-healthcare-costs-of-sjogrens-syndrome-in-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/eular-points-to-consider-for-patient-education-in-physical-activity-and-self-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/eular-pres-recommendations-for-the-diagnosis-and-management-of-stills-disease-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/eular-recommendations-for-the-management-of-anca-associated-vasculitis-2022-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/eular-recommendations-for-the-management-of-psoriatic-arthritis-with-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/eular-recommendations-for-the-management-of-systemic-lupus-erythematosus-2023-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/eular-recommendations-for-the-non-pharmacological-core-management-of-hip-and-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/eular-recommendations-for-the-non-pharmacological-management-of-systemic-lupus-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/eular-recommendations-for-the-use-of-imaging-in-large-vessel-vasculitis-in-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/evaluating-ca-125-and-pet-ct-for-cancer-detection-in-idiopathic-inflammatory-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/evaluating-criteria-symptoms-suggestive-early-osteoarthritis-over-two-years-post-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/evaluating-factors-associated-telehealth-appropriateness-outpatient-rheumatoid-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/evaluating-real-world-effectiveness-belimumab-sle-using-sle-related-laboratory-2024/2026-11-04T06:13:45Z https://currentrheuma.com/studies/evaluating-safety-profile-calcineurin-inhibitors-cancer-risk-systemic-lupus-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/evaluating-the-associations-among-dysautonomia-gastrointestinal-transit-and-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/evaluating-the-efficacy-of-biologics-with-and-without-methotrexate-in-the-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/evaluating-the-impact-of-covid-19-on-dxa-waiting-lists-and-osteoporosis-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/evaluating-the-impact-of-type-2-diabetes-mellitus-on-interstitial-lung-disease-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/evaluation-coping-strategies-questionnaire-revised-fatigue-systemic-sclerosis-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/evaluation-diagnostic-performance-american-college-rheumatology-eular-national-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/evaluation-discontinuation-adverse-events-jak-inhibitors-bdmards-international-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/evaluation-nocebo-effect-after-switching-etanercept-or-adalimumab-originator-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/evaluation-of-changes-in-cardiac-longitudinal-strain-rate-in-patients-with-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/evaluation-of-depressive-and-anxiety-symptoms-in-childhood-onset-systemic-lupus-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/evaluation-of-dynamic-effects-of-depressive-symptoms-on-physical-function-in-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/evaluation-of-epicardial-adipose-tissue-thickness-and-carotid-intima-media-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/evaluation-of-health-literacy-and-its-association-with-medication-adherence-and-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/evaluation-of-myocarditis-in-patients-with-still-disease-clinical-findings-from-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/evaluation-of-osteoarthritis-disease-burden-in-china-during-1990-2019-and-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/evaluation-of-rnase-therapy-in-systemic-lupus-erythematosus-a-randomised-phase-2024/2026-11-04T09:26:49Z https://currentrheuma.com/studies/evaluation-of-survivin-expression-and-regulating-mirnas-of-survivin-expression-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/evaluation-of-temporomandibular-joint-involvement-in-juvenile-idiopathic-2024/2026-11-04T00:12:21Z https://currentrheuma.com/studies/evaluation-of-the-european-society-of-cardiology-risk-assessment-score-in-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/evaluation-of-the-rheumatoid-arthritis-impact-of-disease-raid-score-in-assessing-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/evaluation-of-thyroid-dysfunction-in-childhood-onset-systemic-lupus-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/evaluation-proximod-selective-agonist-sphingosine-1-phosphate-receptor-1-healthy-2024/2026-11-03T23:51:04Z https://currentrheuma.com/studies/evaluation-randomised-controlled-home-urinalysis-testing-sle-at-elevated-risk-2024/2026-11-04T00:09:46Z https://currentrheuma.com/studies/evidence-based-hierarchy-of-pain-outcome-measures-for-osteoarthritis-clinical-2024/2026-11-04T03:22:35Z https://currentrheuma.com/studies/evidence-of-site-specific-mucosal-autoantibody-secretion-in-rheumatoid-arthritis-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/evidence-that-autoantibody-production-may-be-driven-by-acute-epstein-barr-virus-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/ex-vivo-cell-based-assay-for-assessment-of-response-to-tnf-inhibitors-in-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/exacerbating-effects-of-circadian-rhythm-disruption-on-the-systemic-lupus-2024/2026-11-04T06:13:45Z https://currentrheuma.com/studies/examination-of-antinuclear-antibody-staining-patterns-and-titers-in-patients-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/examining-the-biological-pathways-underlying-clinical-heterogeneity-in-sjogrens-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/examining-treatment-targets-and-equity-in-bone-active-medication-use-within-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/exome-sequencing-of-chinese-patients-with-anticitrullinated-protein-antibody-2024/2026-11-03T17:30:27Z https://currentrheuma.com/studies/expansion-of-hla-dr-positive-peripheral-helper-t-and-naive-b-cells-in-2024/2026-11-04T05:52:08Z https://currentrheuma.com/studies/experiences-with-patient-initiated-follow-up-supported-by-asynchronous-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/exploration-combined-role-immune-checkpoints-immune-cells-diagnosis-treatment-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/exploratory-analysis-potential-disconnect-between-objective-inflammatory-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/exploratory-neutron-tomography-of-articular-cartilage-2024/2026-11-04T09:31:04Z https://currentrheuma.com/studies/exploring-a-novel-outcome-measure-of-symptom-progression-in-knee-osteoarthritis-2024/2026-11-04T00:13:14Z https://currentrheuma.com/studies/exploring-complement-biomarkers-in-suspected-axial-spondyloarthritis-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/exploring-effect-primary-endpoints-trials-testing-targeted-therapy-interventions-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/exploring-experiences-people-knee-osteoarthritis-who-received-physiotherapist-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/exploring-gastrointestinal-manifestations-in-childhood-onset-systemic-lupus-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/exploring-influence-baseline-rheumatoid-factor-levels-tnf-inhibitor-retention-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/exploring-paediatric-rheumatology-care-a-ten-year-retrospective-analysis-of-the-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/exploring-pain-adaptation-in-youth-with-juvenile-idiopathic-arthritis-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/exploring-radiographic-patterns-of-the-cervical-spine-including-zygapophyseal-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/exploring-relief-for-behcets-disease-refractory-oral-ulcers-a-comparison-of-tnf-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/exploring-reproductive-experiences-with-women-enrolled-in-the-international-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/exploring-the-association-between-serum-vitamin-d-levels-and-the-development-of-2024/2026-11-04T03:21:42Z https://currentrheuma.com/studies/exploring-the-association-of-gender-role-expectations-of-pain-and-measures-of-2024/2026-11-04T06:17:41Z https://currentrheuma.com/studies/exploring-the-causal-association-between-rheumatoid-arthritis-and-the-risk-of-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/exploring-the-unifying-concept-of-spondyloarthritis-a-latent-class-analysis-of-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/exposure-to-air-pollutants-and-rheumatoid-arthritis-biomarkers-a-scoping-review-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/exposure-to-air-pollution-might-decrease-bone-mineral-density-and-increase-the-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/expression-and-significance-of-nf-b-and-hsp90-in-renal-puncture-tissues-and-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/expression-of-cd163-and-major-histocompatibility-complex-class-i-as-diagnostic-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/expression-quantitative-trait-loci-analysis-in-rheumatoid-arthritis-identifies-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/extracellular-mitochondrial-components-as-new-biomarkers-for-lupus-nephritis-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/extracorporeal-membrane-oxygenation-for-acute-lung-injury-in-idiopathic-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/extracting-immunological-and-clinical-heterogeneity-across-autoimmune-rheumatic-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/extrarenal-symptoms-associate-with-worse-quality-of-life-in-patients-enrolled-in-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/factors-affecting-different-covid-19-outcomes-in-patients-with-systemic-lupus-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/factors-affecting-discrepancies-disease-activity-evaluation-between-physicians-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/factors-associated-biological-targeted-synthetic-disease-modifying-antirheumatic-2024/2026-11-03T23:51:04Z https://currentrheuma.com/studies/factors-associated-disease-flare-following-sars-cov-2-vaccination-people-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/factors-associated-electronic-health-record-based-definition-postacute-sequelae-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/factors-associated-satisfaction-social-roles-activities-people-systemic-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/factors-associated-severity-mortality-covid-19-connective-tissue-diseases-2024/2026-11-04T00:06:14Z https://currentrheuma.com/studies/factors-associated-treatment-pathways-early-axial-spondyloarthritis-multistate-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/factors-associated-with-adherence-of-cervical-cancer-screening-in-women-with-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/factors-associated-with-diagnostic-delay-in-axial-spondyloarthritis-impact-of-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/factors-associated-with-dietary-practices-and-beliefs-on-food-of-patients-with-2024/2026-11-04T03:14:48Z https://currentrheuma.com/studies/factors-associated-with-early-clinical-remission-in-patients-with-idiopathic-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/factors-associated-with-long-term-opioid-use-among-patients-with-axial-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/factors-associated-with-non-adherence-to-medications-in-systemic-lupus-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/factors-associated-with-physical-function-among-people-with-systemic-sclerosis-a-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/factors-associated-with-poor-mental-health-in-patients-with-axial-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/factors-predictive-severe-thrombocytopenia-its-impact-poor-outcomes-latin-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/factors-related-to-elevated-serum-immunoglobulin-g4-igg4-levels-in-a-japanese-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/fam13a-polymorphism-is-associated-with-a-usual-interstitial-pneumonia-pattern-in-2024/2026-11-03T10:53:39Z https://currentrheuma.com/studies/familial-mediterranean-fever-in-patients-with-inflammatory-bowel-diseases-a-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/family-caregiver-influence-on-osteoporosis-management-for-older-people-an-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/family-history-of-arthritis-osteoporosis-and-carpal-tunnel-syndrome-and-risk-of-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/fat-body-mass-and-vertebral-fracture-progression-in-women-with-breast-cancer-2024/2026-11-04T09:34:58Z https://currentrheuma.com/studies/fatigue-levels-and-associated-factors-in-systemic-sclerosis-a-cross-sectional-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/fatty-acid-intake-and-polyunsaturated-fatty-acid-biomarkers-and-risk-of-total-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/favourable-humoral-but-reduced-cellular-immune-response-to-covid-19-mrna-2024/2026-11-04T03:18:08Z https://currentrheuma.com/studies/fc-receptor-iiia-bioactivity-of-circulating-and-synovial-immune-complexes-in-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/feasibility-of-physiotherapist-led-rheumatology-triage-a-randomized-study-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/features-associated-different-inflammatory-phenotypes-calcium-pyrophosphate-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/features-of-axial-spondyloarthritis-in-two-multicenter-cohorts-of-patients-with-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/fibroblast-activation-protein-inhibitor-positron-emission-tomography-imaging-in-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/fibroblast-activation-protein-inhibitor-positron-emission-tomography-in-aortitis-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/fibroblast-activities-are-associated-with-prolonged-qtc-and-pulmonary-arterial-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/fibroblast-like-synoviocyte-targeting-antibodies-are-associated-failure-reach-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/fibromyalgia-mood-disorders-chronic-damage-are-main-determinants-worse-quality-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/field-testing-and-clinical-validation-of-the-msquash-to-measure-physical-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/fine-particulate-matter-components-and-risk-of-rheumatoid-arthritis-a-large-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/first-fracture-in-rheumatoid-arthritis-analysis-by-fracture-site-gender-age-and-2024/2026-11-04T00:13:51Z https://currentrheuma.com/studies/five-year-follow-up-of-patients-with-difficult-to-treat-rheumatoid-arthritis-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/flare-prediction-after-tapering-the-dose-of-tumour-necrosis-factor-inhibitors-in-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/fluid-cognition-among-individuals-with-systemic-lupus-erythematosus-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/follow-up-ultrasound-examination-in-patients-with-newly-diagnosed-giant-cell-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/forefoot-inflammation-in-recent-onset-acpa-positive-and-acpa-negative-ra-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/four-year-effectiveness-safety-and-drug-retention-rate-of-secukinumab-in-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/four-year-secukinumab-treatment-outcomes-in-european-real-world-patients-with-2024/2026-11-04T00:06:14Z https://currentrheuma.com/studies/fracture-risk-among-living-kidney-donors-25-years-after-donation-2024/2026-11-04T09:34:58Z https://currentrheuma.com/studies/fracture-risk-assessment-in-the-presence-of-competing-risk-of-death-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/fractures-in-patients-with-acute-calcium-pyrophosphate-crystal-arthritis-versus-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/fragility-of-randomised-controlled-trials-for-systemic-lupus-erythematosus-and-2024/2026-11-04T09:26:49Z https://currentrheuma.com/studies/fragmented-qrs-complex-could-predict-all-cause-mortality-in-patients-with-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/frailty-and-risk-of-serious-infections-in-patients-with-rheumatoid-arthritis-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/frailty-assessment-in-patients-with-systemic-sclerosis-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/frailty-is-independently-associated-with-subclinical-cardiovascular-disease-in-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/frequency-and-characteristics-of-severe-relapses-in-giant-cell-arteritis-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/frequency-and-implications-of-malnutrition-in-systemic-sclerosis-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/frequency-of-irritable-bowel-syndrome-in-spondyloarthritis-a-multicentric-cross-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/frequency-of-sarcopenia-in-turkish-women-with-systemic-lupus-erythematosus-2024/2026-11-04T06:13:45Z https://currentrheuma.com/studies/frequent-use-of-prescription-nsaids-among-people-with-knee-or-hip-osteoarthritis-2024/2026-11-04T03:22:35Z https://currentrheuma.com/studies/frequently-encountered-artifacts-application-dual-energy-computed-tomography-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/fty720-ameliorates-experimental-mpo-anca-associated-vasculitis-by-regulating-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/functional-patient-reported-outcome-measures-after-hip-or-knee-arthroplasty-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/gabapentinoids-and-risk-of-hip-fracture-2024/2026-11-04T00:16:14Z https://currentrheuma.com/studies/gait-alterations-association-worsening-knee-pain-physical-function-machine-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/gastrointestinal-disorders-in-systemic-sclerosis-cluster-analysis-and-prognosis-2024/2026-11-04T03:15:15Z https://currentrheuma.com/studies/gastrointestinal-dysmotility-is-associated-with-proton-pump-inhibitor-refractory-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/gender-and-age-differences-in-the-associations-between-cortical-thickness-and-2024/2026-11-04T06:17:41Z https://currentrheuma.com/studies/gender-differences-in-patterns-of-cartilage-loss-data-from-the-osteoarthritis-2024/2026-11-04T06:17:41Z https://currentrheuma.com/studies/gene-association-analysis-to-determine-the-causal-relationship-between-immune-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/general-and-pain-associated-psychological-distress-phenotypes-among-patients-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/generating-list-potentially-important-contextual-factors-covering-randomized-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/genes-deregulated-in-giant-cell-arteritis-by-nanostring-ncounter-gene-expression-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/genetic-analysis-of-asymptomatic-antinuclear-antibody-production-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/genetic-association-of-antinuclear-antibodies-with-hla-in-jia-patients-a-swedish-2024/2026-11-04T03:21:42Z https://currentrheuma.com/studies/genetic-association-of-juvenile-idiopathic-arthritis-with-adult-rheumatic-2024/2026-11-04T00:16:14Z https://currentrheuma.com/studies/genetic-influence-on-osteoarthritis-versus-other-rheumatic-diseases-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/genetic-risk-lifestyle-adherence-and-risk-of-developing-hyperuricaemia-in-a-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/genetic-susceptibility-and-clinical-features-of-cyp2d6-associated-with-systemic-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/genetically-predicted-circulating-interleukin-18-levels-are-associated-with-risk-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/genetically-proxied-interleukin-13-inhibition-is-associated-with-risk-of-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/genetics-of-neonatal-lupus-erythematosus-risk-and-specific-manifestations-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/gitr-gitrl-interaction-promotes-the-expansion-of-t-helper-9-and-t-helper-17-in-2024/2026-11-03T08:01:42Z https://currentrheuma.com/studies/gla-d-to-be-walking-better-change-in-self-reported-difficulty-walking-after-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/global-burden-of-early-onset-osteoarthritis-1990-2019-results-from-the-global-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/global-health-axial-spondyloarthritis-thresholds-assessment-spondyloarthritis-2024/2026-11-04T00:05:39Z https://currentrheuma.com/studies/global-regional-and-national-burden-of-gout-1990-2020-and-projections-to-2050-a-2024/2026-11-04T02:58:58Z https://currentrheuma.com/studies/global-regional-national-temporal-trends-prevalence-musculoskeletal-disorders-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/global-tuberculosis-disease-and-infection-in-systemic-lupus-erythematosus-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/glucocorticoid-free-remission-in-patients-with-sle-in-the-era-of-biologics-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/glucocorticoid-sparing-effect-janus-kinase-inhibitors-compared-biologic-disease-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/glucosamine-and-cancer-incidence-in-osteoarthritis-a-prevalent-new-user-cohort-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/glymphatic-abnormality-in-systemic-lupus-erythematosus-detected-by-diffusion-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/good-response-nonsteroidal-antiinflammatory-drugs-does-not-discriminate-2024/2026-11-04T09:22:05Z https://currentrheuma.com/studies/goodbye-to-the-term-ankylosing-spondylitis-hello-axial-spondyloarthritis-time-to-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/gout-in-native-hawaiian-patients-in-hawai-i-clinical-characteristics-and-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/gout-risk-in-adults-with-pre-diabetes-initiating-metformin-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/gout-was-like-the-boss-a-qualitative-study-exploring-the-impact-of-gout-on-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/granulin-in-renal-tubular-epithelia-is-associated-with-interstitial-inflammation-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/granulocyte-macrophage-colony-stimulating-factor-neutralisation-axial-2024/2026-11-04T05:53:11Z https://currentrheuma.com/studies/granulomatosis-with-polyangiitis-with-and-without-antineutrophil-cytoplasmic-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/granzyme-b-producing-regulatory-b-cells-in-patients-with-giant-cell-arteritis-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/grappa-2023-annual-meeting-report-hot-topic-session-on-measurement-of-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/grappa-debate-targeted-small-molecules-versus-biologics-as-first-line-systemic-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/group-3-innate-lymphoid-cells-promotes-th17-cells-differentiation-in-rheumatoid-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/group-based-trajectories-of-potentially-preventable-hospitalisations-among-older-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/growth-arrest-specific-protein-6-as-a-marker-of-nephritis-in-systemic-sclerosis-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/guselkumab-provides-durable-improvement-across-psoriatic-arthritis-disease-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/gut-microbiome-and-bone-health-update-on-mechanisms-clinical-correlations-and-2024/2026-11-04T00:13:51Z https://currentrheuma.com/studies/gut-microbiome-and-intestinal-inflammation-in-preclinical-stages-of-rheumatoid-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/gut-microbiome-composition-and-intestinal-immunity-in-antiphospholipid-syndrome-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/gut-microbiomics-of-sustained-knee-pain-in-patients-with-knee-osteoarthritis-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/gut-microbiota-in-very-early-systemic-sclerosis-the-first-case-control-taxonomic-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/h3k9me3-loss-and-ervs-activation-as-hallmarks-for-osteoarthritis-progression-and-2024/2026-11-04T03:22:35Z https://currentrheuma.com/studies/haematopoietic-stem-cell-derived-immune-cells-have-reduced-x-chromosome-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/hand-osteoarthritis-phenotypes-based-on-a-biopsychosocial-approach-and-their-2024/2026-11-04T06:17:41Z https://currentrheuma.com/studies/handgrip-strength-as-a-predictor-of-1-year-mortality-after-hip-fracture-surgery-2024/2026-11-04T00:13:51Z https://currentrheuma.com/studies/handwriting-speed-in-juvenile-idiopathic-arthritis-using-the-detailed-assessment-2024/2026-11-04T03:21:42Z https://currentrheuma.com/studies/headache-in-systemic-lupus-erythematosus-the-luna-registry-cross-sectional-study-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/health-inequities-and-societal-costs-for-patients-with-fibromyalgia-and-their-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/health-perceptions-multimorbidity-and-new-fractures-and-mortality-among-patients-2024/2026-11-04T06:21:48Z https://currentrheuma.com/studies/health-related-quality-of-life-in-osteoporosis-a-systematic-review-of-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/health-seeking-behaviour-and-diagnostic-delays-in-sle-a-multi-ethnic-malaysian-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/healthcare-utilization-in-general-practice-and-hospitals-preceding-a-diagnosis-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/helicobacter-pylori-upregulates-pad4-expression-via-stabilising-hif-1-to-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/hepatitis-b-reactivation-in-psa-patients-an-slr-and-meta-analysis-for-il-17-il-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/heterogeneity-of-peripheral-immune-cell-landscape-in-systemic-lupus-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/high-density-lipoprotein-cholesterol-subfraction-hdl2-is-associated-with-2024/2026-11-04T09:26:49Z https://currentrheuma.com/studies/high-frequency-of-bcp-but-less-cpp-crystal-mediated-calcification-in-cartilage-2024/2026-11-04T06:17:41Z https://currentrheuma.com/studies/high-leptin-levels-in-blood-are-associated-with-chronic-widespread-pain-in-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/high-prevalence-and-incidence-of-systemic-sclerosis-in-reunion-island-a-french-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/high-prevalence-of-orofacial-pain-in-juvenile-fibromyalgia-as-detected-by-a-2024/2026-11-04T06:11:16Z https://currentrheuma.com/studies/high-prevalence-of-radiographic-erosions-in-early-untreated-psa-results-from-the-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/high-resolution-magnetic-resonance-imaging-visualizes-intracranial-large-artery-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/high-resolution-peripheral-quantitative-computed-tomography-assessment-acro-2024/2026-11-04T09:23:39Z https://currentrheuma.com/studies/high-serum-levels-of-cxcl13-predict-lower-response-to-csdmards-in-both-acpa-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/higher-dietary-inflammatory-index-increased-mortality-rate-adults-hyperuricemia-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/higher-mortality-risk-gynaecological-neoplasms-non-hodgkins-lymphoma-systemic-2024/2026-11-04T06:13:45Z https://currentrheuma.com/studies/higher-prevalence-thyroid-specific-autoantibodies-tpoab-tgab-is-related-higher-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/higher-risk-of-poor-functional-outcome-and-unfavourable-clinical-events-for-late-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/higher-risk-profile-among-patients-with-tet2-mutated-giant-cell-arteritis-a-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/hip-fracture-risk-assessment-tools-for-adults-aged-80-years-and-older-2024/2026-11-04T06:21:48Z https://currentrheuma.com/studies/hip-fracture-treatment-and-outcomes-among-community-dwelling-people-living-with-2024/2026-11-04T06:21:48Z https://currentrheuma.com/studies/hip-fractures-in-patients-with-primary-aldosteronism-a-swedish-nationwide-study-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/hip-pelvis-region-mri-reference-image-atlas-scoring-inflammation-peripheral-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/histogram-based-densitometry-index-to-assess-the-severity-of-interstitial-lung-2024/2026-11-04T09:22:05Z https://currentrheuma.com/studies/histone-specific-cd4-t-cell-plasticity-in-active-and-quiescent-systemic-lupus-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/histopathological-comparison-of-sjogren-related-features-between-paired-labial-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/history-of-pre-eclampsia-does-not-appear-to-be-a-risk-factor-for-vascular-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/hla-b5-prevalence-in-patients-with-spondyloarthritis-and-impact-on-disease-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/hoamir-evaluation-of-circulating-microrna-signature-in-patients-with-erosive-2024/2026-11-04T03:22:35Z https://currentrheuma.com/studies/home-monitoring-of-fetal-heart-rhythm-lived-experiences-of-women-with-anti-ssa-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/hormonal-and-reproductive-factors-in-relation-to-the-risk-of-rheumatoid-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/hospitalised-infections-rituximab-administration-children-adolescents-systemic-2024/2026-11-04T03:18:08Z https://currentrheuma.com/studies/hospitalization-and-mortality-due-to-infection-among-children-and-adolescents-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/how-do-patient-reported-outcome-measures-affect-treatment-intensification-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/how-does-osteoarthritis-education-influence-knowledge-beliefs-and-behavior-in-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/human-epididymitis-protein-4-as-a-biomarker-of-interstitial-lung-disease-in-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/human-leucocyte-antigens-and-japanese-patients-with-polymyalgia-rheumatica-the-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/hydroxychloroquine-and-cardiovascular-events-in-patients-with-systemic-lupus-2024/2026-11-04T03:25:32Z https://currentrheuma.com/studies/hydroxychloroquine-and-pre-eclampsia-in-a-diverse-cohort-of-women-with-systemic-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/hydroxychloroquine-dose-and-hospitalizations-for-active-lupus-2024/2026-11-04T05:52:08Z https://currentrheuma.com/studies/hydroxychloroquine-improves-low-complement-levels-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/hydroxychloroquine-in-lupus-or-rheumatoid-arthritis-pregnancy-and-risk-of-major-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/hydroxychloroquine-in-lupus-pregnancy-and-risk-of-preeclampsia-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/hydroxychloroquine-induced-pigmentation-in-rheumatic-diseases-prevalence-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/hydroxychloroquine-levels-in-pregnancy-and-materno-fetal-outcomes-in-systemic-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/hyperactivation-and-altered-selection-of-b-cells-in-patients-with-paediatric-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/hypertension-as-a-prominent-manifestation-secondary-to-renal-artery-lesions-in-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/hyperuricemia-subtypes-classified-according-renal-uric-acid-handling-manifesting-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/identification-and-characteristics-of-patients-with-potential-difficult-to-treat-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/identification-and-validation-of-anti-protein-arginine-methyltransferase-5-prmt5-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/identification-distinct-subgroups-sjogrens-disease-cluster-analysis-based-2024/2026-11-04T09:04:37Z https://currentrheuma.com/studies/identification-evolution-predictors-sjogrens-disease-associated-mucosa-2024/2026-11-04T02:58:58Z https://currentrheuma.com/studies/identification-ifitm3-as-diagnostic-biomarker-systemic-lupus-erythematosus-its-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/identification-of-a-machine-learning-based-diagnostic-model-for-axial-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/identification-of-circulating-autoantibodies-to-non-modified-proteins-associated-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/identification-of-common-micrornas-expression-signatures-in-antiphospholipid-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/identification-of-early-risk-factors-for-anti-citrullinated-protein-antibody-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/identification-of-new-risk-factors-for-hydroxychloroquine-and-chloroquine-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/identification-of-outcome-domains-in-primary-sjogrens-disease-a-scoping-review-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/identification-of-patient-endotypes-and-adalimumab-treatment-responders-in-axial-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/identification-of-red-flags-for-igg4-related-disease-an-international-european-2024/2026-11-03T23:51:04Z https://currentrheuma.com/studies/identification-of-the-vldlr-locus-associated-with-giant-cell-arteritis-and-the-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/identification-of-two-autoantigens-recognised-by-circulating-autoantibodies-as-2024/2026-11-04T06:11:16Z https://currentrheuma.com/studies/identifying-association-between-serum-urate-levels-gout-flares-taking-urate-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/iga-vasculitis-nephritis-outcomes-in-adult-onset-disease-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/il-40-is-up-regulated-in-the-synovial-fluid-and-cartilage-of-osteoarthritis-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/imaging-findings-in-cardiovascular-involvements-of-igg4-related-disease-a-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/imaging-mass-cytometry-based-characterisation-of-fibroblast-subsets-and-their-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/imaging-to-predict-early-relapses-after-treatment-discontinuation-in-patients-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/immune-checkpoint-inhibitor-associated-remitting-seronegative-symmetrical-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/immune-checkpoint-inhibitor-mediated-polymyalgia-rheumatica-primary-polymyalgia-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/immune-checkpoint-inhibitor-therapy-in-patients-with-cancer-and-pre-existing-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/immune-checkpoint-inhibitors-associated-vasculitis-a-heterogeneous-condition-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/immune-checkpoint-molecules-performance-in-anca-vasculitis-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/immunogenicity-and-influence-on-disease-activity-of-recombinant-zoster-vaccine-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/immunogenicity-and-safety-of-bnt162b2-vaccination-in-adolescents-with-systemic-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/immunogenicity-reactogenicity-safety-two-dose-adjuvanted-herpes-zoster-subunit-2024/2026-11-04T05:53:11Z https://currentrheuma.com/studies/immunogenicity-third-dose-covid-19-vaccine-strategies-who-are-immunocompromised-2024/2026-11-04T05:53:11Z https://currentrheuma.com/studies/immunogenicity-to-herpes-zoster-recombinant-subunit-vaccine-in-immune-mediated-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/immunoglobulin-g-immunoglobulin-m-autoantibody-ratios-in-incomplete-systemic-2024/2026-11-04T09:23:05Z https://currentrheuma.com/studies/immunosuppressive-agents-or-intravenous-immunoglobulin-addition-glucocorticoids-2024/2026-11-04T02:58:58Z https://currentrheuma.com/studies/immunosuppressives-discontinuation-after-renal-response-lupus-nephritis-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/impact-autoantibodies-efficacy-biological-disease-modifying-anti-rheumatic-drugs-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/impact-digital-health-application-vivira-spinal-mobility-physical-function-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/impact-dmard-treatment-systemic-inflammation-all-cause-mortality-rheumatoid-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/impact-fracture-liaison-service-hospital-anti-osteoporosis-treatment-subsequent-2024/2026-11-04T00:13:51Z https://currentrheuma.com/studies/impact-glucocorticoid-dose-complete-response-serious-infections-mortality-during-2024/2026-11-04T05:52:08Z https://currentrheuma.com/studies/impact-guidance-fracture-liaison-services-introduction-new-fee-secondary-2024/2026-11-04T00:13:51Z https://currentrheuma.com/studies/impact-initiation-targeted-therapy-use-psoriatic-arthritis-related-treatments-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/impact-multimorbidity-first-ts-bdmard-effectiveness-retention-rate-after-two-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/impact-of-a-clinical-pharmacist-consultation-on-enhancing-knowledge-and-safety-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/impact-of-anti-human-igg-hinge-peptide-antibodies-on-identification-of-patients-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/impact-of-autoantibody-status-on-stratifying-the-risk-of-organ-involvement-and-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/impact-of-baseline-proteinuria-level-on-long-term-outcomes-in-lupus-nephritis-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/impact-of-biological-therapy-in-reducing-the-risk-of-arthritis-development-in-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/impact-of-body-composition-on-clinical-outcomes-in-patients-with-active-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/impact-of-conventional-and-biological-disease-modifying-anti-rheumatic-drugs-on-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/impact-of-depressive-symptoms-on-direct-medical-cost-among-medicare-recipients-2024/2026-11-04T06:17:41Z https://currentrheuma.com/studies/impact-of-disease-activity-patterns-on-health-related-quality-of-life-hrqol-in-2024/2026-11-04T03:18:08Z https://currentrheuma.com/studies/impact-of-exposure-to-environmental-particulate-matter-on-the-onset-of-giant-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/impact-of-filgotinib-on-pain-control-in-the-phase-3-finch-studies-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/impact-of-high-rheumatoid-factor-levels-on-treatment-outcomes-with-certolizumab-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/impact-of-igg-fc-glycosylation-on-disease-dynamics-in-patients-with-primary-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/impact-of-incident-rheumatoid-arthritis-on-earnings-a-nationwide-sibling-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/impact-of-inflammation-and-anti-inflammatory-therapies-on-the-incidence-of-major-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/impact-of-inflammation-on-cognitive-function-in-patients-with-highly-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/impact-of-intimate-partner-violence-on-quality-of-life-and-disease-activity-in-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/impact-of-patient-characteristics-on-asdas-disease-activity-state-cut-offs-in-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/impact-of-perception-of-illness-on-quality-of-life-in-juvenile-systemic-lupus-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/impact-of-preeclampsia-on-infant-and-maternal-health-among-women-with-rheumatic-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/impact-of-pregnancy-on-sacroiliac-imaging-in-women-with-axial-spondyloarthritis-2024/2026-11-04T06:09:55Z https://currentrheuma.com/studies/impact-of-season-environmental-temperature-and-humidity-on-raynaud-phenomenon-in-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/impact-of-sex-serostatus-and-smoking-on-risk-for-rheumatoid-arthritis-associated-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/impact-of-structural-severity-on-outcomes-in-knee-osteoarthritis-an-analysis-of-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/impact-of-time-to-diagnosis-in-patients-with-primary-sjogrens-syndrome-a-cross-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/impact-of-treatments-on-fatigue-in-axial-spondyloarthritis-a-systematic-review-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/impact-on-patient-outcomes-of-spondyloarthritis-inflammatory-bowel-disease-multi-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/impact-ra-treatment-strategies-lipids-vascular-inflammation-rheumatoid-arthritis-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/impact-systemic-inflammation-disease-activity-incidence-interstitial-lung-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/impact-time-initiation-line-biologic-therapy-retention-rate-secukinumab-axial-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/impaired-coagulation-parameters-in-early-ra-are-restored-by-effective-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/impaired-immune-tolerance-mediated-by-reduced-tfr-cells-in-rheumatoid-arthritis-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/impairment-of-white-matter-microstructure-and-structural-network-in-patients-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/implementation-of-a-clinician-led-medication-adherence-intervention-among-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/implementation-study-of-the-carra-uveitis-consensus-treatment-plans-feasibility-2024/2026-11-04T00:12:21Z https://currentrheuma.com/studies/implementing-a-staff-led-smoking-cessation-intervention-in-a-diverse-safety-net-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/implications-of-thyroid-related-autoantibodies-in-patients-with-sjogrens-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/improved-diagnostic-accuracy-for-polymyalgia-rheumatica-using-fdg-pet-ct-with-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/improved-pain-morning-stiffness-and-fatigue-with-bimekizumab-in-axial-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/improved-physical-functioning-sleep-work-productivity-overall-health-related-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/improvement-in-spinal-pain-at-night-and-its-impact-on-long-term-outcomes-in-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/improvement-of-bone-mineral-density-and-new-vertebral-fractures-during-8-years-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/improvement-of-high-density-lipoprotein-atheroprotective-properties-in-patients-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/improvement-work-productivity-psoriatic-arthritis-treated-biologic-or-targeted-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/improvements-patient-reported-outcomes-after-treatment-deucravacitinib-psoriatic-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/improving-gout-care-in-a-canadian-academic-medical-center-through-a-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/improving-identification-of-at-risk-behaviors-in-adolescents-with-rheumatic-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/improving-routine-mental-health-screening-for-depression-and-anxiety-in-a-2024/2026-11-04T00:09:46Z https://currentrheuma.com/studies/improving-the-arthritis-component-of-the-sledai-2k-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/incidence-and-clinical-manifestations-of-giant-cell-arteritis-in-spain-results-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/incidence-and-genetic-risk-of-juvenile-idiopathic-arthritis-in-norway-by-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/incidence-and-risk-factors-of-major-cardiovascular-events-in-rheumatoid-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/incidence-and-risk-factors-of-mental-illnesses-among-patients-with-systemic-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/incidence-and-risk-of-arterial-and-venous-thrombotic-events-in-systemic-lupus-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/incidence-checkpoint-inhibitor-associated-inflammatory-arthritis-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/incidence-of-and-risk-of-mortality-after-hip-fractures-in-rheumatoid-arthritis-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/incidence-of-chronic-recurrent-multifocal-osteomyelitis-in-children-and-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/incidence-of-clinically-diagnosed-psoriatic-arthritis-in-sweden-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/incidence-of-hip-fractures-in-mexico-2006-2019-increasing-numbers-but-decreasing-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/incidence-of-juvenile-idiopathic-arthritis-in-finland-2000-2020-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/incidence-of-psoriatic-arthritis-in-a-primary-care-psoriasis-population-in-the-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/incidence-of-seropositive-and-seronegative-rheumatoid-arthritis-in-denmark-a-2024/2026-11-04T03:14:15Z https://currentrheuma.com/studies/incidence-of-systemic-vasculitides-after-mycobacterium-tuberculosis-infection-a-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/incidence-of-total-knee-arthroplasty-after-arthroscopic-surgery-for-knee-2024/2026-11-04T06:21:48Z https://currentrheuma.com/studies/incidence-ofpneumocystis-jiroveciipneumonia-and-prophylaxis-associated-adverse-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/incidence-outcome-covid-19-following-vaccine-hybrid-immunity-immunosuppressive-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/incidence-rate-of-recurrent-cardiovascular-events-in-patients-with-radiographic-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/incidence-uveitis-axial-spondylarthritis-treated-biologics-or-targeted-2024/2026-11-04T05:52:08Z https://currentrheuma.com/studies/incident-rheumatoid-arthritis-in-patients-living-in-turkey-and-in-denmark-a-2024/2026-11-04T00:05:39Z https://currentrheuma.com/studies/incident-use-of-hydroxychloroquine-for-the-treatment-of-rheumatoid-arthritis-and-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/inclusion-body-myositis-associated-with-sjogrens-disease-clinical-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/inclusion-fibrinoid-necrosis-increases-accuracy-synovial-tissue-assessment-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/incorporating-computer-vision-on-smart-phone-photographs-into-screening-for-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/increase-in-stress-contributes-to-impaired-jaw-function-in-juvenile-idiopathic-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/increased-diagnostic-accuracy-of-the-labial-gland-biopsy-in-primary-sjogren-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/increased-interferon-signaling-in-vaginal-tissue-of-patients-with-primary-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/increased-predictive-value-of-optical-spectral-transmission-in-early-rheumatoid-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/increased-prevalence-of-hearing-loss-tinnitus-and-sudden-deafness-among-patients-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/increased-prevalence-of-malignancies-in-patients-with-igg4-related-disease-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/increased-prevalence-osteopenia-osteoporosis-systemic-sclerosis-including-men-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/increased-risk-cardiovascular-events-under-treatments-janus-kinase-inhibitors-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/increased-risk-of-adverse-gestational-outcomes-in-pregnant-women-with-primary-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/increased-risk-of-hip-and-major-osteoporotic-fractures-in-8463-patients-who-have-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/increased-risk-of-malignancy-and-osteoporosis-in-primary-sjogrens-syndrome-with-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/increased-serum-level-of-il-6-predicts-poor-prognosis-in-anti-mda5-positive-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/increased-serum-soluble-interleukin-2-receptor-concentrations-are-linked-to-high-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/increased-vascular-deposition-of-oxidized-ldl-in-untreated-juvenile-2024/2026-11-04T03:21:42Z https://currentrheuma.com/studies/increased-vascular-inflammation-on-pet-ct-in-psoriatic-arthritis-patients-in-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/increasing-etanercept-dose-treat-target-approach-juvenile-idiopathic-arthritis-2024/2026-11-04T06:16:46Z https://currentrheuma.com/studies/increasing-uptake-through-collaboration-in-the-development-of-core-outcome-sets-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/induction-interleukin-21-receptor-expression-via-enhanced-intracellular-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/induction-of-regulatory-t-cells-and-efficacy-of-low-dose-interleukin-2-in-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/induction-treatment-for-lupus-nephritis-at-a-high-complexity-hospital-in-chile-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/inebilizumab-for-treatment-of-igg4-related-disease-2024/2026-11-04T00:14:58Z https://currentrheuma.com/studies/infiltrations-of-plasma-cells-in-synovium-predict-inadequate-response-to-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/inflammaging-contributes-to-osteoarthritis-development-and-human-microbiota-2024/2026-11-04T00:13:14Z https://currentrheuma.com/studies/inflammation-in-the-posterior-elements-in-particular-the-facet-joint-and-facet-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/inflammation-of-the-temporalis-muscle-and-adjacent-nerve-tissue-in-giant-cell-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/inflammatory-arthritis-in-systemic-sclerosis-its-epidemiology-associations-and-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/inflammatory-biomarker-analysis-confirms-reduced-disease-severity-in-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/inflammatory-biomarkers-predicting-long-term-remission-active-disease-juvenile-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/infliximab-vs-interferon-in-the-treatment-of-behcets-syndrome-clinical-data-from-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/influence-characteristics-harm-estimates-randomised-controlled-trials-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/influence-of-doctor-patient-relationships-and-health-related-factors-on-the-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/influence-of-gender-on-behcets-disease-phenotype-and-irreversible-organ-damage-2024/2026-11-04T00:06:14Z https://currentrheuma.com/studies/influenza-knowledge-and-barriers-to-vaccination-in-immunosuppressed-patients-in-2024/2026-11-04T00:12:21Z https://currentrheuma.com/studies/information-and-communication-technology-based-patient-education-for-autoimmune-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/informing-digital-programs-for-lupus-self-management-education-a-systematic-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/infrapatellar-fat-pad-size-and-subcutaneous-fat-in-knee-osteoarthritis-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/inhibition-of-jak-stat-pathway-corrects-salivary-gland-inflammation-and-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/initial-glucocorticoid-bridging-in-rheumatoid-arthritis-does-it-affect-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/initiation-glucocorticoids-before-entering-rheumatology-care-associates-long-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/initiation-of-belimumab-with-higher-daily-prednisolone-is-effective-for-rapid-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/insights-into-2023-acr-eular-antiphospholipid-syndrome-classification-criteria-2024/2026-11-03T13:56:47Z https://currentrheuma.com/studies/integrated-analysis-of-genome-wide-copy-number-variation-and-exome-wide-rare-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/integrated-multi-omics-revealed-that-dysregulated-lipid-metabolism-played-an-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/integrated-safety-analysis-filgotinib-moderate-severe-rheumatoid-arthritis-over-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/integrating-carotid-doppler-greyscale-us-and-aortic-oscillometry-to-evaluate-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/integrating-evidence-lived-experience-aboriginal-people-clinical-practice-2024/2026-11-03T23:51:04Z https://currentrheuma.com/studies/integrating-radiomics-and-neural-networks-for-knee-osteoarthritis-incidence-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/integration-of-genetic-and-clinical-risk-factors-for-risk-classification-of-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/integrative-metabolomic-proteomic-analysis-uncovers-a-new-therapeutic-approach-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/intense-symptoms-pain-are-associated-poor-sleep-fibromyalgia-depression-sleep-2024/2026-11-04T06:10:35Z https://currentrheuma.com/studies/intensive-training-programme-ultrasound-guided-minimally-invasive-synovial-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/interaction-genetic-variation-at-adh1b-mlxipl-alcohol-consumption-elevated-serum-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/interaction-of-5-httlpr-and-sle-disease-status-on-resting-state-brain-function-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/intercurrent-infection-as-a-risk-factor-for-disease-flares-in-patients-with-2024/2026-11-04T03:18:08Z https://currentrheuma.com/studies/interferon-as-a-biomarker-to-predict-renal-outcomes-in-lupus-nephritis-2024/2026-11-04T00:09:46Z https://currentrheuma.com/studies/interleukin-6-trans-signalling-regulates-monocyte-chemoattractant-protein-1-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/international-map-of-axial-spondyloarthritis-imas-results-from-the-perspective-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/interpersonal-process-of-dyadic-coping-in-rheumatoid-arthritis-a-perspective-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/interplay-between-polygenic-risk-score-and-solar-insolation-implication-for-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/interrupting-an-ifn-dependent-feedback-loop-in-the-syndrome-of-pyogenic-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/interstitial-fibrosis-increases-the-risk-of-end-stage-kidney-disease-in-patients-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/interstitial-lung-disease-in-patients-with-rheumatoid-arthritis-or-psoriatic-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/intra-articular-mineralization-on-computerized-tomography-of-the-knee-and-risk-2024/2026-11-04T05:52:08Z https://currentrheuma.com/studies/intraoperative-physician-assessment-during-total-hip-arthroplasty-correlates-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/intravenous-golimumab-children-polyarticular-course-juvenile-idiopathic-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/introduction-of-an-order-set-after-hip-fracture-improves-osteoporosis-medication-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/investigating-influence-patient-eligibility-characteristics-number-deferrable-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/investigating-physical-inactivity-and-associated-health-parameters-in-patients-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/investigating-protease-mediated-peptides-of-inflammation-and-tissue-remodeling-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/investigating-the-bidirectional-association-of-rheumatoid-arthritis-and-thyroid-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/investigating-the-concomitance-of-anti-neutrophil-cytoplasmic-antibody-anca-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/investigating-the-disparities-among-drug-categories-in-drug-induced-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/investigating-trajectory-functional-disability-systemic-sclerosis-group-based-2024/2026-11-04T03:15:15Z https://currentrheuma.com/studies/investigation-differential-therapeutic-effects-romosozumab-postmenopausal-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/investigation-ferroptosis-associated-molecular-subtypes-immunological-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/investigation-of-pyroptosis-related-hub-genes-and-the-immune-microenvironment-in-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/is-detection-disease-modifying-osteoarthritis-drug-treatment-more-effective-when-2024/2026-11-04T06:17:41Z https://currentrheuma.com/studies/is-rheumatoid-arthritis-always-preceded-by-a-symptomatic-at-risk-phase-of-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/is-there-a-role-for-autologous-conditioned-serum-injections-in-osteoarthritis-a-2024/2026-11-04T06:17:41Z https://currentrheuma.com/studies/itaconate-is-a-metabolic-regulator-of-bone-formation-in-homeostasis-and-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/itraq-based-mass-spectrometry-screen-to-identify-serum-biomarkers-in-systemic-2024/2026-11-04T06:13:45Z https://currentrheuma.com/studies/jak-inhibitors-attenuate-hyperactivation-of-nonswitched-memory-b-cells-in-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/janus-kinase-inhibition-jaki-therapy-in-refractory-anti-synthetase-syndrome-a-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/janus-kinase-inhibitors-tumour-necrosis-factor-inhibitors-show-favourable-safety-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/joint-involvement-in-sarcoidosis-systematic-review-and-meta-analysis-of-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/joint-surgery-rates-in-lupus-a-long-term-cohort-study-2024/2026-11-04T09:26:49Z https://currentrheuma.com/studies/juvenile-eosinophilic-fasciitis-a-single-center-case-series-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/juvenile-idiopathic-recurrent-parotitis-jirp-treated-short-course-steroids-case-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/juvenile-neuropsychiatric-systemic-lupus-erythematosus-a-specific-clinical-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/kawasaki-disease-in-kenya-and-review-of-the-african-literature-2024/2026-11-04T06:16:46Z https://currentrheuma.com/studies/ketoglutarate-dependent-kdm6-histone-demethylases-and-interferon-stimulated-gene-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/key-considerations-for-modelling-the-long-term-costs-and-benefits-of-treatments-2024/2026-11-04T09:24:09Z https://currentrheuma.com/studies/key-insights-into-antiresorptive-drug-use-and-osteonecrosis-in-osteoporotic-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/kidney-whole-transcriptome-profiling-in-primary-antiphospholipid-syndrome-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/kl6-il-18-levels-are-negatively-correlated-respiratory-function-tests-ild-extent-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/klf2-controls-the-apoptosis-of-neutrophils-and-is-associated-with-disease-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/knee-braces-for-knee-osteoarthritis-a-scoping-review-and-narrative-synthesis-of-2024/2026-11-04T03:22:35Z https://currentrheuma.com/studies/krill-oil-for-knee-osteoarthritis-a-randomized-clinical-trial-2024/2026-11-04T06:21:28Z https://currentrheuma.com/studies/labor-force-participation-adults-osteoarthritis-or-joint-symptoms-typical-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/lack-of-awareness-of-systemic-lupus-erythematosus-and-its-consequences-in-a-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/large-language-model-driven-sentiment-analysis-for-facilitating-fibromyalgia-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/large-language-models-for-accurate-disease-detection-in-electronic-health-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/large-overlap-in-neutrophil-transcriptome-between-lupus-and-covid-19-with-2024/2026-11-04T09:26:49Z https://currentrheuma.com/studies/large-scale-integrative-analysis-of-juvenile-idiopathic-arthritis-for-new-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/large-vessel-involvement-in-anca-associated-vasculitis-a-multicenter-case-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/large-vessel-vasculitis-is-a-risk-factor-for-relapse-only-in-giant-cell-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/laser-capture-microscopy-rna-sequencing-for-topological-mapping-of-synovial-2024/2026-11-04T05:52:08Z https://currentrheuma.com/studies/latent-tuberculosis-screening-new-users-biologic-or-targeted-synthetic-disease-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/lay-health-worker-interventions-in-rheumatology-a-scoping-review-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/learning-from-serum-markers-reflecting-endothelial-activation-longitudinal-data-2024/2026-11-04T03:18:08Z https://currentrheuma.com/studies/learning-imaging-in-axial-spondyloarthritis-more-than-just-a-matter-of-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/level-correlates-physical-activity-children-adolescents-juvenile-idiopathic-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/leveraging-consolidated-framework-implementation-research-develop-american-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/life-expectancy-and-death-pattern-associated-with-systemic-lupus-erythematosus-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/lifetime-clinical-presentation-of-stills-disease-in-the-afro-descendant-2024/2026-11-04T00:06:14Z https://currentrheuma.com/studies/lifetime-cost-effectiveness-of-structured-education-and-exercise-therapy-for-2024/2026-11-04T00:16:14Z https://currentrheuma.com/studies/limb-arteries-involvement-assessed-by-fdg-pet-ct-at-diagnosis-of-giant-cell-2024/2026-11-04T06:10:35Z https://currentrheuma.com/studies/limitations-in-activities-of-daily-living-among-individuals-with-systemic-lupus-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/limited-diagnostic-and-prognostic-value-of-routine-radiographs-in-newly-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/lipoxygenase-derived-oxylipins-are-enriched-anti-citrullinated-protein-antibody-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/lncrna-nrir-serves-as-a-biomarker-for-systemic-lupus-erythematosus-and-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/lncrna-xist-mir-381-3p-stat1-axis-as-a-potential-biomarker-for-lupus-nephritis-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/local-ancestry-at-the-major-histocompatibility-complex-region-is-not-a-major-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/local-injection-of-infliximab-into-calcinosis-lesions-in-patients-with-juvenile-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/long-non-coding-rna-h19x-as-a-regulator-of-mononuclear-cell-adhesion-to-the-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/long-noncoding-rnas-ctc-471j1-2-nest-as-epigenetic-risk-factors-of-active-2024/2026-11-04T06:16:46Z https://currentrheuma.com/studies/long-short-term-opioid-therapy-fibromyalgia-syndrome-risk-depression-sleep-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/long-term-association-between-physical-activity-global-functioning-axial-2024/2026-11-04T03:14:15Z https://currentrheuma.com/studies/long-term-autoimmune-inflammatory-rheumatic-outcomes-of-covid-19-a-binational-2024/2026-11-04T09:35:40Z https://currentrheuma.com/studies/long-term-clinical-and-radiological-effectiveness-and-safety-of-ultralow-doses-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/long-term-clinical-outcomes-in-early-rheumatoid-arthritis-that-was-treated-to-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/long-term-clinical-outcomes-of-certolizumab-pegol-treatment-in-non-radiographic-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/long-term-data-on-efficacy-and-safety-of-selexipag-for-digital-systemic-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/long-term-effectiveness-lifestyle-intervention-rheumatoid-arthritis-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/long-term-effectiveness-of-the-combination-of-iguratimod-and-alendronate-in-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/long-term-effects-abatacept-atherosclerosis-arthritis-older-younger-rheumatoid-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/long-term-efficacy-2-year-mri-treat-target-strategy-disease-activity-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/long-term-efficacy-and-safety-of-subcutaneous-tocilizumab-in-clinical-trials-of-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/long-term-efficacy-of-sarilumab-on-the-progression-of-interstitial-lung-disease-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/long-term-follow-up-of-109-children-with-juvenile-idiopathic-oligoarthritis-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/long-term-follow-up-of-anti-infliximab-antibodies-in-patients-with-radiographic-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/long-term-incidence-risk-factors-and-complications-for-venous-thromboembolism-in-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/long-term-mortality-following-sars-cov-2-infection-rural-urban-dwellers-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/long-term-mortality-in-treated-to-target-ra-and-ua-results-of-the-best-and-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/long-term-outcome-autologous-haematopoietic-stem-cell-transplantation-systemic-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/long-term-outcomes-of-childhood-onset-systemic-lupus-erythematosus-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/long-term-retention-rate-adverse-event-temporal-patterns-and-rescue-treatment-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/long-term-safety-and-effectiveness-of-canakinumab-in-patients-with-monogenic-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/long-term-safety-and-efficacy-of-anti-tnf-multivalent-vhh-antibodies-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/long-term-safety-effectiveness-tacrolimus-lupus-nephritis-japan-10-year-analysis-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/long-term-safety-efficacy-upadacitinib-adalimumab-rheumatoid-arthritis-5-year-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/long-term-safety-ixekizumab-adults-psoriasis-psoriatic-arthritis-or-axial-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/long-term-survival-of-subcutaneous-biosimilar-tumor-necrosis-factor-inhibitors-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/long-term-sustainability-response-upadacitinib-active-rheumatoid-arthritis-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/longitudinal-analysis-of-serum-urate-in-prediabetic-phase-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/longitudinal-assessment-of-disease-activity-and-muscle-strength-in-juvenile-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/longitudinal-association-hand-osteoarthritis-paid-unpaid-work-restrictions-2024/2026-11-04T00:13:14Z https://currentrheuma.com/studies/longitudinal-follow-up-mixed-connective-tissue-disease-overlapping-autoimmune-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/longitudinal-patterns-and-predictors-of-response-to-standard-of-care-therapy-in-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/longitudinal-program-evaluation-of-an-inter-institutional-mentorship-network-for-2024/2026-11-04T03:21:42Z https://currentrheuma.com/studies/longitudinal-stability-of-molecular-endotypes-of-knee-osteoarthritis-patients-2024/2026-11-04T00:13:14Z https://currentrheuma.com/studies/longitudinal-study-of-patients-with-anti-sae-antibody-positive-dermatomyositis-a-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/longitudinal-trajectories-of-the-scleroderma-health-assessment-questionnaire-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/low-cd4-t-cell-count-is-related-to-specific-anti-nuclear-antibodies-ifn-protein-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/low-density-granulocytes-and-neutrophil-extracellular-trap-formation-are-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/low-dose-glucocorticoid-increase-the-risk-of-fracture-in-postmenopausal-women-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/low-dose-methotrexate-impaired-t-cell-transmigration-through-down-regulating-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/low-incidence-of-late-onset-giant-cell-arteritis-during-the-first-year-in-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/low-remission-rates-and-high-incidence-of-adverse-events-in-a-prospective-vexas-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/low-socioeconomic-status-and-female-sex-are-associated-with-worse-functional-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/low-uveitis-rates-in-patients-with-axial-spondyloarthritis-treated-with-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/lower-body-mass-and-lower-adiposity-are-associated-with-differential-responses-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/lower-circulating-igf-1-levels-in-fibromyalgia-meta-analysis-highlighting-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/lung-imaging-patterns-in-connective-tissue-disease-associated-interstitial-lung-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/lupus-low-disease-activity-state-organ-damage-relation-quality-life-systemic-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/lupus-nephritis-and-socioeconomic-status-findings-from-the-southern-california-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/lupus-nephritis-randomised-controlled-trials-evidence-gaps-and-under-represented-2024/2026-11-04T00:09:46Z https://currentrheuma.com/studies/lupus-or-not-idiopathic-full-house-glomerulonephritis-a-rare-nephropathy-with-2024/2026-11-03T11:13:22Z https://currentrheuma.com/studies/lymphadenopathy-in-systemic-lupus-erythematosus-no-microbial-trigger-found-by-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/lymphocyte-apoptosis-and-its-association-with-the-inflammatory-markers-and-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/lymphoma-in-sjogrens-syndrome-no-need-for-repetitive-screening-ultrasounds-of-2024/2026-11-04T03:14:15Z https://currentrheuma.com/studies/m6a-rna-methylation-controls-salivary-gland-epithelial-cell-function-and-has-a-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/machine-learning-driven-immunophenotypic-stratification-of-mixed-connective-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/machine-learning-identifies-risk-factors-associated-with-long-term-opioid-use-in-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/machine-learning-in-the-prediction-of-treatment-response-in-rheumatoid-arthritis-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/machine-learning-prediction-and-explanatory-models-of-serious-infections-in-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/macrophage-activation-syndrome-in-patients-with-systemic-juvenile-idiopathic-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/macrophage-colony-stimulating-factor-receptor-cd115-non-classical-monocytes-are-2024/2026-11-04T03:14:15Z https://currentrheuma.com/studies/macrophage-requirements-for-abatacept-response-in-rheumatoid-arthritis-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/macrophage-subpopulations-in-pediatric-patients-with-lupus-nephritis-and-other-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/magnetic-resonance-imaging-patterns-revealing-muscle-pathology-and-clinical-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/magnetic-resonance-imaging-to-monitor-disease-activity-in-giant-cell-arteritis-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/maintenance-of-remission-of-anca-vasculitis-by-rituximab-based-on-b-cell-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/major-cardiovascular-events-in-patients-with-cardiovascular-monosodium-urate-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/male-fertility-is-preserved-following-ixekizumab-treatment-a-real-life-pilot-2024/2026-11-03T13:56:47Z https://currentrheuma.com/studies/male-inflammatory-joint-diseases-are-less-likely-than-controls-be-childless-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/malignancy-is-increased-in-patients-with-antineutrophil-cytoplasmic-antibody-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/management-and-outcomes-of-interstitial-lung-disease-associated-with-anti-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/management-of-systemic-lupus-erythematosus-a-systematic-literature-review-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/management-pregnancy-autoimmune-rheumatic-diseases-maternal-disease-course-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/management-treatment-outcomes-rheumatoid-arthritis-era-biologic-targeted-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/mapping-analysis-protein-gene-profile-identification-important-role-transforming-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/mapping-in-healthy-subjects-different-body-areas-for-dermal-thickness-and-skin-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/maternal-and-fetal-outcomes-in-pregnancy-complicated-by-pre-existing-lupus-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/maternal-fetal-outcomes-pregnancy-women-primary-systemic-vasculitis-single-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/matrix-metalloproteinase-12-an-indicator-potentially-contributing-to-the-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/maximal-exercise-tolerance-objective-trunk-strength-and-mobility-measurements-in-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/measurable-outcomes-of-an-ophthalmology-and-rheumatology-coordinated-care-clinic-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/medication-utilisation-trends-during-pregnancy-and-factors-influencing-adverse-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/mental-comorbidities-in-adolescents-and-young-adults-with-juvenile-idiopathic-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/mental-health-conditions-in-patients-with-systemic-lupus-erythematosus-a-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/mesa-the-association-of-microvascular-disease-and-endothelial-dysfunction-with-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/mesenchymal-stem-cells-for-chronic-knee-pain-secondary-to-osteoarthritis-a-2024/2026-11-04T06:17:41Z https://currentrheuma.com/studies/metabolic-syndrome-adipokines-and-response-to-advanced-therapies-in-rheumatoid-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/metabolic-syndrome-is-associated-with-an-increased-risk-of-rheumatoid-arthritis-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/metabolic-syndrome-radiographic-osteoarthritis-progression-chronic-pain-knee-men-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/metformin-treatment-reduces-the-incidence-of-osteoporosis-a-two-sample-mendelian-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/methotrexate-promotes-release-granulocyte-macrophage-colony-stimulating-factor-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/methotrexate-safety-and-efficacy-in-combination-therapies-in-patients-with-early-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/methotrexate-treatment-hampers-induction-of-vaccine-specific-cd4-t-cell-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/methyl-donor-supplementation-women-systemic-lupus-erythematosus-different-2024/2026-11-04T00:09:46Z https://currentrheuma.com/studies/methylprednisolone-pulses-prolonged-remission-systemic-lupus-erythematosus-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/mezagitamab-in-systemic-lupus-erythematosus-clinical-and-mechanistic-findings-of-2024/2026-11-04T09:26:49Z https://currentrheuma.com/studies/microrna-signature-for-early-prediction-of-knee-osteoarthritis-structural-2024/2026-11-04T00:13:14Z https://currentrheuma.com/studies/microstructural-changes-of-the-white-matter-in-systemic-lupus-erythematosus-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/microwave-ablation-of-synovial-hypertrophy-in-recurrent-monoarthritis-the-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/minimal-detectable-changes-health-assessment-questionnaire-disability-index-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/minimally-invasive-interventional-procedures-for-osteoarthritis-and-inflammatory-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/minor-genetic-overlap-among-rheumatoid-arthritis-myocardial-infarction-and-2024/2026-11-04T05:52:08Z https://currentrheuma.com/studies/mirnas-as-potential-biomarkers-for-subclinical-atherosclerosis-in-sjogrens-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/misdiagnosis-missed-diagnosis-and-delayed-diagnosis-of-lupus-a-qualitative-study-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/missed-opportunities-treatment-inflammatory-arthritis-factors-associated-non-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/mitochondrial-control-of-proteasomal-psmb5-drives-the-differentiation-of-tissue-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/mitochondrial-structural-alterations-in-fibromyalgia-a-pilot-electron-microscopy-2024/2026-11-04T06:11:16Z https://currentrheuma.com/studies/mitonuclear-epistasis-involving-tp63-and-haplogroup-uk-risk-of-rapid-progression-2024/2026-11-04T09:31:04Z https://currentrheuma.com/studies/mitophagy-drives-maldifferentiation-of-tissue-resident-memory-t-cells-in-2024/2026-11-04T00:05:39Z https://currentrheuma.com/studies/mobile-health-application-integrated-electronic-health-record-rheumatoid-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/modelling-long-term-outcomes-for-patients-with-systemic-lupus-erythematosus-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/moderate-and-high-disease-activity-levels-increase-the-risk-of-subclinical-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/modifiable-risk-factors-and-inflammation-related-proteins-in-polymyalgia-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/modifying-t-cell-phenotypes-using-tyk2-inhibitor-and-its-implications-for-the-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/modulation-interleukin-23-signaling-guselkumab-biologic-naive-tumor-necrosis-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/molecular-characterisation-lupus-low-disease-activity-state-lldas-doris-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/molecular-determinants-of-neutrophil-extracellular-vesicles-that-drive-cartilage-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/monoclonal-gammopathy-systemic-lupus-erythematosus-is-associated-distinctive-2024/2026-11-04T03:18:08Z https://currentrheuma.com/studies/monocyte-derived-transcriptomes-explain-the-ineffectiveness-of-abatacept-in-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/monogenic-interferon-mediated-diseases-novel-phenotype-and-genotype-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/monosodium-urate-crystal-depletion-bone-erosion-remodeling-during-pegloticase-2024/2026-11-04T09:23:39Z https://currentrheuma.com/studies/more-severe-parotid-gland-histopathology-in-paediatric-onset-than-in-adult-onset-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/mortality-and-prognostic-factors-among-inpatients-with-systemic-lupus-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/mortality-in-patients-with-psoriatic-arthritis-in-sweden-a-nationwide-population-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/mortality-in-patients-with-systemic-lupus-erythematosus-a-meta-analysis-of-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/mri-based-synthetic-ct-new-method-structural-damage-assessment-spine-axial-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/mri-of-shoulder-girdle-in-polymyalgia-rheumatica-inflammatory-findings-and-their-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/mrvas-introducing-a-standardized-magnetic-resonance-scoring-system-for-assessing-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/muc5b-promoter-variant-and-survival-in-rheumatoid-arthritis-associated-2024/2026-11-03T10:53:39Z https://currentrheuma.com/studies/multi-centre-modified-delphi-exercise-to-identify-candidate-items-for-2024/2026-11-04T00:13:14Z https://currentrheuma.com/studies/multi-domain-effectiveness-guselkumab-evaluated-via-composite-indices-through-1-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/multidisciplinary-re-evaluation-of-neuropsychiatric-events-to-confirm-the-2024/2026-11-04T06:13:45Z https://currentrheuma.com/studies/multimodal-imaging-of-structural-damage-and-inflammation-in-psoriatic-arthritis-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/multimorbidity-in-psoriasis-as-a-risk-factor-for-psoriatic-arthritis-a-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/multiorgan-involvement-and-circulating-igg1-predict-hypocomplementaemia-in-igg4-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/multiple-morbidities-are-associated-with-serious-infections-in-patients-with-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/multiple-polygenic-risk-scores-can-improve-the-prediction-of-systemic-lupus-2024/2026-11-04T06:13:45Z https://currentrheuma.com/studies/multiple-serum-biomarkers-associate-with-mortality-and-interstitial-lung-disease-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/multiplicative-impact-of-adverse-social-determinants-of-health-on-outcomes-in-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/muscle-involvement-in-systemic-sclerosis-high-mortality-not-associated-with-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/muscle-tissue-transcriptome-idiopathic-inflammatory-myopathy-reflects-muscle-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/musculoskeletal-magnetic-resonance-imaging-findings-support-a-common-spectrum-of-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/musculoskeletal-symptoms-and-their-impact-on-health-related-quality-of-life-in-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/musculoskeletal-ultrasound-characteristics-of-checkpoint-inhibitor-associated-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/musculoskeletal-ultrasound-findings-in-adult-onset-stills-disease-a-case-series-2024/2026-11-04T03:14:48Z https://currentrheuma.com/studies/mycophenolate-mofetil-and-new-onset-systemic-lupus-erythematosus-a-randomized-2024/2026-11-04T03:25:32Z https://currentrheuma.com/studies/mycophenolate-mofetil-withdrawal-in-patients-with-systemic-lupus-erythematosus-a-2024/2026-11-04T09:04:37Z https://currentrheuma.com/studies/myeloablation-followed-by-hematopoietic-stem-cell-transplantation-and-long-term-2024/2026-11-04T05:52:08Z https://currentrheuma.com/studies/myocardial-infarction-in-a-population-based-cohort-of-patients-with-biopsy-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/myocardial-performance-index-to-assess-cardiac-function-in-autoimmune-connective-2024/2026-11-04T00:09:46Z https://currentrheuma.com/studies/myositis-associated-autoantibodies-in-patients-with-juvenile-myositis-are-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/myositis-clinical-trials-consortium-international-collaborative-initiative-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/nailfold-capillaroscopy-findings-of-a-multicentric-multi-ethnic-cohort-of-2024/2026-11-04T09:24:09Z https://currentrheuma.com/studies/nailfold-videocapillaroscopy-abnormalities-and-vascular-manifestations-in-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/nailfold-videocapillaroscopy-findings-and-associations-with-organ-involvement-in-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/nailfold-videocapillaroscopy-findings-correlate-with-lung-outcomes-in-idiopathic-2024/2026-11-03T10:53:39Z https://currentrheuma.com/studies/nailfold-videocapillaroscopy-in-antineutrophil-cytoplasmic-antibody-associated-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/national-burden-of-rheumatoid-arthritis-in-canada-1990-2019-findings-from-the-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/national-institute-health-care-excellence-clinical-criteria-diagnosis-knee-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/native-myocardial-t1-and-right-ventricular-size-by-cmr-predict-outcome-in-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/natural-language-processing-to-identify-and-characterize-spondyloarthritis-in-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/needs-assessment-of-musculoskeletal-ultrasound-training-in-north-american-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/needs-for-discharge-planning-and-facilitators-barriers-to-implementing-discharge-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/neighborhood-characteristics-and-walking-behavior-among-adults-with-arthritis-a-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/neighborhood-disadvantage-and-knee-osteoarthritis-pain-do-sleep-and-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/neoehrlichia-mikurensis-is-uncommon-rheumatological-receiving-tumour-necrosis-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/neonatal-lupus-erythematosus-24-years-of-experience-from-a-tertiary-centre-at-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/neuralgic-amyotrophy-of-parsonage-and-turner-which-nerves-are-most-frequently-2024/2026-11-04T03:14:48Z https://currentrheuma.com/studies/neuropathic-pain-in-spondyloarthritis-decoding-its-prevalence-risk-factors-and-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/neuropsychiatric-symptoms-systemic-lupus-erythematosus-mixed-methods-analysis-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/neutrophil-activation-markers-and-rheumatoid-arthritis-treatment-response-to-the-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/neutrophil-and-mononuclear-leukocyte-pathways-and-upstream-regulators-revealed-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/neutrophil-extracellular-traps-and-oxidative-stress-in-systemic-lupus-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/neutrophil-gelatinase-associated-lipocalin-levels-are-associated-skin-thickness-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/neutrophil-to-lymphocyte-ratio-as-a-biomarker-for-clinical-response-after-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/neutrophils-impaired-by-anti-galectin-3-antibodies-elicit-inflammation-of-2024/2026-11-04T03:15:15Z https://currentrheuma.com/studies/new-onset-work-disability-rheumatoid-arthritis-is-underrecognized-cardiovascular-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/next-generation-rheumatoid-factor-assay-provides-improved-predictive-power-for-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/nintedanib-in-rheumatoid-arthritis-related-interstitial-lung-disease-real-world-2024/2026-11-03T17:30:27Z https://currentrheuma.com/studies/nipocalimab-anti-fcrn-monoclonal-antibody-participants-moderate-severe-active-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/no-difference-clinical-parameters-drug-retention-psa-receiving-b-tsdmard-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/nociceptive-neuropathic-or-nociplastic-low-back-pain-the-low-back-pain-2024/2026-11-04T09:04:37Z https://currentrheuma.com/studies/non-adherence-to-urate-lowering-therapy-in-gout-after-5-years-is-related-to-poor-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/non-criteria-antiphospholipid-antibody-profiles-and-thrombotic-outcomes-in-a-2024/2026-11-04T00:09:46Z https://currentrheuma.com/studies/non-invasive-biomarkers-of-disease-activity-and-organ-damage-in-anca-associated-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/non-negligible-prevalence-of-focal-lymphocytic-sialadenitis-in-minor-salivary-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/non-osteoporotic-fractures-are-associated-with-increased-risk-of-subsequent-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/non-steroidal-anti-inflammatory-drugs-in-psoriatic-arthritis-clinical-practice-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/normative-data-on-lower-extremity-entheseal-tendon-thicknesses-in-healthy-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/novel-autoantibodies-help-diagnose-anti-ssa-antibody-negative-sjogren-disease-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/novel-deep-learning-analysis-connective-tissue-disease-related-interstitial-lung-2024/2026-11-03T10:53:39Z https://currentrheuma.com/studies/novel-endothelial-progenitor-cells-populations-as-biomarkers-of-damage-and-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/novel-endotypes-antisynthetase-syndrome-identified-independent-anti-aminoacyl-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/novel-genetic-loci-in-early-onset-gout-derived-from-whole-genome-sequencing-of-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/novel-inhibitory-pathway-synovial-inflammation-exerted-glucocorticoids-tumour-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/novel-multiclass-classification-machine-learning-approach-for-the-early-stage-2024/2026-11-04T09:26:49Z https://currentrheuma.com/studies/novel-multiple-z-score-models-for-detection-of-coronary-artery-dilation-2024/2026-11-04T00:12:21Z https://currentrheuma.com/studies/novel-potential-lncrna-biomarker-in-b-cells-indicates-essential-pathogenic-2024/2026-11-04T06:13:45Z https://currentrheuma.com/studies/nsaid-exposure-delays-time-to-pregnancy-in-patients-with-spondyloarthritis-an-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/nutritional-status-as-independent-prognostic-factor-of-outcome-and-mortality-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/oa-11-phase-3-56-week-randomised-double-blind-placebo-controlled-utilising-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/obesity-is-a-risk-factor-for-poor-response-to-treatment-in-early-rheumatoid-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/objective-diagnosis-gout-calcium-pyrophosphate-deposition-disease-machine-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/occupational-and-hobby-exposures-associated-with-myositis-phenotypes-in-a-2024/2026-11-03T21:03:47Z https://currentrheuma.com/studies/occupational-smoking-and-biomass-fuel-exposure-in-a-cohort-of-mexican-patients-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/old-before-their-time-the-impact-of-osteoarthritis-on-younger-adults-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/olokizumab-plus-methotrexate-safety-and-efficacy-over-106-weeks-of-treatment-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/omeract-2023-systemic-lupus-erythematosus-special-interest-group-winnowing-and-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/omeract-systemic-lupus-erythematosus-domain-survey-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/omeract-validation-of-a-deep-learning-algorithm-for-automated-absolute-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/on-demand-corticosteroid-use-in-the-syndrome-of-undifferentiated-recurrent-fever-2024/2026-11-03T11:13:22Z https://currentrheuma.com/studies/once-weekly-semaglutide-in-persons-with-obesity-and-knee-osteoarthritis-2024/2026-11-04T00:14:58Z https://currentrheuma.com/studies/one-leg-testing-in-hip-and-knee-osteoarthritis-a-comparison-with-a-two-leg-2024/2026-11-04T09:31:04Z https://currentrheuma.com/studies/one-versus-2-years-of-alendronate-following-denosumab-the-card-extension-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/one-year-effectiveness-of-long-term-exercise-therapy-in-people-with-axial-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/one-year-survival-benefit-plasma-exchange-idiopathic-inflammatory-myositis-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/opioid-treatment-for-adults-with-and-without-systemic-autoimmune-inflammatory-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/opioid-use-and-healthcare-utilization-in-adults-with-psoriatic-arthritis-and-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/opportunistic-use-of-lumbar-computed-tomography-and-magnetic-resonance-imaging-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/opportunistically-identifiable-vertebral-fractures-on-routine-radiological-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/optical-coherence-tomography-angiography-findings-systemic-lupus-erythematosus-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/optimal-exposure-of-mycophenolic-acid-for-induction-therapy-of-childhood-lupus-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/optimising-gout-treatment-insights-from-a-nurse-led-cohort-study-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/optimising-the-implementation-of-evidence-based-osteoarthritis-guidelines-in-2024/2026-11-04T09:31:04Z https://currentrheuma.com/studies/oral-lesions-of-systemic-lupus-erythematosus-a-collaborative-latin-american-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/orbital-ocular-inflammatory-involvement-in-vexas-syndrome-data-from-the-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/osteoarthritis-across-joint-sites-in-the-million-veteran-program-cohort-insights-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/osteoarthritis-and-hypertension-observational-and-mendelian-randomization-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/osteoarthritis-year-in-review-2024-biomechanics-2024/2026-11-04T00:13:14Z https://currentrheuma.com/studies/osteoporosis-and-fracture-risk-assessment-in-adults-with-ischaemic-stroke-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/osteoporosis-in-older-patients-with-idiopathic-normal-pressure-hydrocephalus-2024/2026-11-04T00:13:51Z https://currentrheuma.com/studies/osteoporosis-is-associated-with-anti-topoisomerase-i-positivity-and-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/osteoporosis-management-adults-schizophrenia-following-index-hip-fracture-event-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/osteoporosis-testing-and-treatment-remain-low-in-both-traditional-medicare-and-2024/2026-11-04T00:13:51Z https://currentrheuma.com/studies/osteoporotic-fracture-risks-of-thiazides-and-dihydropyridines-in-angiotensin-2024/2026-11-04T00:13:51Z https://currentrheuma.com/studies/outcome-clusters-their-stability-over-1-year-sle-self-reported-performance-based-2024/2026-11-04T03:18:08Z https://currentrheuma.com/studies/outcomes-after-anti-tumour-necrosis-factor-originator-biosimilar-switching-2024/2026-11-04T05:53:11Z https://currentrheuma.com/studies/outcomes-of-patients-with-diffuse-systemic-sclerosis-eligible-for-autologous-2024/2026-11-04T05:52:08Z https://currentrheuma.com/studies/outdoor-walking-genetic-predisposition-and-the-risk-of-incident-osteoporosis-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/outgrowth-of-escherichia-is-susceptible-to-aggravation-of-systemic-lupus-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/overexpression-of-bag3-bcl2-associated-athanogene-3-in-serum-and-skin-of-2024/2026-11-04T03:15:15Z https://currentrheuma.com/studies/overlap-international-league-associations-rheumatology-preliminary-pediatric-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/oxidised-low-density-lipoprotein-and-antibodies-against-oxidised-low-density-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/oxysterols-contribute-to-immune-cell-recruitment-in-sle-skin-lesions-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/paediatric-non-infectious-granulomatous-uveitis-a-retrospective-cohort-study-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/pain-catastrophizing-negatively-impacts-drug-retention-rate-psoriatic-arthritis-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/pain-interference-in-juvenile-idiopathic-arthritis-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/pain-is-common-in-myositis-and-associated-with-disease-activity-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/pain-reduction-with-oral-methotrexate-in-knee-osteoarthritis-a-randomized-2024/2026-11-04T03:26:04Z https://currentrheuma.com/studies/pain-sensitisation-and-joint-inflammation-in-patients-with-active-rheumatoid-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/pan-american-league-of-associations-for-rheumatology-recommendations-for-the-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/paprika-a-question-bank-for-assessing-psoriatic-arthritis-risk-in-individuals-of-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/part-5-allogeneic-hsct-in-refractory-sjia-with-lung-disease-recent-cases-from-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/participation-in-a-digital-self-management-intervention-for-osteoarthritis-and-2024/2026-11-04T06:09:55Z https://currentrheuma.com/studies/pathological-autoantibody-internalisation-in-myositis-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/patient-and-health-professional-views-on-risk-stratified-monitoring-of-immune-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/patient-burden-and-joint-inflammation-during-development-of-ra-from-arthralgia-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/patient-global-assessment-and-inflammatory-markers-in-patients-with-idiopathic-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/patient-initiated-follow-up-supported-asynchronous-telemedicine-usual-care-2024/2026-11-03T23:51:04Z https://currentrheuma.com/studies/patient-perspective-and-feasibility-of-home-finger-prick-testing-to-complement-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/patient-perspectives-on-a-decision-aid-for-systemic-lupus-erythematosus-insights-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/patient-profiles-in-randomized-controlled-trials-versus-a-real-world-study-in-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/patient-reported-impact-of-symptoms-in-fibromyalgia-prism-fm-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/patient-reported-outcome-for-physical-function-in-idiopathic-inflammatory-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/patient-reported-outcomes-and-radiographic-progression-in-patients-with-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/patient-reported-outcomes-axial-spondyloarthritis-psoriatic-arthritis-treated-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/patient-reported-outcomes-pros-and-pro-remission-rates-in-12-262-biologic-naive-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/patient-reported-sinonasal-symptoms-and-risk-of-relapse-in-antineutrophil-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/patient-research-partner-involvement-rheumatology-research-systematic-literature-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/patient-self-assessment-of-walking-ability-and-fracture-risk-in-older-australian-2024/2026-11-04T09:34:58Z https://currentrheuma.com/studies/patients-perspectives-on-axial-pain-in-relation-to-inflammation-and-structural-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/patients-recollection-about-the-onset-of-sjogrens-disease-a-mixed-methods-study-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/patients-unmet-needs-and-treatment-preferences-concerning-digital-ulcers-in-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/patients-with-npsle-experience-poorer-hrqol-and-more-fatigue-than-sle-patients-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/patients-with-obesity-have-more-inflamed-joints-and-higher-crp-levels-during-the-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/patients-with-psoriatic-arthritis-related-enthesitis-and-persistence-on-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/patients-with-systemic-sclerosis-and-low-cd4-numbers-after-autologous-stem-cell-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/patterns-comorbidities-differentially-affect-long-term-functional-evolution-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/patterns-of-infliximab-biosimilar-uptake-for-medicare-medicaid-and-private-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/patterns-of-reproductive-health-in-inflammatory-rheumatic-diseases-and-other-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/pd-1-pd-l1-governed-cross-talk-of-exhausted-cd8-t-and-memory-b-cells-in-systemic-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/pd-1-signaling-uncovers-a-pathogenic-subset-of-t-cells-in-inflammatory-arthritis-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/pediatrics-hyperuricemia-in-clinical-practice-a-retrospective-analysis-in-1753-2024/2026-11-04T00:06:14Z https://currentrheuma.com/studies/peer-led-symptom-management-intervention-to-enhance-resilience-in-people-with-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/people-short-symptom-duration-knee-osteoarthritis-benefit-more-exercise-therapy-2024/2026-11-04T03:22:35Z https://currentrheuma.com/studies/peptidoglycan-in-osteoarthritis-synovial-tissue-is-associated-with-joint-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/perceived-access-to-healthcare-of-indigenous-peoples-in-canada-with-rheumatoid-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/perfectra-pragmatic-multicentre-real-life-comparing-treat-target-strategies-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/performance-detect-pulmonary-arterial-hypertension-algorithm-according-2024/2026-11-04T05:52:08Z https://currentrheuma.com/studies/performance-eular-systemic-sclerosis-impact-disease-scleroid-questionnaire-as-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/performance-of-clinical-and-histological-prognostic-scores-for-kidney-survival-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/performance-of-clinical-laboratory-and-imaging-features-for-diagnosing-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/performance-of-cut-offs-of-the-asas-health-index-to-discriminate-between-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/performance-of-standardized-patient-reported-outcomes-developed-for-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/performance-of-the-2022-acr-eular-classification-criteria-in-comparison-with-the-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/performance-of-the-2023-american-college-of-rheumatology-eular-classification-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/performance-of-the-rheumatoid-arthritis-impact-of-disease-raid-score-in-relation-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/peripartum-maternal-outcomes-in-individuals-with-systemic-lupus-erythematosus-in-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/peripheral-blood-regulatory-t-cells-and-disease-activity-quality-of-life-and-2024/2026-11-04T03:21:42Z https://currentrheuma.com/studies/peripheral-mononuclear-cells-systemic-lupus-erythematosus-association-integrated-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/periprosthetic-fractures-are-osteoporotic-fractures-missed-opportunities-for-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/peritenon-extensor-tendon-inflammation-at-metacarpophalangeal-joints-level-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/persistence-power-doppler-ultrasonography-detected-synovitis-over-1-year-follow-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/persistence-safety-anti-tnf-biosimilars-originators-immune-mediated-inflammatory-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/personalised-care-packages-for-people-with-rheumatoid-arthritis-a-mixed-methods-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/personalizing-cardiovascular-risk-prediction-for-patients-with-systemic-lupus-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/perspective-of-dutch-patients-with-gout-on-continuation-or-discontinuation-of-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/perspectives-systemic-sclerosis-related-raynauds-phenomenon-feet-qualitative-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/pharmacokinetics-efficacy-safety-upadacitinib-pediatric-polyarticular-course-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/pharmacological-interventions-for-early-stage-frozen-shoulder-a-systematic-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/pharmakon-or-the-healing-art-experience-of-artistic-transformative-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/phase-1-randomized-double-blind-placebo-controlled-single-multiple-dose-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/phase-2-trial-of-deucravacitinib-in-psoriatic-arthritis-biomarkers-associated-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/phase-3-28-week-multicentre-randomised-double-blind-placebo-controlled-oa-10-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/phase-3-randomized-double-blind-active-controlled-clinical-compare-bat1806-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/phase-specific-healthcare-costs-associated-with-giant-cell-arteritis-in-ontario-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/phenotype-of-diffuse-cutaneous-systemic-sclerosis-patients-with-positive-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/phenotypic-characteristics-of-patients-with-chronic-widespread-pain-and-2024/2026-11-04T09:23:05Z https://currentrheuma.com/studies/phosphoproteomic-profiling-of-early-rheumatoid-arthritis-synovium-reveals-active-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/physical-function-trajectory-after-wrist-or-lower-arm-fracture-in-postmenopausal-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/physical-in-activity-and-screen-based-media-use-of-adolescents-with-juvenile-2024/2026-11-04T00:12:21Z https://currentrheuma.com/studies/physical-performance-and-sarcopenia-assessment-in-patients-with-a-recent-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/physical-performance-in-a-diverse-population-based-cohort-of-individuals-with-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/pilocarpine-treatment-of-sjogrens-syndrome-curative-effect-of-meta-analysis-of-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/pincer-morphology-is-not-associated-with-hip-osteoarthritis-unless-hip-pain-is-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/placental-lesions-in-systemic-lupus-erythematosus-pregnancies-associated-with-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/plant-based-diets-and-risk-of-hip-fracture-in-postmenopausal-women-2024/2026-11-04T09:34:58Z https://currentrheuma.com/studies/plasma-exosomes-may-mediate-the-development-of-lupus-nephritis-in-patients-with-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/plasma-haem-oxygenase-1-may-represent-a-first-in-class-biomarker-of-oxidative-2024/2026-11-04T03:14:15Z https://currentrheuma.com/studies/plasma-interferon-alpha-protein-levels-during-pregnancy-are-associated-with-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/plasma-matrix-metalloproteinase-concentrations-and-risk-of-interstitial-lung-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/plasma-mtdna-as-a-possible-contributor-to-and-biomarker-of-inflammation-in-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/pleural-irregularities-a-new-ultrasound-marker-for-lung-involvement-in-primary-2024/2026-11-04T00:06:14Z https://currentrheuma.com/studies/pm-10-increases-mortality-risk-in-rheumatoid-arthritis-associated-interstitial-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/pneumococcal-vaccine-uptake-in-patients-with-inflammatory-arthritis-a-single-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/poly-refractory-rheumatoid-arthritis-an-uncommon-subset-of-difficult-to-treat-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/polyarticular-juvenile-idiopathic-arthritis-has-a-distinct-co-inhibitor-receptor-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/polyautoimmunity-anticyclic-citrullinated-peptide-antibody-positive-negative-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/polygenic-risk-score-predicts-earlier-onset-adult-systemic-lupus-erythematosus-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/polymyalgia-rheumatica-is-a-risk-factor-for-more-recalcitrant-disease-in-giant-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/polymyositis-is-a-rare-and-favourable-outcome-subtype-of-idiopathic-inflammatory-2024/2026-11-04T09:24:09Z https://currentrheuma.com/studies/polypharmacy-drug-drug-interactions-and-adverse-drug-reactions-among-systemic-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/poor-prognostic-factors-for-relapse-of-interstitial-lung-disease-in-microscopic-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/poor-prognostic-factors-independently-impact-remission-treatment-escalation-2024/2026-11-04T00:06:14Z https://currentrheuma.com/studies/population-based-epidemiological-projections-of-rheumatoid-arthritis-in-germany-2024/2026-11-04T09:23:05Z https://currentrheuma.com/studies/positive-feedback-loop-pu-1-il9-in-th9-promotes-rheumatoid-arthritis-development-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/positive-psychological-capital-post-traumatic-growth-social-support-quality-life-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/positive-psychosocial-factors-may-protect-against-perceived-stress-in-people-2024/2026-11-04T06:13:45Z https://currentrheuma.com/studies/positivity-of-antiphosphatidylserine-prothrombin-antibodies-identifies-a-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/post-covid-19-psychological-condition-in-systemic-lupus-erythematosus-patients-a-2024/2026-11-03T11:13:22Z https://currentrheuma.com/studies/post-hoc-analysis-of-two-gout-remission-definitions-in-a-two-year-randomized-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/potential-benefits-of-statin-therapy-in-reducing-osteoarthritis-risk-a-mendelian-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/potential-causal-association-between-systemic-lupus-erythematosus-endocrine-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/potential-difficult-to-treat-psoriatic-arthritis-real-world-prevalence-and-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/potential-impact-of-european-medicines-agency-measures-to-minimize-risk-of-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/potential-involvement-of-circulating-exosomal-mirna-146a-in-disease-activity-and-2024/2026-11-04T09:26:49Z https://currentrheuma.com/studies/power-doppler-signal-at-enthesis-bone-erosions-are-most-discriminative-omeract-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/pragmatic-targets-moderate-severe-sle-their-implications-clinical-care-design-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/prediagnostic-amino-acid-metabolites-and-risk-of-gout-accounting-for-serum-urate-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/predicting-gout-flares-in-people-starting-allopurinol-using-the-start-low-go-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/predicting-risk-cardiovascular-cerebrovascular-event-systemic-lupus-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/predicting-the-onset-of-end-stage-knee-osteoarthritis-over-two-and-five-years-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/prediction-models-for-treatment-success-after-an-interdisciplinary-multimodal-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/prediction-of-ineffectiveness-of-biological-drugs-using-machine-learning-and-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/prediction-of-progressive-fibrosing-interstitial-lung-disease-in-patients-with-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/predictive-biomarkers-for-low-dose-il-2-therapy-efficacy-in-systemic-lupus-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/predictive-diagnostic-biomarkers-cytomegalovirus-infection-rheumatic-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/predictive-factors-and-treatment-outcomes-associated-with-difficult-to-treat-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/predictive-models-radiographic-progression-pain-progression-knee-osteoarthritis-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/predictive-tool-use-and-willingness-for-surgery-in-patients-with-knee-2024/2026-11-04T09:34:58Z https://currentrheuma.com/studies/predictive-utility-of-anca-positivity-and-antigen-specificity-in-the-assessment-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/predictive-validity-of-lupus-patient-reported-outcome-for-damage-accrual-in-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/predictive-value-of-doppler-echocardiography-parameters-for-cardiovascular-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/predictors-and-prognosis-of-pulmonary-hypertension-complicating-interstitial-2024/2026-11-03T10:53:39Z https://currentrheuma.com/studies/predictors-for-severe-persisting-pain-in-rheumatoid-arthritis-are-associated-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/predictors-functional-improvement-pain-reduction-rheumatoid-arthritis-who-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/predictors-of-damage-accrual-and-its-impact-on-health-related-quality-of-life-of-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/predictors-of-fibrogenesis-in-children-with-jia-a-single-center-pilot-study-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/predictors-of-first-hospitalization-due-to-disease-activity-and-infections-in-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/predictors-of-irreversible-renal-dysfunction-in-patients-with-idiopathic-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/predictors-of-lack-of-response-to-methotrexate-in-juvenile-idiopathic-arthritis-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/predictors-of-organ-damage-in-systemic-lupus-erythematosus-in-the-asia-pacific-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/predictors-of-renal-flares-in-systemic-lupus-erythematosus-a-post-hoc-analysis-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/predictors-of-return-to-work-after-multidisciplinary-rehabilitation-program-for-2024/2026-11-04T00:06:14Z https://currentrheuma.com/studies/predictors-of-rituximab-efficacy-in-systemic-sclerosis-associated-interstitial-2024/2026-11-03T10:53:39Z https://currentrheuma.com/studies/predictors-of-the-effectiveness-of-first-line-ctla4-ig-in-patients-with-ra-the-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/predictors-of-thrombotic-events-in-patients-with-idiopathic-inflammatory-2024/2026-11-03T08:01:42Z https://currentrheuma.com/studies/prednisone-use-disease-activity-occurrence-hyperglycaemia-diabetes-early-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/preferences-for-tapering-biologic-disease-modifying-antirheumatic-drugs-among-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/pregnancy-outcome-predictors-in-systemic-lupus-erythematosus-a-systematic-review-2024/2026-11-04T02:58:58Z https://currentrheuma.com/studies/pregnancy-outcomes-in-a-diverse-us-lupus-cohort-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/pregnancy-outcomes-in-women-with-rheumatoid-arthritis-an-11-year-french-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/pregnancy-outcomes-multidisciplinary-obstetric-medicine-rheumatology-clinic-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/preliminary-investigation-dissociation-between-subjective-cognitive-complaints-2024/2026-11-04T06:11:16Z https://currentrheuma.com/studies/preliminary-nomogram-model-for-predicting-irreversible-organ-damage-of-patients-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/preoperative-package-care-osteoarthritis-consisting-weight-loss-orthotics-2024/2026-11-04T09:04:37Z https://currentrheuma.com/studies/prescription-non-steroidal-anti-inflammatory-drugs-inflammatory-arthritis-2024/2026-11-04T06:09:55Z https://currentrheuma.com/studies/pretreatment-mortality-risk-prediction-model-in-patients-with-polymyositis-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/prevalence-and-characteristics-of-adults-with-difficult-to-treat-rheumatoid-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/prevalence-and-classification-of-meniscal-calcifications-in-the-human-knee-2024/2026-11-04T03:22:35Z https://currentrheuma.com/studies/prevalence-and-clinical-value-of-autoantibodies-directed-against-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/prevalence-and-outcomes-of-gastrointestinal-manifestations-in-an-australian-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/prevalence-and-prognostic-relevance-of-electrocardiographic-abnormalities-among-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/prevalence-and-progression-of-arterial-calcifications-on-computed-tomography-in-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/prevalence-and-risk-factors-of-postacute-sequelae-of-covid-19-in-adults-with-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/prevalence-anxiety-depression-association-self-management-behaviour-12-000-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/prevalence-associations-between-metabolic-syndrome-components-hyperuricemia-race-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/prevalence-cardiovascular-cancer-risk-factors-rheumatoid-arthritis-prescribed-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/prevalence-characteristics-and-outcome-of-subclinical-vasculitis-in-polymyalgia-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/prevalence-clinical-characteristics-rheumatoid-arthritis-interstitial-lung-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/prevalence-clinically-relevant-findings-magnetic-resonance-imaging-middle-aged-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/prevalence-fibromyalgia-widespread-pain-psoriatic-arthritis-association-disease-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/prevalence-incidence-and-geographic-distribution-of-familial-mediterranean-fever-2024/2026-11-03T11:13:22Z https://currentrheuma.com/studies/prevalence-incidence-uveitis-spondyloarthritis-impact-biologics-era-data-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/prevalence-location-inflammatory-structural-lesions-rheumatoid-arthritis-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/prevalence-major-adverse-cardiovascular-events-saudi-systemic-lupus-2024/2026-11-04T06:13:45Z https://currentrheuma.com/studies/prevalence-of-and-trends-in-hyperuricemia-by-race-and-ethnicity-among-us-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/prevalence-of-cardiovascular-events-in-a-population-based-registry-of-patients-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/prevalence-of-coeliac-disease-in-patients-with-systemic-lupus-erythematosus-a-2024/2026-11-04T09:26:49Z https://currentrheuma.com/studies/prevalence-of-crystal-deposits-in-asymptomatic-hyperuricemia-according-to-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/prevalence-of-spine-pain-among-tunisian-children-and-adolescents-and-related-2024/2026-11-04T03:21:42Z https://currentrheuma.com/studies/prevalence-predictors-and-prognosis-of-serious-infections-in-takayasu-arteritis-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/prevalence-preexisting-articular-bone-pathology-osteoarthritis-screened-2024/2026-11-04T03:22:35Z https://currentrheuma.com/studies/prevalence-risk-factors-echocardiographic-predictors-pulmonary-hypertension-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/prevalence-severity-and-measures-of-anxiety-in-rheumatoid-arthritis-a-systematic-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/prevalence-target-attainment-traditional-cardiovascular-risk-factors-systemic-2024/2026-11-04T05:53:11Z https://currentrheuma.com/studies/preventive-effects-of-early-immunosuppressive-treatment-on-the-development-of-2024/2026-11-03T10:53:39Z https://currentrheuma.com/studies/primary-central-nervous-system-vasculitis-with-intracranial-aneurysm-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/primary-headache-in-sle-systematic-review-and-meta-analysis-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/primary-osteoarthritis-chondrocyte-map-of-chromatin-conformation-reveals-novel-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/primary-sjogrens-syndrome-independently-promotes-premature-subclinical-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/primary-versus-systemic-sclerosis-associated-raynauds-phenomenon-relationship-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/prior-fragility-fractures-are-associated-with-a-higher-risk-of-8-year-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/prioritising-domains-of-glucocorticoid-therapy-to-measure-in-trials-results-from-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/proactive-therapeutic-drug-monitoring-of-biologic-drugs-in-adult-patients-with-2024/2026-11-04T00:15:50Z https://currentrheuma.com/studies/prodromal-symptoms-of-rheumatoid-arthritis-in-a-primary-care-database-variation-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/profile-of-hla-b27-positive-enthesitis-spondylitis-related-arthritis-in-senegal-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/prognosis-management-reclassified-systemic-lupus-erythematosus-associated-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/prognostic-and-functional-importance-of-both-overt-and-subclinical-left-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/prognostic-factors-and-changes-in-pain-physical-functioning-and-participation-in-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/prognostic-factors-and-the-value-of-radiographic-osteoarthritis-for-persistent-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/prognostic-factors-for-colchicine-prophylaxis-related-adverse-events-when-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/prognostic-factors-for-interstitial-lung-disease-progression-in-rheumatoid-2024/2026-11-04T03:14:15Z https://currentrheuma.com/studies/prognostic-factors-for-patients-with-cancer-associated-dermatomyositis-a-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/prognostic-factors-liver-blood-kidney-adverse-events-glucocorticoid-sparing-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/prognostic-model-to-predict-the-incidence-of-radiographic-knee-osteoarthritis-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/prognostic-role-of-interferon-3-in-anti-melanoma-differentiation-associated-gene-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/prognostic-significance-of-tubulointerstitial-macrophage-density-in-mpo-anca-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/prognostic-value-of-hypermetabolic-bone-sarcoidosis-observed-by-18f-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/prognostic-value-serum-protein-electrophoresis-constituents-arthritis-2024/2026-11-04T09:23:05Z https://currentrheuma.com/studies/progression-to-anca-associated-vasculitis-in-patients-with-idiopathic-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/progressive-resistance-training-or-neuromuscular-exercise-for-hip-osteoarthritis-2024/2026-11-04T06:22:33Z https://currentrheuma.com/studies/proinflammatory-phenotype-of-b10-and-b10pro-cells-elicited-by-tnf-in-rheumatoid-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/prologue-spondyloarthritis-unmet-research-needs-conference-iv-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/promis-29-in-rheumatoid-arthritis-patients-who-screen-positive-or-negative-for-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/pronounced-benefits-of-jak-inhibition-with-baricitinib-in-covid-19-pneumonia-in-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/prospective-assessment-of-glucocorticoid-toxicity-in-rheumatology-practice-a-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/prospective-study-of-complications-and-sequelae-of-glucocorticoid-therapy-in-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/prospective-study-to-characterize-adalimumab-exposure-in-pediatric-patients-with-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/protein-kinase-r-is-highly-expressed-in-dermatomyositis-and-promotes-interferon-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/protein-profiling-in-systemic-sclerosis-patients-with-different-pulmonary-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/proteomic-profiling-identifies-spp1-associated-with-rapidly-progressive-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/proton-pump-inhibitors-bone-and-phosphocalcic-metabolism-2024/2026-11-04T09:23:39Z https://currentrheuma.com/studies/provider-assessment-of-the-temporomandibular-joint-in-juvenile-idiopathic-2024/2026-11-04T06:16:46Z https://currentrheuma.com/studies/proximal-weakness-and-creatine-kinase-elevation-in-systemic-sclerosis-clinical-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/psoriatic-arthritis-phenotype-may-vary-depending-on-whether-the-skin-or-joint-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/psoriatic-arthritis-priority-setting-partnership-patient-and-clinician-informed-2024/2026-11-03T13:56:47Z https://currentrheuma.com/studies/psychological-distress-over-12-months-post-diagnosis-in-an-early-inflammatory-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/psychological-impact-of-life-events-in-systemic-lupus-erythematosus-patients-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/psychometric-properties-evaluation-of-the-persian-version-of-the-self-report-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/psychometric-properties-of-patient-global-assessment-in-psoriatic-arthritis-a-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/psychosocial-factors-in-knee-osteoarthritis-scoping-review-of-evidence-and-2024/2026-11-04T06:17:41Z https://currentrheuma.com/studies/pulmonary-and-extra-pulmonary-effects-of-lung-transplantation-in-an-italian-2024/2026-11-03T10:53:39Z https://currentrheuma.com/studies/pulmonary-involvement-in-systemic-sclerosis-can-sex-play-a-role-2024/2026-11-03T13:56:47Z https://currentrheuma.com/studies/qrisk3-and-score2-are-equally-reliable-predictors-of-carotid-plaques-in-patients-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/quantification-coronary-artery-calcification-systemic-sclerosis-using-visual-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/quantifying-the-need-for-specialist-palliative-care-management-in-patients-with-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/quantitative-18f-fdg-pet-ct-can-assess-presence-and-extent-of-interstitial-lung-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/quantitative-comparison-between-essential-medicines-rheumatic-diseases-children-2024/2026-11-04T03:21:42Z https://currentrheuma.com/studies/race-specific-frax-models-are-evidence-based-support-equitable-care-response-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/racial-and-ethnic-associations-with-interstitial-lung-disease-and-healthcare-2024/2026-11-03T10:53:39Z https://currentrheuma.com/studies/racial-and-ethnic-composition-of-populations-served-by-freestanding-childrens-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/racial-and-ethnic-determinants-of-psoriatic-arthritis-phenotypes-and-disease-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/racial-and-ethnic-disparities-in-providing-guideline-concordant-care-after-hip-2024/2026-11-04T03:25:32Z https://currentrheuma.com/studies/racial-disparities-and-achievement-of-the-low-lupus-disease-activity-state-a-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/racial-ethnic-differences-prevalence-arthritis-severe-joint-pain-who-received-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/racial-variability-in-immune-responses-only-partially-explains-differential-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/racialized-inequities-in-knee-arthroplasty-receipt-after-osteoarthritis-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/rage-signalling-contributes-to-oxidative-stress-and-inflammation-in-knee-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/ramosetron-as-an-add-on-therapy-for-refractory-fibromyalgia-a-randomized-double-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/randomised-parallel-group-double-blind-placebo-controlled-phase-3-determine-2024/2026-11-04T03:15:15Z https://currentrheuma.com/studies/randomised-trial-of-genetic-testing-and-targeted-intervention-to-prevent-the-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/rapid-reduction-fracture-risk-after-discontinuation-long-term-oral-2024/2026-11-04T00:13:51Z https://currentrheuma.com/studies/rationale-for-osteoporosis-screening-in-men-2024/2026-11-04T00:13:51Z https://currentrheuma.com/studies/rbm15-an-m6a-enzyme-suppresses-nlrp3-inflammasome-activation-in-rheumatoid-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/real-world-application-of-the-2023-acr-eular-antiphospholipid-antibody-syndrome-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/real-world-application-of-the-pediatric-glucocorticoid-toxicity-index-in-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/real-world-assessment-of-the-efficacy-and-tolerability-profile-of-jak-inhibitors-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/real-world-coverage-with-influenza-pneumococcal-and-herpes-zoster-vaccines-among-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/real-world-effectiveness-of-belimumab-in-patients-with-lupus-in-china-reliable-2024/2026-11-04T03:18:08Z https://currentrheuma.com/studies/real-world-effectiveness-of-pegloticase-associated-with-use-of-concomitant-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/real-world-efficacy-teriparatide-biosimilar-rgb-10-compared-reference-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/real-world-outcomes-of-a-dedicated-fast-track-polymyalgia-rheumatica-clinic-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/real-world-psychosocial-impact-among-patients-with-juvenile-idiopathic-arthritis-2024/2026-11-04T00:12:21Z https://currentrheuma.com/studies/real-world-treatment-patterns-healthcare-resource-utilisation-and-costs-in-2024/2026-11-04T00:09:46Z https://currentrheuma.com/studies/real-world-treatment-patterns-in-patients-with-systemic-lupus-erythematosus-2024/2026-11-04T03:18:08Z https://currentrheuma.com/studies/reappraisal-of-large-artery-involvement-in-giant-cell-arteritis-a-population-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/reasons-for-multiple-biologic-and-targeted-synthetic-dmard-switching-and-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/receipt-of-rheumatology-care-and-lupus-specific-labs-among-young-adults-with-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/recommendations-early-referral-individuals-suspected-polymyalgia-rheumatica-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/recommendations-for-physical-activity-and-exercise-in-persons-living-with-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/recommendations-of-the-french-society-of-rheumatology-for-the-management-in-2024/2026-11-04T06:10:35Z https://currentrheuma.com/studies/reduced-deltex1-expression-in-t-cells-indicates-increased-disease-activity-in-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/reduced-dose-versus-high-dose-glucocorticoids-added-to-rituximab-on-remission-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/reduction-of-non-classical-monocytes-that-suppress-interferon-in-patients-with-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/referral-patterns-for-people-with-musculoskeletal-complaints-in-general-practice-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/refining-treat-to-target-strategies-in-cryopyrin-associated-periodic-syndromes-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/regenerative-treatments-for-scleroderma-in-cutaneous-manifestations-of-the-face-2024/2026-11-04T03:15:15Z https://currentrheuma.com/studies/regression-to-the-mean-for-physical-function-and-quality-of-life-in-clinical-2024/2026-11-04T00:13:14Z https://currentrheuma.com/studies/regular-physical-activity-improves-physical-function-health-related-quality-life-2024/2026-11-04T00:13:51Z https://currentrheuma.com/studies/regulatory-t-and-b-cells-in-pediatric-henoch-schonlein-purpura-friends-or-foes-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/relapses-and-serious-adverse-events-during-rituximab-maintenance-therapy-in-anca-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/relationship-between-adalimumab-concentrations-antidrug-antibodies-disease-2024/2026-11-04T09:22:05Z https://currentrheuma.com/studies/relationship-between-high-resolution-computed-tomography-quantitative-imaging-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/relationship-between-ocular-manifestations-laboratory-findings-echocardiographic-2024/2026-11-04T06:16:46Z https://currentrheuma.com/studies/relationship-between-spinal-structural-damage-and-sagittal-balance-in-axial-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/relationship-between-ultrasound-physical-examination-assessment-enthesitis-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/relationship-of-fatigue-pain-interference-and-physical-disability-in-children-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/relationship-of-serum-and-dietary-vitamin-d-with-high-cardiometabolic-risk-in-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/relationship-regional-ultraviolet-index-data-rash-systemic-disease-activity-2024/2026-11-04T06:16:46Z https://currentrheuma.com/studies/relationships-between-patellofemoral-bone-remodeling-cartilage-composition-2024/2026-11-04T03:22:35Z https://currentrheuma.com/studies/relationships-of-work-productivity-and-activity-impairment-with-patient-reported-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/reliability-assessment-of-the-omeract-whole-body-magnetic-resonance-imaging-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/reliability-of-colour-doppler-ultrasonography-of-the-major-salivary-glands-in-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/remission-and-low-disease-activity-are-associated-with-lower-healthcare-costs-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/remission-definitions-guiding-immunosuppressive-therapy-in-rheumatoid-arthritis-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/remission-low-disease-activity-as-treatment-targets-rheumatoid-arthritis-how-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/remote-monitoring-rheumatoid-arthritis-low-disease-activity-state-mixed-methods-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/remote-patient-reported-outcome-measure-triage-score-for-monitoring-disease-2024/2026-11-04T00:05:39Z https://currentrheuma.com/studies/renal-arteriosclerosis-in-kidney-biopsies-associated-with-higher-10-year-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/renal-response-outcomes-of-the-eurolupus-and-national-institutes-of-health-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/renal-response-status-to-predict-long-term-renal-survival-in-patients-with-lupus-2024/2026-11-04T00:09:46Z https://currentrheuma.com/studies/reporting-determinants-health-inequities-participant-characteristics-randomized-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/reproductive-outcomes-for-women-with-vasculitis-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/residual-disease-activity-in-canadian-patients-with-psoriatic-arthritis-treated-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/resolution-immune-checkpoint-inhibitors-induced-inflammatory-arthritis-while-2024/2026-11-04T00:06:14Z https://currentrheuma.com/studies/resource-utilization-and-costs-of-transitioning-from-pediatric-to-adult-care-for-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/responsiveness-and-sensitivity-of-proms-to-change-in-disease-activity-status-in-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/results-and-prognosis-of-kidney-transplantation-in-lupus-nephritis-experience-of-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/retention-rate-and-predictors-of-discontinuation-for-secukinumab-treatment-real-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/retention-rate-novel-autoinjector-e-device-introduced-chronic-arthritis-treated-2024/2026-11-04T03:14:15Z https://currentrheuma.com/studies/retention-rates-of-different-janus-kinase-inhibitors-in-rheumatoid-arthritis-2024/2026-11-04T06:09:55Z https://currentrheuma.com/studies/retention-triple-therapy-methotrexate-sulfasalazine-hydroxychloroquine-compared-2024/2026-11-04T06:10:35Z https://currentrheuma.com/studies/retrospective-analysis-safety-tacrolimus-use-its-optimal-cut-off-concentration-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/retrospective-cohort-study-identifying-pulmonary-complications-in-a-cohort-of-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/return-on-investment-of-fracture-liaison-services-a-systematic-review-and-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/revealing-novel-genomic-insights-and-therapeutic-targets-for-juvenile-idiopathic-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/reversibility-of-pulmonary-hypertension-in-systemic-lupus-erythematosus-after-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/rheuma-vor-study-optimising-healthcare-of-rheumatic-diseases-by-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/rheumatoid-arthritis-and-changes-on-spirometry-by-smoking-status-in-two-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/rheumatoid-arthritis-and-risk-of-depression-in-south-korea-2024/2026-11-04T09:34:58Z https://currentrheuma.com/studies/rheumatoid-arthritis-and-risk-of-osteoarticular-infection-and-death-following-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/rheumatoid-arthritis-and-the-risk-of-ischaemic-stroke-after-diagnosis-of-atrial-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/rheumatoid-arthritis-associated-interstitial-lung-disease-clinical-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/rheumatoid-arthritis-care-experiences-of-black-people-living-in-canada-a-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/rheumatoid-arthritis-disease-activity-significantly-impacts-on-the-severity-of-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/rheumatoid-arthritis-disease-modifying-antirheumatic-drugs-and-risk-of-major-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/rheumatoid-arthritis-patients-harbour-aberrant-enteric-bacteriophages-with-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/rheumatoid-arthritis-patients-perspective-on-the-use-of-prediction-models-in-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/rheumatologic-complications-of-car-t-cell-therapy-experience-of-a-single-center-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/rhupus-syndrome-in-children-a-multi-center-retrospective-cohort-study-and-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/right-ventricular-pulmonary-arterial-coupling-ratio-derived-3-dimensional-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/risk-and-predictors-of-fractures-in-early-rheumatoid-arthritis-a-long-term-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/risk-extended-major-adverse-cardiovascular-event-endpoints-tofacitinib-tnf-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/risk-factors-associated-with-1-year-mortality-after-osteoporotic-hip-fracture-in-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/risk-factors-associated-with-venous-thromboembolism-in-rheumatoid-arthritis-in-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/risk-factors-for-hospitalization-in-mexican-patients-with-systemic-lupus-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/risk-factors-for-shoulder-pain-and-stiffness-in-adults-aged-44-and-older-an-11-2024/2026-11-04T00:05:39Z https://currentrheuma.com/studies/risk-factors-of-covid-19-related-hospitalization-of-paediatric-patients-with-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/risk-factors-of-first-thrombosis-in-obstetric-antiphospholipid-syndrome-2024/2026-11-04T09:26:49Z https://currentrheuma.com/studies/risk-factors-of-mortality-in-patients-with-rheumatoid-arthritis-associated-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/risk-flare-damage-accrual-after-tapering-glucocorticoids-modified-serologically-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/risk-loci-involved-in-giant-cell-arteritis-susceptibility-a-genome-wide-2024/2026-11-04T05:53:11Z https://currentrheuma.com/studies/risk-of-cardiovascular-comorbidities-before-and-after-the-onset-of-rheumatic-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/risk-of-cardiovascular-disease-associated-with-long-term-use-of-non-steroidal-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/risk-of-cardiovascular-disease-decreases-over-time-in-psoriatic-arthritis-but-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/risk-of-cardiovascular-disease-with-high-dose-versus-low-dose-use-of-non-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/risk-of-chronic-kidney-disease-in-260-patients-with-lupus-nephritis-analysis-of-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/risk-of-developing-psoriatic-arthritis-in-psoriasis-cohorts-with-arthralgia-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/risk-of-diabetes-mellitus-in-systemic-lupus-erythematosus-systematic-review-and-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/risk-of-flare-in-patients-with-sle-in-remission-after-hydroxychloroquine-or-2024/2026-11-04T03:14:48Z https://currentrheuma.com/studies/risk-of-gastrointestinal-perforation-in-patients-with-rheumatic-diseases-exposed-2024/2026-11-04T05:52:08Z https://currentrheuma.com/studies/risk-of-hypertensive-disorders-and-preterm-birth-in-pregnant-women-with-systemic-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/risk-of-incident-gout-following-exposure-to-recombinant-zoster-vaccine-in-us-2024-2/2026-11-04T03:10:54Z https://currentrheuma.com/studies/risk-of-incident-gout-following-exposure-to-recombinant-zoster-vaccine-in-us-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/risk-of-neuroinflammatory-diseases-among-new-recipients-of-biologic-and-targeted-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/risk-of-non-thyroidal-autoimmune-diseases-in-patients-with-graves-disease-a-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/risk-of-relapse-of-antineutrophil-cytoplasmic-antibody-associated-vasculitis-in-2024/2026-11-04T05:52:08Z https://currentrheuma.com/studies/risk-of-rituximab-induced-hepatitis-b-flare-after-antiviral-discontinuation-in-2024/2026-11-04T03:15:15Z https://currentrheuma.com/studies/risk-of-severe-infection-associated-with-immunoglobulin-deficiency-under-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/risk-of-urolithiasis-associated-with-allopurinol-versus-benzbromarone-among-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/risk-of-venous-thromboembolism-with-tofacitinib-versus-tumor-necrosis-factor-2024/2026-11-04T05:52:08Z https://currentrheuma.com/studies/risk-perception-well-being-depression-anxiety-children-adolescents-rheumatic-2024/2026-11-04T06:16:46Z https://currentrheuma.com/studies/risk-prediction-modelling-idiopathic-inflammatory-myositis-associated-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/risk-prediction-new-onset-thrombocytopenia-systemic-lupus-erythematosus-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/risk-profiles-for-rheumatoid-arthritis-associated-interstitial-lung-disease-in-a-2024/2026-11-04T00:05:39Z https://currentrheuma.com/studies/risk-serious-infection-associated-different-classes-targeted-therapies-used-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/risk-stratification-for-infection-during-immunosuppressive-therapy-in-patients-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/risk-stratified-monitoring-for-sulfasalazine-toxicity-prognostic-model-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/rituximab-as-an-effective-add-on-maintenance-therapy-for-disease-activities-in-2024/2026-11-04T09:26:49Z https://currentrheuma.com/studies/rituximab-as-maintenance-therapy-anca-associated-vasculitides-pooled-analysis-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/rituximab-in-the-treatment-of-progressive-interstitial-lung-disease-associated-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/rituximab-retention-rate-in-systemic-sclerosis-a-long-term-real-life-multicentre-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/role-of-intravenous-immunoglobulins-in-systemic-sclerosis-ssc-a-systematic-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/role-of-intravenous-immunoglobulins-in-the-management-of-systemic-lupus-2024/2026-11-04T00:09:46Z https://currentrheuma.com/studies/role-of-physical-therapy-in-adult-chronic-non-bacterial-osteitis-patients-and-2024/2026-11-04T06:09:55Z https://currentrheuma.com/studies/romosozumab-in-patients-who-experienced-an-on-study-fracture-post-hoc-analyses-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/routine-radiographs-of-hands-and-feet-do-not-have-diagnostic-or-prognostic-value-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/s100-proteins-as-potential-predictive-biomarkers-of-abatacept-response-in-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/sacroiliac-radiographic-progression-over-10-years-in-axspa-data-from-the-desir-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/sacroiliitis-in-inflammatory-bowel-disease-on-abdominal-computed-tomography-2024/2026-11-04T06:09:55Z https://currentrheuma.com/studies/safety-and-effectiveness-of-abatacept-in-juvenile-idiopathic-arthritis-results-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/safety-and-efficacy-of-colchicine-in-crystal-induced-arthritis-flare-in-54-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/safety-and-tolerability-of-intravenous-immunoglobulin-in-patients-with-active-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/safety-efficacy-subcutaneous-iscalimab-cfz533-two-distinct-populations-sjogrens-2024/2026-11-04T03:25:08Z https://currentrheuma.com/studies/safety-pharmacokinetics-biomarker-response-efficacy-e6742-dual-antagonist-toll-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/sarcopenia-assessed-by-dxa-and-hand-grip-dynamometer-a-potential-marker-of-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/satisfaction-and-effectiveness-of-switching-from-intravenous-to-subcutaneous-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/school-well-being-and-academic-performance-of-children-with-juvenile-idiopathic-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/scleritis-and-development-of-immune-mediated-disease-a-retrospective-chart-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/scoping-review-vasculitis-as-immune-related-adverse-event-checkpoint-inhibitor-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/screening-comorbid-autoimmune-disease-should-be-considered-children-ana-positive-2024/2026-11-04T00:12:21Z https://currentrheuma.com/studies/screening-for-juvenile-idiopathic-arthritis-associated-uveitis-with-laser-flare-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/screening-of-environmental-chemicals-to-characterize-exposures-in-participants-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/screening-tools-for-spondyloarthritis-in-patients-with-psoriasis-uveitis-and-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/selective-estrogen-receptor-modulators-serms-vitamin-d-composite-agent-can-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/self-administered-acupressure-for-probable-knee-osteoarthritis-in-middle-aged-2024/2026-11-04T06:21:48Z https://currentrheuma.com/studies/self-determined-motivation-and-physical-activity-in-patients-with-rheumatoid-2024/2026-11-04T09:23:05Z https://currentrheuma.com/studies/self-efficacy-is-associated-with-a-lower-probability-of-damage-accrual-in-2024/2026-11-03T11:13:22Z https://currentrheuma.com/studies/self-esteem-self-concept-and-body-image-of-young-people-with-rheumatic-and-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/self-guided-digital-behavioural-therapy-versus-active-control-for-fibromyalgia-2024/2026-11-04T03:25:08Z https://currentrheuma.com/studies/self-reported-skin-severity-and-quality-of-life-in-systemic-sclerosis-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/semaphorin-5a-promotes-th17-differentiation-via-pi3k-akt-mtor-in-systemic-lupus-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/semi-automatic-proximal-humeral-trabecular-bone-density-assessment-tool-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/senescent-cells-in-giant-cell-arteritis-display-an-inflammatory-phenotype-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/sensitive-b-cell-receptor-repertoire-analysis-shows-repopulation-correlates-with-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/sensitivity-of-classification-criteria-from-time-of-diagnosis-in-an-incident-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/sensitivity-to-change-of-structural-outcomes-in-axial-spondyloarthritis-after-10-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/septic-arthritis-of-the-facet-joint-is-also-a-severe-vertebral-infection-a-2024/2026-11-04T09:23:39Z https://currentrheuma.com/studies/serial-assessment-of-ultrasound-sensitivity-and-scores-in-patients-with-giant-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/serious-infections-and-tuberculosis-adversely-impact-outcomes-of-juvenile-onset-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/serious-infections-in-patients-with-vexas-syndrome-data-from-the-french-vexas-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/serological-response-after-covid-19-infection-compared-to-vaccination-against-2024/2026-11-04T03:21:42Z https://currentrheuma.com/studies/seroprevalence-of-toxoplasma-gondii-immunoglobulins-and-its-association-with-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/serpina3-fga-agp1-itih3-and-saa1-as-novel-biomarkers-for-eosinophilic-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/serum-and-salivary-inflammatory-biomarkers-in-juvenile-idiopathic-arthritis-an-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/serum-args-aggrecan-in-a-phase-2-clinical-trial-targeting-osteoarthritis-2024/2026-11-04T06:17:41Z https://currentrheuma.com/studies/serum-ccl24-as-a-biomarker-of-fibrotic-and-vascular-disease-severity-in-systemic-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/serum-gm-csf-level-is-a-predictor-of-treatment-response-to-tocilizumab-in-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/serum-hepcidin-evaluation-as-a-promising-biomarker-in-juvenile-idiopathic-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/serum-interleukin-34-levels-in-dermatomyositis-a-potential-biomarker-for-anti-2024/2026-11-03T10:53:39Z https://currentrheuma.com/studies/serum-levels-of-free-light-chains-and-syndecan-1-in-patients-with-rheumatoid-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/serum-levels-of-hydroxylated-metabolites-of-arachidonic-acid-cross-sectionally-2024/2026-11-04T06:17:41Z https://currentrheuma.com/studies/serum-long-non-coding-ribonucleic-acid-h19-serves-as-a-biomarker-for-systemic-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/serum-protein-profiling-reveals-distinct-patient-clusters-in-giant-cell-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/serum-proteomic-profiles-of-patients-with-chronic-recurrent-multifocal-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/serum-syndecan1-has-the-potential-to-reflect-activity-at-diagnosis-and-predict-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/serum-tissue-biomarkers-associated-composite-relevant-endpoints-sjogren-syndrome-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/serum-urate-and-recurrent-gout-2024/2026-11-04T09:34:04Z https://currentrheuma.com/studies/serum-urate-change-among-gout-patients-treated-with-sodium-glucose-cotransporter-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/serum-wnt3a-levels-are-significantly-associated-cross-sectional-vasculitis-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/seven-year-follow-up-atherosclerotic-plaque-progression-in-patients-with-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/severe-enterovirus-infections-in-patients-with-immune-mediated-inflammatory-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/severe-features-of-systemic-juvenile-idiopathic-arthritis-in-patients-with-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/severe-gastrointestinal-involvements-in-patients-with-adult-dermatomyositis-with-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/severe-haematological-involvement-in-children-with-systemic-lupus-erythematosus-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/severe-hypocalcemia-with-denosumab-among-older-female-dialysis-dependent-2024/2026-11-04T09:34:04Z https://currentrheuma.com/studies/severe-methotrexate-toxicity-in-elderly-patients-under-diuretics-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/sex-as-predictor-clinical-phenotype-determinant-immune-response-igg4-related-2024/2026-11-04T05:53:11Z https://currentrheuma.com/studies/sex-differences-and-predictors-of-anti-osteoporosis-medication-use-in-the-12-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/sex-differences-effectiveness-first-line-tumor-necrosis-factor-inhibitors-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/sex-differences-in-cytokines-and-adipokines-in-obese-patients-with-psa-and-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/sex-differences-in-hemoglobin-levels-and-five-year-refracture-risk-in-patients-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/sex-differences-in-patellar-facet-shape-among-healthy-and-osteoarthritic-cohorts-2024/2026-11-04T03:22:35Z https://currentrheuma.com/studies/sex-differences-in-time-to-initiate-nonsteroidal-anti-inflammatory-drugs-or-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/sex-differences-patient-reported-outcome-measures-association-clinical-factors-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/sex-differential-impact-of-comorbidities-in-spondyloarthritis-data-from-comospa-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/sex-related-differences-in-dispensation-of-rheumatic-medications-in-older-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/sex-specific-disparities-disease-activity-scores-axial-spondyloarthritis-their-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/sex-specific-impact-inflammation-traditional-cardiovascular-risk-factors-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/sexual-dysfunction-in-male-patients-treated-with-methorexate-for-arthritis-2024/2026-11-04T09:23:39Z https://currentrheuma.com/studies/sf-36v2-and-facit-fatigue-quality-of-life-improvements-with-organ-specific-2024/2026-11-04T06:13:45Z https://currentrheuma.com/studies/shared-lung-and-joint-t-cell-repertoire-in-early-rheumatoid-arthritis-driven-by-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/short-and-long-term-mortality-of-hospitalized-patients-with-autoimmune-rheumatic-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/short-and-long-term-outcomes-of-patients-with-pure-membranous-lupus-nephritis-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/short-term-and-long-term-outcomes-of-patients-with-anti-melanoma-differentiation-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/short-term-effectiveness-of-guselkumab-in-psoriatic-arthritis-patients-and-axial-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/short-term-risk-of-cardiovascular-events-in-people-newly-diagnosed-with-gout-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/should-major-trauma-fractures-be-part-of-a-fracture-liaison-services-remit-a-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/shoulder-symptom-trajectories-over-four-years-data-from-a-longitudinal-study-on-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/sick-leave-and-disability-pension-following-delivery-in-women-with-systemic-2024/2026-11-04T06:09:55Z https://currentrheuma.com/studies/significant-decrease-osteoporosis-osteoporotic-fractures-rheumatoid-arthritis-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/significant-heightened-methylation-levels-of-runx3-gene-promoter-in-patients-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/significant-overlap-inflammatory-degenerative-features-imaging-degenerative-disc-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/single-cell-profiling-of-bone-marrow-b-cells-and-early-b-cell-developmental-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/single-cell-profiling-reveals-kidney-cd163-dendritic-cell-participation-in-human-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/single-cell-resolution-of-longitudinal-blood-transcriptome-profiles-in-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/single-cell-rna-sequencing-submandibular-gland-reveals-collagen-type-xv-positive-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/single-cell-transcriptome-analyses-reveal-disturbed-decidual-homoeostasis-in-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/single-center-clinical-analysis-of-macrophage-activation-syndrome-complicating-2024/2026-11-04T06:16:46Z https://currentrheuma.com/studies/sjogrens-disease-systemic-lupus-erythematosus-overlap-syndrome-as-distinct-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/skeletal-muscle-composition-power-and-mitochondrial-energetics-in-older-men-and-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/skeletal-muscle-mass-and-quality-in-gout-patients-versus-non-gout-controls-a-2024/2026-11-04T06:10:35Z https://currentrheuma.com/studies/sle-inflammatory-musculoskeletal-abnormalities-confirmed-by-mri-show-a-specific-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/sle-patient-satisfaction-with-care-in-jordan-a-single-center-study-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/slesis-r-an-improved-score-for-prediction-of-serious-infection-in-patients-with-2024/2026-11-04T06:13:45Z https://currentrheuma.com/studies/small-extracellular-vesicles-derived-from-synovial-fibroblasts-contain-distinct-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/smoking-related-bias-of-standardized-mortality-ratios-in-rheumatoid-arthritis-a-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/sodium-glucose-cotransporter-2-inhibitors-and-nephritis-among-patients-with-2024/2026-11-04T06:21:48Z https://currentrheuma.com/studies/soluble-cxcl16-is-a-prognostic-biomarker-associated-with-rapidly-progressive-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/soluble-urine-activated-leukocyte-cell-adhesion-molecule-is-a-strong-predictor-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/somatization-differentiates-fibromyalgia-from-low-back-pain-a-comparative-cross-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/spatiotemporal-changes-in-imaging-features-associated-with-diffuse-idiopathic-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/specific-cytokine-associations-with-outcomes-in-knee-osteoarthritis-subgroups-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/specific-descriptions-of-axial-involvement-are-associated-with-radiographic-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/specific-isoforms-of-the-ubiquitin-ligase-gene-wwp2-are-targets-of-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/spontaneous-pneumomediastinum-in-anti-mda5-positive-dermatomyositis-prevalence-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/stability-of-symptom-based-subtypes-in-sjogrens-disease-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/standardization-interstitial-lung-disease-assessment-ultrasound-results-delphi-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/standardized-reporting-for-systematic-global-evaluation-of-axial-2024/2026-11-04T06:10:35Z https://currentrheuma.com/studies/steroid-sparing-strategies-for-managing-ici-induced-arthritis-safety-and-2024/2026-11-03T11:13:22Z https://currentrheuma.com/studies/strategies-to-promote-implementation-of-core-outcomes-for-medication-adherence-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/stratification-according-to-autoantibody-status-in-systemic-sclerosis-reveals-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/subchondral-bone-marrow-adipose-tissue-lipolysis-regulates-bone-formation-in-2024/2026-11-04T00:13:14Z https://currentrheuma.com/studies/subclinical-aortic-inflammation-in-patients-with-polymyalgia-rheumatica-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/subclinical-dactylitis-is-linked-with-active-phenotype-of-psoriatic-arthritis-2024/2026-11-04T03:14:48Z https://currentrheuma.com/studies/subclinical-giant-cell-arteritis-increases-the-risk-of-relapse-in-polymyalgia-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/subclinical-myocardial-involvement-in-a-cohort-of-patients-with-antisynthetase-2024/2026-11-04T09:24:09Z https://currentrheuma.com/studies/subcutaneous-vs-intravenous-abatacept-in-rheumatoid-arthritis-interstitial-lung-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/substantive-similarities-between-synovial-fluid-and-synovial-tissue-t-cells-in-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/superiority-of-low-dose-benzbromarone-add-on-to-low-dose-febuxostat-compared-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/supporting-self-management-low-back-pain-internet-intervention-without-telephone-2024/2026-11-04T05:53:11Z https://currentrheuma.com/studies/survival-early-outcomes-following-lung-transplantation-interstitial-lung-disease-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/susceptibility-to-mycobacterial-infection-in-vexas-syndrome-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/sustained-depression-of-b-cell-counts-in-lupus-nephritis-after-treatment-with-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/sustained-dmard-free-remission-in-subgroups-of-patients-with-rheumatoid-2024/2026-11-03T23:51:04Z https://currentrheuma.com/studies/sustained-drug-free-remission-in-giant-cell-arteritis-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/sustained-limb-level-loading-a-ground-reaction-force-phenotype-common-to-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/sustained-response-guselkumab-regardless-baseline-characteristics-active-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/symptom-severity-and-glucocorticoid-dosing-in-patients-with-polymyalgia-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/symptoms-prior-to-diagnosis-of-multiple-sclerosis-in-individuals-younger-than-18-2024/2026-11-04T00:16:14Z https://currentrheuma.com/studies/synovial-5-lipoxygenase-derived-oxylipins-define-a-lympho-myeloid-enriched-2024/2026-11-04T05:52:08Z https://currentrheuma.com/studies/synovial-tissue-features-associated-with-poor-prognosis-in-inflammatory-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/synovitis-acne-pustulosis-hyperostosis-osteitis-palmoplantar-pustulosis-and-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/synovitis-scoring-hand-osteoarthritis-ultrasonography-performance-global-omeract-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/synthesis-guidance-available-assessing-methodological-quality-grading-evidence-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/systematic-evaluation-of-abdominal-aortic-calcification-in-patients-with-a-2024/2026-11-04T00:13:51Z https://currentrheuma.com/studies/systematic-literature-review-to-inform-the-eular-recommendations-for-the-use-of-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/systematic-review-metaanalysis-pharmacological-interventions-adult-onset-still-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/systematic-review-of-health-related-quality-of-life-impact-in-juvenile-localized-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/systematic-review-of-treatments-for-the-gastrointestinal-manifestations-of-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/systematic-screening-multimorbidities-inflammatory-rheumatic-diseases-enhanced-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/systemic-auto-inflammatory-manifestations-in-patients-with-spondyloarthritis-2024/2026-11-04T03:14:48Z https://currentrheuma.com/studies/systemic-inflammation-in-asymptomatic-hyperuricaemia-with-sonographic-crystal-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/systemic-inflammatory-cytokine-profiles-in-patients-with-gout-during-flare-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/systemic-juvenile-idiopathic-arthritis-adult-onset-stills-disease-are-same-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/systemic-lupus-erythematosus-disease-activity-score-remission-low-disease-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/systemic-lupus-erythematosus-is-a-risk-factor-for-having-multiple-subtypes-of-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/systemic-lupus-erythematosus-is-associated-increased-risk-mortality-acute-kidney-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/systemic-lupus-international-collaborating-clinics-2012-european-league-against-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/systemic-sclerosis-and-cancer-in-the-uk-an-epidemiological-analysis-using-the-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/systemic-sclerosis-associated-pulmonary-arterial-hypertension-is-characterized-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/systemic-sclerosis-in-individuals-with-exposure-to-world-trade-center-ground-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/systemic-sclerosis-related-fecal-incontinence-a-scoping-review-focusing-on-a-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/systemic-sclerosis-sine-scleroderma-a-time-of-reappraisal-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/systemic-sclerosis-sine-scleroderma-is-more-aggressive-in-children-than-in-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/systemic-score-may-identify-life-threatening-evolution-still-disease-data-girrcs-2024/2026-11-04T05:52:08Z https://currentrheuma.com/studies/tacrolimus-personalized-therapy-based-on-cyp3a5-genotype-in-chinese-patients-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/taper-versus-discontinuation-of-tocilizumab-in-patients-with-giant-cell-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/targeting-cd13-aminopeptidase-n-as-a-novel-therapeutic-approach-for-scleroderma-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/telerehabilitation-consultations-physiotherapist-chronic-knee-pain-person-2024/2026-11-04T09:33:34Z https://currentrheuma.com/studies/telerheumatology-shared-care-model-leveraging-expertise-advanced-clinician-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/telitacicept-add-on-therapy-in-refractory-idiopathic-inflammatory-myopathy-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/telitacicept-in-patients-with-active-systemic-lupus-erythematosus-results-of-a-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/temporal-and-regional-variation-in-the-use-of-biologic-and-targeted-synthetic-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/temporal-trends-in-mortality-in-patients-with-systemic-lupus-erythematosus-a-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/temporal-trends-overall-infection-incidence-inflammatory-arthritides-treated-2024/2026-11-03T11:13:22Z https://currentrheuma.com/studies/tendon-involvement-and-its-association-with-pain-and-hand-function-in-patients-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/testosterone-treatment-and-fractures-in-men-with-hypogonadism-2024/2026-11-04T09:33:11Z https://currentrheuma.com/studies/tetraspanin-profiles-of-serum-extracellular-vesicles-reflect-functional-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/th1-th2-associated-transcription-factors-and-cytokines-in-pregnancies-with-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/th17-1-and-ex-th17-cells-are-detected-in-patients-with-polyarticular-juvenile-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/the-2024-british-society-for-rheumatology-guideline-for-management-of-systemic-2024-2/2026-11-03T23:52:12Z https://currentrheuma.com/studies/the-2024-british-society-for-rheumatology-guideline-for-management-of-systemic-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/the-4th-nextgen-therapies-for-sjia-and-mas-part-1-the-elephant-in-the-room-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/the-4th-nextgen-therapies-for-sjia-and-mas-part-2-phenotypes-of-refractory-sjia-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/the-4th-nextgen-therapies-for-sjia-and-mas-part-3-clinical-trials-in-refractory-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/the-4th-nextgen-therapies-of-sjia-and-mas-part-4-it-is-time-for-il-18-based-2024/2026-11-04T09:29:47Z https://currentrheuma.com/studies/the-abnormal-expression-of-peripheral-blood-cd4-t-lymphocyte-subsets-are-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/the-additional-role-of-anti-nucleosome-antibodies-in-the-prediction-of-renal-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/the-assessment-of-bone-health-in-children-with-juvenile-idiopathic-arthritis-2024/2026-11-04T03:21:42Z https://currentrheuma.com/studies/the-association-between-cam-morphology-and-hip-pain-in-males-and-females-within-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/the-association-between-myasthenia-gravis-and-risk-of-fracture-a-systematic-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/the-association-of-rheumatologist-supply-and-multidisciplinary-care-with-timely-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/the-association-of-stair-climbing-behaviors-with-hazard-of-all-cause-mortality-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/the-association-of-tnf-inhibitor-use-with-incident-cardiovascular-events-in-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/the-burden-and-determinants-of-fatigue-in-incident-and-prevalent-systemic-2024/2026-11-04T03:15:15Z https://currentrheuma.com/studies/the-burden-of-illness-of-the-organ-manifestations-of-systemic-sclerosis-a-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/the-burden-of-spine-structural-damage-on-function-in-patients-with-axial-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/the-causal-relationship-between-immune-cells-and-ankylosing-spondylitis-a-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/the-clinical-characteristics-of-pharyngeal-and-laryngeal-lesions-in-anti-mda5-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/the-clinical-phenotype-of-isolated-ocular-or-oral-dryness-in-sjogrens-disease-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/the-clinical-relevance-of-different-antiphospholipid-antibody-profiles-in-2024/2026-11-04T06:16:46Z https://currentrheuma.com/studies/the-co-occurrence-of-igg4-related-disease-and-malignancy-insights-from-a-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/the-comparison-of-clinical-and-pathological-features-between-patients-of-sapho-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/the-control-group-matters-pain-physical-function-and-strength-improvements-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/the-dermatomyositis-disease-symptom-questionnaire-dm-dsq-a-measure-to-assess-the-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/the-development-and-initial-validation-of-igg4-related-disease-damage-index-a-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/the-development-and-validation-of-a-novel-training-infographic-for-the-physician-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/the-diagnostic-utility-of-intima-media-thickness-measurement-compared-with-the-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/the-diagnostic-value-of-mri-based-vertebral-bone-quality-score-for-osteoporosis-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/the-differential-role-of-ssa-ssb-and-ro52-antibodies-in-defining-clinical-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/the-effect-of-alcohol-consumption-on-clinical-outcomes-and-structural-damage-in-2024/2026-11-04T00:06:14Z https://currentrheuma.com/studies/the-effect-of-biological-treatment-on-female-fertility-a-cohort-study-of-women-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/the-effect-of-denosumab-on-minimum-3-years-bmd-changes-in-patients-with-2024/2026-11-04T00:13:51Z https://currentrheuma.com/studies/the-effect-of-denosumab-on-risk-for-emergently-treated-hypocalcemia-by-stage-of-2024/2026-11-04T00:17:01Z https://currentrheuma.com/studies/the-effect-of-rituximab-on-patient-reported-outcomes-in-the-preclinical-phase-of-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/the-effect-of-romosozumab-on-bone-mineral-density-depending-on-prior-treatment-a-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/the-effectiveness-of-telitacicept-in-patients-with-systemic-lupus-erythematosus-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/the-effects-of-age-and-frailty-on-the-risks-of-end-stage-renal-disease-death-and-2024/2026-11-04T02:58:58Z https://currentrheuma.com/studies/the-efficacy-and-safety-of-a-fixed-dose-combination-of-apocynin-and-paeonol-appa-2024/2026-11-04T06:17:41Z https://currentrheuma.com/studies/the-experience-and-implications-of-pain-in-systemic-lupus-erythematosus-a-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/the-expression-of-siglec-10-on-naive-b-cells-is-involved-in-the-pathology-of-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/the-healing-and-therapeutic-effects-of-perioperative-bisphosphonate-use-in-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/the-hidden-burden-of-fibromyalgia-exploring-work-impairment-and-quality-of-life-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/the-hip-fracture-incidence-in-the-high-risk-area-oslo-continues-to-decline-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/the-hla-region-in-anca-associated-vasculitis-characterisation-of-genetic-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/the-immune-pathology-of-bursitis-in-rheumatic-inflammatory-diseases-degenerative-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/the-impact-of-an-illness-perception-conversation-on-open-label-placebo-response-2024/2026-11-04T03:22:35Z https://currentrheuma.com/studies/the-impact-of-an-online-lifestyle-intervention-programme-on-the-lives-of-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/the-impact-of-cardiovascular-and-cerebrovascular-disease-on-the-risk-of-dementia-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/the-impact-of-community-based-common-non-pharmaceutical-interventions-on-sleep-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/the-impact-of-first-line-tumour-necrosis-factor-inhibitor-treatment-on-anti-2024/2026-11-03T08:01:42Z https://currentrheuma.com/studies/the-impact-of-gastroesophageal-reflux-disease-and-its-treatment-on-interstitial-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/the-impact-of-libman-sacks-endocarditis-on-inpatient-outcomes-with-systemic-2024/2026-11-04T06:14:51Z https://currentrheuma.com/studies/the-impact-of-multimorbidity-on-quality-of-life-in-inflammatory-myopathies-a-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/the-impact-of-pain-on-daily-activities-in-patients-with-idiopathic-inflammatory-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/the-impact-of-periodontitis-and-periodontal-treatment-on-rheumatoid-arthritis-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/the-impact-of-pregnancy-readiness-on-lupus-activity-maternal-mental-health-and-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/the-impact-of-two-different-rituximab-based-strategies-in-cryoglobulinaemic-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/the-implication-of-anti-ro60-with-or-without-anti-ro52-antibody-in-patients-with-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/the-incidence-of-subsequent-contralateral-hip-fracture-and-factors-associated-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/the-influence-of-the-cardiac-cycle-on-the-halo-sign-and-its-impact-on-the-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/the-information-required-by-people-with-inflammatory-arthritis-when-taking-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/the-joint-vasculitis-registry-in-german-speaking-countries-gevas-subgroup-2024/2026-11-04T06:11:16Z https://currentrheuma.com/studies/the-link-between-traumatic-stress-and-autoimmune-rheumatic-diseases-a-systematic-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/the-lipid-paradox-is-also-present-in-early-axial-spondyloarthritis-results-from-2024/2026-11-04T00:05:39Z https://currentrheuma.com/studies/the-mediation-effects-of-malalignment-on-the-relation-of-sex-to-the-risk-of-2024/2026-11-04T06:17:41Z https://currentrheuma.com/studies/the-msquash-is-a-feasible-and-valid-measurement-tool-to-uniformly-assess-daily-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/the-omeract-giant-cell-arteritis-ultrasonography-score-a-potential-predictive-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/the-omeract-whole-body-mri-scoring-system-for-inflammation-in-peripheral-joints-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/the-one-year-infection-risk-among-patients-diagnosed-with-giant-cell-arteritis-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/the-operational-definition-of-old-age-and-impact-on-outcomes-in-dmard-treated-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/the-patients-voice-a-cross-sectional-study-of-physical-health-and-disability-in-2024/2026-11-04T00:12:21Z https://currentrheuma.com/studies/the-place-of-jak-inhibitors-in-systemic-juvenile-idiopathic-arthritis-with-lung-2024/2026-11-03T10:53:39Z https://currentrheuma.com/studies/the-plasma-metabolome-of-juvenile-idiopathic-arthritis-varies-according-to-2024/2026-11-04T00:12:21Z https://currentrheuma.com/studies/the-prevalence-epidemiological-characteristics-and-mortality-trends-of-2024/2026-11-04T03:15:15Z https://currentrheuma.com/studies/the-prevalence-of-sarcopenia-in-spondyloarthritis-patients-a-meta-analysis-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/the-problem-of-pain-in-systemic-lupus-erythematosus-a-comprehensive-analysis-of-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/the-projected-burden-of-arthritis-among-adults-and-children-in-australia-to-the-2024/2026-11-03T23:51:04Z https://currentrheuma.com/studies/the-real-world-use-and-effectiveness-of-avacopan-in-routine-practice-for-the-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/the-relationship-between-the-complement-system-and-subclinical-carotid-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/the-risk-of-fragility-fractures-in-men-with-prostate-cancer-treated-with-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/the-risk-of-lung-cancer-in-rheumatoid-arthritis-and-rheumatoid-arthritis-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/the-role-of-m1-m2-macrophage-polarization-in-primary-sjogrens-syndrome-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/the-role-of-nailfold-video-capillaroscopy-in-the-assessment-of-dermatomyositis-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/the-role-of-the-gastrointestinal-microbiome-on-rheumatoid-arthritis-psoriatic-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/the-role-of-tobacco-smoking-in-antineutrophil-cytoplasmic-antibody-associated-2024/2026-11-04T03:15:15Z https://currentrheuma.com/studies/the-significance-of-intracellular-versus-extracellular-calcium-pyrophosphate-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/the-significance-of-recent-fracture-location-for-imminent-risk-of-hip-and-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/the-sjogrens-working-group-the-2023-omeract-meeting-and-provisional-domain-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/the-state-of-patient-reported-outcome-measures-in-rheumatology-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/the-type-1-2-systemic-lupus-erythematosus-model-perspectives-of-people-living-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/the-use-of-belimumab-on-patients-with-both-systemic-lupus-erythematosus-and-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/the-use-of-intravenous-methylprednisolone-in-giant-cell-arteritis-a-population-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/the-value-of-axillary-facial-occipital-subclavian-and-common-carotid-arteries-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/the-worldwide-prevalence-of-psoriatic-arthritis-a-systematic-review-and-meta-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/the-yield-of-routine-laboratory-examination-in-osteoporosis-evaluation-in-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/therapeutic-drug-monitoring-of-mycophenolic-acid-and-clinical-outcomes-of-lupus-2024/2026-11-04T09:26:49Z https://currentrheuma.com/studies/therapeutic-hydroxychloroquine-blood-levels-are-associated-fewer-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/therapeutic-serum-level-for-adalimumab-in-rheumatoid-arthritis-explorative-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/therapeutic-strategies-and-outcomes-in-neuropsychiatric-systemic-lupus-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/thigh-muscle-composition-changes-in-knee-osteoarthritis-patients-during-weight-2024/2026-11-04T06:17:41Z https://currentrheuma.com/studies/thorough-assessment-of-the-effectiveness-of-belimumab-in-a-large-spanish-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/three-year-follow-up-of-lumbar-spine-and-sacroiliac-magnetic-resonance-imaging-2024/2026-11-04T00:05:39Z https://currentrheuma.com/studies/thresholds-for-unacceptable-work-state-in-radiographic-axial-spondyloarthritis-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/thrombotic-manifestations-in-pediatric-behcet-syndrome-a-multicenter-comparative-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/thymic-stromal-lymphopoietin-in-systemic-sclerosis-interstitial-lung-disease-a-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/thyroid-disease-in-anca-associated-vasculitis-a-clinical-and-epidemiological-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/thyroid-hormone-induces-ossification-and-terminal-maturation-in-a-preserved-oa-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/time-diagnosis-systemic-lupus-erythematosus-associated-factors-its-impact-damage-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/time-to-improvement-of-pain-morning-stiffness-fatigue-and-disease-activity-in-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/timely-escalation-second-line-therapies-after-failure-methotrexate-early-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/tixagevimab-cilgavimab-for-the-prevention-of-covid-19-real-world-experience-in-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/tnf-alpha-blockade-in-primary-chronic-non-bacterial-osteomyelitis-of-the-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/tnfrsf11a-variants-contribute-to-systemic-autoinflammatory-diseases-a-case-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/tocilizumab-discontinuation-after-remission-achievement-in-patients-with-adult-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/tocilizumab-in-cranial-and-extracranial-giant-cell-arteritis-a-national-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/tocilizumab-may-not-be-a-good-option-for-vascular-involvement-due-to-behcets-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/tocilizumab-tcz-for-giant-cell-arteritis-clinical-outcomes-following-relapses-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/tofacitinib-versus-thalidomide-for-mucocutaneous-lesions-of-systemic-lupus-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/toll-like-receptor-8-is-expressed-monocytes-contrast-plasmacytoid-dendritic-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/tomographic-ultrasound-for-three-dimensional-visualization-of-temporal-arteries-2024/2026-11-04T09:23:05Z https://currentrheuma.com/studies/topological-structural-characteristics-in-patients-with-systemic-lupus-2024/2026-11-04T03:18:08Z https://currentrheuma.com/studies/total-body-positron-emission-tomography-a-tool-for-systemic-quantitative-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/total-hip-replacement-or-resistance-training-for-severe-hip-osteoarthritis-2024/2026-11-04T00:14:58Z https://currentrheuma.com/studies/total-knee-arthroplasty-and-periprosthetic-distal-femoral-fracture-looking-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/total-knee-arthroplasty-versus-education-and-exercise-for-knee-osteoarthritis-a-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/towards-a-histological-diagnosis-of-childhood-small-vessel-cns-vasculitis-2024/2026-11-04T00:12:21Z https://currentrheuma.com/studies/towards-an-understanding-of-the-biopsychosocial-determinants-of-cvd-in-sle-a-2024/2026-11-04T03:18:08Z https://currentrheuma.com/studies/towards-lowest-efficacious-dose-results-multicenter-noninferiority-randomized-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/trabecular-bone-mineral-density-as-measured-thoracic-vertebrae-predicts-incident-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/training-increase-minority-enrollment-lupus-clinical-trials-community-engagement-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/trajectories-of-disease-evolution-upon-treatment-initiation-in-systemic-lupus-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/trajectories-of-oral-bisphosphonate-use-after-hip-fractures-a-population-based-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/transcranial-direct-current-stimulation-for-knee-osteoarthritis-a-systematic-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/transcriptional-profiling-of-tofacitinib-treatment-in-juvenile-idiopathic-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/transcutaneous-neurostimulation-parameters-neuropathic-radicular-pain-results-2024/2026-11-04T00:06:14Z https://currentrheuma.com/studies/transforming-growth-factor-beta-is-increased-in-sputum-from-individuals-with-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/transiently-increased-circulating-cd39-foxp3-treg-cells-predicts-the-clinical-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/transitioning-from-pediatric-to-adult-oriented-healthcare-in-rheumatology-the-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/transorbital-ultrasound-in-the-diagnosis-of-giant-cell-arteritis-2024/2026-11-04T02:59:55Z https://currentrheuma.com/studies/treat-to-target-and-shared-decision-making-in-systemic-lupus-erythematosus-from-2024/2026-11-04T03:15:15Z https://currentrheuma.com/studies/treat-to-target-recommendations-in-giant-cell-arteritis-and-polymyalgia-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/treatment-adherence-and-quality-of-life-in-colombian-patients-with-lupus-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/treatment-early-oligoarticular-psoriatic-arthritis-apremilast-primary-outcomes-2024/2026-11-03T23:48:11Z https://currentrheuma.com/studies/treatment-for-osteoporosis-and-risk-of-osteonecrosis-of-the-jaw-among-female-2024/2026-11-04T00:13:51Z https://currentrheuma.com/studies/treatment-modalities-marginal-zone-lymphoma-overall-survival-haematological-2024/2026-11-04T02:58:58Z https://currentrheuma.com/studies/treatment-of-giant-cell-arteritis-with-ultra-short-glucocorticoids-and-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/treatment-of-psoriasis-with-different-classes-of-biologics-reduces-the-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/treatment-outcomes-in-63-cases-of-juvenile-dermatomyositis-associated-calcinosis-2024/2026-11-03T08:01:42Z https://currentrheuma.com/studies/treatment-patterns-effectiveness-tofacitinib-initiating-therapy-rheumatoid-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/treatment-patterns-in-patients-with-systemic-lupus-erythematosus-in-new-zealand-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/treatment-patterns-in-women-with-postmenopausal-osteoporosis-using-abaloparatide-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/treatment-response-in-rheumatoid-arthritis-is-predicted-by-the-microbiome-a-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/treatment-trends-of-systemic-lupus-erythematosus-from-2007-to-2023-in-the-usa-2024/2026-11-04T00:09:46Z https://currentrheuma.com/studies/treatment-with-janus-kinase-inhibitors-in-juvenile-dermatomyositis-a-review-of-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/trends-in-anxiety-and-depression-among-individuals-with-rheumatoid-arthritis-a-2024/2026-11-03T21:13:23Z https://currentrheuma.com/studies/trends-in-avascular-necrosis-and-related-arthroplasties-in-hospitalized-patients-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/trends-in-hip-fracture-rates-in-us-male-veterans-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/trends-in-incidence-of-hip-fracture-and-hip-replacement-in-denmark-1996-to-2018-2024/2026-11-04T06:21:48Z https://currentrheuma.com/studies/trends-new-use-disease-modifying-antirheumatic-drugs-juvenile-idiopathic-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/trim63-and-atrogin-1-are-key-drivers-of-systemic-and-muscle-inflammation-in-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/trimethoprim-sulfamethoxazole-prophylaxis-and-serious-infections-in-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/triple-combination-therapy-did-not-improve-prognosis-in-anti-mda5-positive-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/truth-unveiled-time-marbled-definition-d2t-ra-retrospective-analysis-persistence-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/tumour-necrosis-factor-like-weak-inducer-of-apoptosis-participates-in-the-2024/2026-11-03T21:16:06Z https://currentrheuma.com/studies/twelve-month-resistance-impact-exercise-program-or-risedronate-provides-relative-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/twenty-year-trajectories-of-morbidity-in-individuals-with-and-without-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/two-broad-categories-overlapping-with-rheumatoid-arthritis-observed-in-synovial-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/two-year-clinical-follow-up-enhances-the-diagnosis-of-early-stage-hip-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/two-year-post-distraction-cartilage-related-structural-improvement-is-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/type-2-diabetes-and-fracture-risk-in-older-women-2024/2026-11-04T03:25:32Z https://currentrheuma.com/studies/type-2-diabetes-incidence-in-patients-initiating-denosumab-or-alendronate-2024/2026-11-04T03:23:34Z https://currentrheuma.com/studies/type-i-interferon-biomarker-in-idiopathic-inflammatory-myopathies-associations-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/type-i-interferon-blockade-anifrolumab-systemic-lupus-erythematosus-modulates-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/type-i-interferon-gene-expression-signature-as-a-marker-to-predict-response-to-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/ultra-rare-genetic-variation-in-relapsing-polychondritis-a-whole-exome-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/ultraprocessed-food-intake-and-risk-of-systemic-lupus-erythematosus-among-women-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/ultrasonographic-findings-in-diabetic-cheiroarthropathy-a-pilot-study-2024/2026-11-04T03:14:15Z https://currentrheuma.com/studies/ultrasonographic-scores-and-parotid-histopathology-in-sjogrens-disease-2024/2026-11-04T00:07:26Z https://currentrheuma.com/studies/ultrasonography-for-the-assessment-of-enthesitis-in-psoriatic-arthritis-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/ultrasonography-led-multimodal-diagnostic-pathway-for-giant-cell-arteritis-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/ultrasound-evaluation-contrasts-clinical-disease-activity-evaluation-in-2024/2026-11-04T06:05:46Z https://currentrheuma.com/studies/ultrasound-for-day-to-day-clinical-use-construction-of-a-simple-discriminator-2024/2026-11-03T14:12:39Z https://currentrheuma.com/studies/ultrasound-of-the-forefeet-besides-the-hands-in-patients-at-risk-for-rheumatoid-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/unclosing-premature-mortality-gap-among-patients-with-gout-in-the-us-general-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/understanding-patient-perspectives-health-related-searches-internet-insights-2024/2026-11-04T00:10:50Z https://currentrheuma.com/studies/understanding-psychosocial-determinants-effective-disease-management-rheumatoid-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/understanding-the-employment-landscape-in-people-with-systemic-sclerosis-2024/2026-11-04T06:08:18Z https://currentrheuma.com/studies/understanding-the-role-of-the-complement-system-in-insulin-resistance-and-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/undiagnosed-vertebral-fragility-fractures-distal-radius-fragility-fractures-2024/2026-11-04T06:19:09Z https://currentrheuma.com/studies/unique-characteristics-of-anti-mda-5-associated-dermatomyositis-in-southern-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/unique-transcriptomic-profile-of-peripheral-blood-monocytes-in-rheumatoid-2024/2026-11-03T10:53:39Z https://currentrheuma.com/studies/unmet-need-in-rheumatology-reports-from-the-advances-in-targeted-therapies-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/unmet-needs-in-axial-spondyloarthritis-proceedings-of-the-french-2024/2026-11-04T06:10:35Z https://currentrheuma.com/studies/unmet-needs-in-spondyloarthritis-pathogenesis-clinical-trial-design-and-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/unraveling-the-genetics-of-shared-clinical-and-serological-manifestations-in-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/unraveling-transcriptomic-signatures-and-dysregulated-pathways-in-systemic-lupus-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/unravelling-the-clinical-heterogeneity-of-undefined-recurrent-fever-over-time-in-2024/2026-11-04T06:16:46Z https://currentrheuma.com/studies/untangling-the-relationship-between-smoking-and-systemic-sclerosis-an-analysis-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/unveiling-distinctive-ossification-patterns-diffuse-idiopathic-skeletal-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/unveiling-inflammatory-prehypertrophic-cell-populations-as-key-contributors-knee-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/unveiling-metabolic-similarities-entheses-psoriasis-psoriatic-arthritis-using-2024/2026-11-04T02:57:06Z https://currentrheuma.com/studies/unveiling-the-dynamics-of-b-lymphocytes-in-systemic-lupus-erythematosus-patients-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/upadacitinib-monotherapy-methotrexate-monotherapy-rheumatoid-arthritis-efficacy-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/upadacitinib-rheumatoid-arthritis-inadequate-response-conventional-synthetic-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/upadacitinib-therapy-in-refractory-inflammatory-myositis-a-case-series-of-10-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/update-on-palmar-fasciitis-and-polyarthritis-syndrome-a-systematic-review-2024/2026-11-04T03:14:48Z https://currentrheuma.com/studies/updated-systematic-review-meta-analysis-randomised-controlled-trials-effects-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/upper-respiratory-tract-and-orofacial-manifestations-of-new-onset-giant-cell-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/uptake-and-safety-of-pneumococcal-vaccination-in-adults-with-immune-mediated-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/urate-lowering-therapy-serum-urate-inflammatory-biomarkers-and-renal-function-in-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/urinary-biomarkers-associated-with-pathogenic-pathways-reflecting-histologic-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/urinary-methotrexate-dosage-in-rheumatoid-arthritis-in-patients-treated-for-at-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/urinary-prostanoids-are-elevated-anti-tnf-anti-il6-receptor-disease-modifying-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/usability-preliminary-effectiveness-app-based-physical-activity-education-2024/2026-11-04T06:00:38Z https://currentrheuma.com/studies/use-of-belimumab-in-treating-patients-with-systemic-lupus-erythematosus-a-single-2024/2026-11-04T03:06:36Z https://currentrheuma.com/studies/use-of-biologic-or-targeted-synthetic-disease-modifying-antirheumatic-drugs-and-2024/2026-11-04T00:16:14Z https://currentrheuma.com/studies/use-of-implementation-strategies-to-promote-the-uptake-of-knee-osteoarthritis-2024/2026-11-04T05:58:48Z https://currentrheuma.com/studies/use-of-interleukin-6-receptor-antibodies-in-the-second-and-third-trimester-of-2024/2026-11-04T02:58:58Z https://currentrheuma.com/studies/use-risk-chart-algorithms-identification-psoriatic-arthritis-at-high-risk-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/usefulness-of-18f-fdg-pet-ct-for-assessing-large-vessel-involvement-in-patients-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/using-adaptive-choice-based-conjoint-approach-to-facilitate-shared-decision-2024/2026-11-03T23:56:21Z https://currentrheuma.com/studies/using-combination-albumin-fibrinogen-ratio-prognostic-nutritional-index-model-2024/2026-11-04T09:27:58Z https://currentrheuma.com/studies/using-electronic-health-records-and-linked-claims-data-to-assess-new-medication-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/using-linked-electronic-medical-record-pharmacy-data-to-examine-lupus-medication-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/using-photovoice-to-investigate-patient-experiences-of-lupus-nephritis-in-canada-2024/2026-11-04T00:09:46Z https://currentrheuma.com/studies/using-polygenic-risk-scores-to-aid-diagnosis-of-patients-with-early-inflammatory-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/using-ultrasound-to-improve-diagnostic-confidence-and-management-of-psoriatic-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/utility-of-factor-d-and-other-alternative-complement-factors-as-biomarkers-in-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/utility-of-pan-immune-inflammation-value-as-a-predictor-of-the-prognosis-of-2024/2026-11-04T03:19:09Z https://currentrheuma.com/studies/utility-of-the-2019-eular-acr-sle-classification-criteria-for-predicting-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/utility-testing-third-generation-anticyclic-citrullinated-peptide-anti-ccp3-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/utilization-of-biologic-disease-modifying-antirheumatic-therapy-in-patients-with-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/uveitis-treatment-in-the-childhood-arthritis-and-rheumatology-research-alliance-2024/2026-11-03T17:33:24Z https://currentrheuma.com/studies/vaccination-and-the-risk-of-systemic-lupus-erythematosus-a-meta-analysis-of-2024/2026-11-04T09:12:57Z https://currentrheuma.com/studies/validating-claims-based-algorithms-systemic-lupus-erythematosus-diagnosis-2024/2026-11-04T00:09:46Z https://currentrheuma.com/studies/validation-and-incorporation-of-digital-entheses-into-a-preliminary-global-2024/2026-11-04T02:55:37Z https://currentrheuma.com/studies/validation-of-a-new-glucocorticoid-specific-patient-reported-outcome-2024/2026-11-04T08:59:58Z https://currentrheuma.com/studies/validation-of-a-questionnaire-for-central-nervous-system-aspects-of-joint-pain-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/validation-of-different-dementia-code-based-definitions-in-a-population-based-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/validation-of-hand-oa-us-inflammatory-and-structural-damage-score-house-for-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/validation-of-sparcc-mri-retic-e-tools-for-increasing-scoring-proficiency-of-mri-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/validation-of-the-ankle-specific-pediatric-arthritis-ultrasound-scoring-system-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/validation-of-the-behcets-syndrome-overall-damage-index-bodi-for-retrospective-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/validation-of-the-international-myositis-assessment-and-clinical-studies-group-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/validity-score-interpretation-12-item-psoriatic-arthritis-impact-disease-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/validity-ultrasonographic-joint-specific-scoring-system-juvenile-idiopathic-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/value-musculoskeletal-ultrasound-predicting-gout-flares-index-joints-prospective-2024/2026-11-04T09:19:37Z https://currentrheuma.com/studies/value-of-sle-das-in-assessing-disease-activity-in-patients-with-systemic-lupus-2024/2026-11-04T06:13:45Z https://currentrheuma.com/studies/value-of-the-central-sensitisation-inventory-in-patients-with-axial-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/value-of-ultrasound-assessed-dactylitis-in-the-early-diagnosis-of-psoriatic-2024/2026-11-04T00:02:22Z https://currentrheuma.com/studies/vasculitic-neuropathy-related-disability-pain-quality-of-life-and-autonomic-2024/2026-11-03T23:52:12Z https://currentrheuma.com/studies/vasculitis-associated-with-vexas-syndrome-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/vasodilator-drugs-and-heart-related-outcomes-in-systemic-sclerosis-an-2024/2026-11-03T23:59:50Z https://currentrheuma.com/studies/vertebral-fracture-severity-assessment-on-anteroposterior-radiographs-with-a-new-2024/2026-11-04T09:31:38Z https://currentrheuma.com/studies/very-low-dose-glucocorticoid-therapy-in-rheumatoid-arthritis-impact-of-b-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/vessel-wall-mri-in-giant-cell-arteritis-standardized-protocol-and-scoring-2024/2026-11-03T17:10:42Z https://currentrheuma.com/studies/vexas-defining-uba1-somatic-variants-in-245-368-diverse-individuals-in-the-nih-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/visual-manifestations-in-giant-cell-arteritis-identification-of-risk-factors-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/vitamin-d-and-marine-n-3-fatty-acids-for-autoimmune-disease-prevention-outcomes-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/vitamin-k-antagonists-for-pregnant-women-with-antiphospholipid-antibodies-a-2024/2026-11-04T00:04:04Z https://currentrheuma.com/studies/von-willebrand-factor-a-possible-biomarker-for-disease-activity-in-vasculitis-2024/2026-11-04T09:23:05Z https://currentrheuma.com/studies/vps13c-and-sting-expression-in-neuropsychiatric-systemic-lupus-erythematosus-2024/2026-11-04T03:18:08Z https://currentrheuma.com/studies/weight-bearing-physical-activity-lower-limb-muscle-mass-and-risk-of-knee-2024/2026-11-04T06:21:48Z https://currentrheuma.com/studies/weight-loss-after-receiving-anti-obesity-medications-and-gout-among-individuals-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/weight-loss-for-patients-with-gout-and-concomitant-obesity-a-proof-of-concept-2024/2026-11-04T09:02:12Z https://currentrheuma.com/studies/weight-reduction-and-target-serum-urate-level-a-longitudinal-study-of-annual-2024/2026-11-03T23:49:41Z https://currentrheuma.com/studies/well-being-therapy-in-systemic-sclerosis-outpatients-a-randomized-controlled-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/what-benefit-risk-trade-offs-are-acceptable-to-rheumatoid-arthritis-patients-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/what-came-first-population-based-evaluation-health-care-encounters-depression-2024/2026-11-04T09:09:53Z https://currentrheuma.com/studies/what-role-do-socioeconomic-and-clinical-factors-play-in-disease-activity-states-2024/2026-11-04T03:08:38Z https://currentrheuma.com/studies/when-does-obesity-exert-its-effect-in-conferring-risk-of-developing-ra-a-large-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/when-is-the-right-time-to-change-therapy-an-observational-study-of-the-time-to-2024/2026-11-04T03:18:08Z https://currentrheuma.com/studies/when-should-i-get-my-next-covid-19-vaccine-data-from-the-surveillance-of-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/when-usual-care-is-not-so-usual-protocol-violations-and-generalizability-in-a-2024/2026-11-04T03:05:02Z https://currentrheuma.com/studies/which-advanced-treatment-should-be-used-following-failure-first-line-anti-tnf-2024/2026-11-03T20:56:14Z https://currentrheuma.com/studies/which-educational-topics-and-smartphone-app-functions-are-prioritized-by-us-2024/2026-11-04T03:12:50Z https://currentrheuma.com/studies/whole-phenotype-of-patients-with-systemic-sclerosis-and-sicca-manifestations-2024/2026-11-04T03:10:54Z https://currentrheuma.com/studies/window-of-opportunity-in-psoriatic-arthritis-the-earlier-the-better-2024/2026-11-04T09:15:30Z https://currentrheuma.com/studies/withdrawal-immunosuppressants-low-dose-steroids-stable-igg4-rd-wins-igg4-rd-2024/2026-11-04T05:50:52Z https://currentrheuma.com/studies/work-related-physical-strain-and-development-of-joint-inflammation-in-the-2024/2026-11-04T06:02:29Z https://currentrheuma.com/studies/xgboost-shap-based-interpretable-diagnostic-framework-for-knee-osteoarthritis-a-2024/2026-11-03T23:57:56Z https://currentrheuma.com/studies/zoledronate-sequential-therapy-after-denosumab-discontinuation-to-prevent-bone-2024/2026-11-04T00:16:14Z